[{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":74,"end":92,"probability":0.3442,"type":"Other","normalized_text":"Substances Division"}],"hashtags":[{"start":56,"end":70,"tag":"Certification"}],"urls":{}},"conversation_id":"641233355195973633","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"641186623724593152"}],"lang":"en","text":"RT @edqm_news: The last monthly activity report for the #Certification of Substances Division is now available: August 2015 http://t.co/ceS…","id":"641233355195973633","possibly_sensitive":false,"created_at":"2015-09-08T12:55:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":91,"end":97,"tag":"PhEur"},{"start":98,"end":107,"tag":"european"},{"start":108,"end":122,"tag":"pharmacopoeia"},{"start":123,"end":133,"tag":"monograph"}],"urls":[{"start":68,"end":90,"url":"http://t.co/szyZV7Nz0i","expanded_url":"http://bit.ly/1N5G1tN","display_url":"bit.ly/1N5G1tN"}]},"conversation_id":"641233253295345664","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"641187327289769984"}],"lang":"en","text":"RT @edqm_news: This new supplement will be released in October 2015 http://t.co/szyZV7Nz0i #PhEur #european #pharmacopoeia #monograph","id":"641233253295345664","possibly_sensitive":false,"created_at":"2015-09-08T12:54:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":19,"end":24,"probability":0.927,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":40,"end":44,"tag":"HIV"}],"urls":{}},"conversation_id":"641233047510216705","source":"TweetDeck","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"641191038607036416"}],"lang":"en","text":"RT @ECDC_EU: How's Europe responding to #HIV? New ECDC reports summarise recent progress and identify key areas for action:  http://t.co/oT…","id":"641233047510216705","possibly_sensitive":false,"created_at":"2015-09-08T12:54:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":36,"end":96,"probability":0.5514,"type":"Organization","normalized_text":"Head of Regulatory, Science and Innovation Support Department"}],"hashtags":[{"start":122,"end":134,"tag":"recruitment"}],"urls":[{"start":99,"end":121,"url":"http://t.co/2949i1v7Ri","expanded_url":"http://bit.ly/1IfXj4v","display_url":"bit.ly/1IfXj4v"}]},"conversation_id":"641162889978609664","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"One week left to apply for a job as Head of Regulatory, Science and Innovation Support Department: http://t.co/2949i1v7Ri #recruitment","id":"641162889978609664","possibly_sensitive":false,"created_at":"2015-09-08T08:15:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":38,"end":48,"tag":"guideline"}],"urls":[{"start":109,"end":131,"url":"http://t.co/rYsPf2IR8D","expanded_url":"http://bit.ly/1JAPCCc","display_url":"bit.ly/1JAPCCc"}]},"conversation_id":"640811456162885632","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"One week left to send comments on our #guideline on the processing of renewals in the centralised procedure: http://t.co/rYsPf2IR8D","id":"640811456162885632","possibly_sensitive":false,"created_at":"2015-09-07T08:58:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":21,"end":30,"tag":"workshop"}],"urls":[{"start":110,"end":132,"url":"http://t.co/ugyHebY5Nw","expanded_url":"http://bit.ly/1KvnU0k","display_url":"bit.ly/1KvnU0k"}]},"conversation_id":"639809238710288384","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Register now for our #workshop on demonstrating significant benefit of orphan medicines. Deadline 31 October: http://t.co/ugyHebY5Nw","id":"639809238710288384","possibly_sensitive":false,"created_at":"2015-09-04T14:36:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":17,"end":56,"probability":0.3514,"type":"Organization","normalized_text":"EU Institutional Liaison Support Officer"}],"hashtags":[{"start":127,"end":139,"tag":"recruitment"}],"urls":[{"start":104,"end":126,"url":"http://t.co/Kt7mqNPD6V","expanded_url":"http://bit.ly/1Ogbw1D","display_url":"bit.ly/1Ogbw1D"}]},"conversation_id":"639732277820395520","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We're seeking an EU Institutional Liaison Support Officer, Advisory functions and Corporate Governance: http://t.co/Kt7mqNPD6V #recruitment","id":"639732277820395520","possibly_sensitive":false,"created_at":"2015-09-04T09:30:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"VitalTransform","id":"2154356701"},{"start":21,"end":35,"username":"AdaptSmartIMI","id":"3434258763"},{"start":78,"end":87,"username":"EMA_News","id":"116716199"},{"start":88,"end":94,"username":"EFPIA","id":"52084584"},{"start":95,"end":104,"username":"TIPharma","id":"394674294"},{"start":105,"end":121,"username":"eupatientsforum","id":"545343465"},{"start":122,"end":131,"username":"eurordis","id":"26993786"}],"annotations":{},"hashtags":[{"start":53,"end":59,"tag":"MAPPs"}],"urls":{}},"conversation_id":"639731569016610816","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"639699146082021376"}],"lang":"en","text":"RT @VitalTransform: .@AdaptSmartIMI goes live to put #MAPPs into EU practice! @EMA_News @EFPIA @TIPharma @eupatientsforum @eurordis http://…","id":"639731569016610816","possibly_sensitive":false,"created_at":"2015-09-04T09:27:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":111,"end":123,"tag":"recruitment"},{"start":124,"end":138,"tag":"ITspecialists"}],"urls":[{"start":88,"end":110,"url":"http://t.co/f3IW37EMi9","expanded_url":"http://bit.ly/1EF7IHE","display_url":"bit.ly/1EF7IHE"}]},"conversation_id":"639731014168879104","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Apply now for our position as Business Analyst, Information Technology. Deadline 4 Oct: http://t.co/f3IW37EMi9 #recruitment #ITspecialists","id":"639731014168879104","possibly_sensitive":false,"created_at":"2015-09-04T09:25:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":127,"end":139,"tag":"recruitment"}],"urls":[{"start":104,"end":126,"url":"http://t.co/TwO4smE5na","expanded_url":"http://bit.ly/1JDxFUn","display_url":"bit.ly/1JDxFUn"}]},"conversation_id":"639727961860653056","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We're looking for a Risk Management Specialist, Human Medicines Evaluation Division. Apply by 4 October:http://t.co/TwO4smE5na #recruitment","id":"639727961860653056","possibly_sensitive":false,"created_at":"2015-09-04T09:13:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":128,"end":140,"tag":"recruitment"}],"urls":[{"start":105,"end":127,"url":"http://t.co/e4pERNNJDK","expanded_url":"http://bit.ly/1O1ABzA","display_url":"bit.ly/1O1ABzA"}]},"conversation_id":"639721130828427264","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We're recruiting a quality specialist in our human medicines evaluation division - deadline 4th October: http://t.co/e4pERNNJDK #recruitment","id":"639721130828427264","possibly_sensitive":false,"created_at":"2015-09-04T08:46:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":9,"end":17,"tag":"Liberia"},{"start":76,"end":82,"tag":"Ebola"}],"urls":[{"start":83,"end":105,"url":"http://t.co/5uSSVsTNlx","expanded_url":"http://goo.gl/y5L5D8","display_url":"goo.gl/y5L5D8","unwound_url":"http://goo.gl/y5L5D8"}]},"conversation_id":"639361269179547648","source":"TweetDeck","public_metrics":{"retweet_count":73,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"639348057134469120"}],"lang":"en","text":"RT @WHO: #Liberia now enters a 90-day period of heightened surveillance for #Ebola http://t.co/5uSSVsTNlx","id":"639361269179547648","possibly_sensitive":false,"created_at":"2015-09-03T08:56:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/CxdjuzZiAf","expanded_url":"http://bit.ly/1JuzneC","display_url":"bit.ly/1JuzneC"}]},"conversation_id":"639095575116386304","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Interested in representing civil society in our scientific committees? Applications accepted until 30 September http://t.co/CxdjuzZiAf","id":"639095575116386304","possibly_sensitive":false,"created_at":"2015-09-02T15:20:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":33,"end":40,"tag":"Odomzo"},{"start":42,"end":52,"tag":"sonidegib"},{"start":56,"end":65,"tag":"medicine"},{"start":102,"end":107,"tag":"skin"},{"start":108,"end":115,"tag":"cancer"}],"urls":[{"start":117,"end":139,"url":"http://t.co/IxA5pfE3B9","expanded_url":"http://bit.ly/1LTCXRJ","display_url":"bit.ly/1LTCXRJ"}]},"conversation_id":"639030886596517888","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Assessment report published  for #Odomzo (#sonidegib) a #medicine for basal cell carcinoma, a type of #skin #cancer: http://t.co/IxA5pfE3B9","id":"639030886596517888","possibly_sensitive":false,"created_at":"2015-09-02T11:03:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":19,"end":27,"tag":"Omidria"},{"start":29,"end":43,"tag":"phenylephrine"},{"start":46,"end":56,"tag":"ketorolac"}],"urls":[{"start":96,"end":118,"url":"http://t.co/MQIStYOxga","expanded_url":"http://bit.ly/1XbXFQ2","display_url":"bit.ly/1XbXFQ2"}]},"conversation_id":"638757252359393280","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"EPAR published for #Omidria (#phenylephrine / #ketorolac) used during lens replacement surgery: http://t.co/MQIStYOxga","id":"638757252359393280","possibly_sensitive":false,"created_at":"2015-09-01T16:56:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":51,"tag":"Unituxin"},{"start":53,"end":65,"tag":"dinutuximab"},{"start":76,"end":90,"tag":"neuroblastoma"}],"urls":[{"start":104,"end":126,"url":"http://t.co/boD16y1tzz","expanded_url":"http://bit.ly/1KDP4AG","display_url":"bit.ly/1KDP4AG"}]},"conversation_id":"638756652926242816","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Unituxin (#dinutuximab) to treat #neuroblastoma in children: http://t.co/boD16y1tzz","id":"638756652926242816","possibly_sensitive":false,"created_at":"2015-09-01T16:53:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":73,"end":75,"probability":0.5918,"type":"Organization","normalized_text":"AFP"}],"hashtags":{},"urls":{}},"conversation_id":"638751964742963200","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"638743308366446592"}],"lang":"en","text":"RT @WHO_Europe: WHO recommends all countries strengthen surveillance for AFP cases &amp; maintain high routine immunization coverage http://t.c…","id":"638751964742963200","possibly_sensitive":false,"created_at":"2015-09-01T16:35:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":32,"end":39,"tag":"Kanuma"},{"start":41,"end":52,"tag":"sebelipase"},{"start":61,"end":70,"tag":"medicine"}],"urls":[{"start":117,"end":139,"url":"http://t.co/v776P5ego4","expanded_url":"http://bit.ly/1huZV4e","display_url":"bit.ly/1huZV4e"}]},"conversation_id":"638734309306802176","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Assessment report published for #Kanuma (#sebelipase alfa) a #medicine for # lysosomal acid lipase (LAL) deficiency: http://t.co/v776P5ego4","id":"638734309306802176","possibly_sensitive":false,"created_at":"2015-09-01T15:25:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":35,"end":95,"probability":0.6026,"type":"Organization","normalized_text":"Head of Regulatory, Science and Innovation Support Department"}],"hashtags":[{"start":121,"end":133,"tag":"recruitment"}],"urls":[{"start":98,"end":120,"url":"http://t.co/2949i1v7Ri","expanded_url":"http://bit.ly/1IfXj4v","display_url":"bit.ly/1IfXj4v"}]},"conversation_id":"638713896413564928","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"2 weeks left to apply for a job as Head of Regulatory, Science and Innovation Support Department: http://t.co/2949i1v7Ri #recruitment","id":"638713896413564928","possibly_sensitive":false,"created_at":"2015-09-01T14:03:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"medical"}],"urls":[{"start":78,"end":100,"url":"http://t.co/tmwIMhIStH","expanded_url":"http://bit.ly/1VtuiHl","display_url":"bit.ly/1VtuiHl"}]},"conversation_id":"638712373453451264","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"EMA starts its full #medical literature monitoring service today. Learn more: http://t.co/tmwIMhIStH","id":"638712373453451264","possibly_sensitive":false,"created_at":"2015-09-01T13:57:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":14,"end":19,"probability":0.9879,"type":"Place","normalized_text":"Europe"},{"start":104,"end":107,"probability":0.3528,"type":"Place","normalized_text":"Hajj"}],"hashtags":[{"start":50,"end":55,"tag":"MERS"}],"urls":[{"start":113,"end":135,"url":"http://t.co/KnmaTviFva","expanded_url":"http://bit.ly/1MSUWq2","display_url":"bit.ly/1MSUWq2"}]},"conversation_id":"637284212106756096","source":"TweetDeck","public_metrics":{"retweet_count":66,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"637283756596961280"}],"lang":"en","text":"RT @ECDC_Flu: Europe can expect sporadic imported #MERS cases given numbers travelling to SaudiArabia &amp; Hajj http://t.co/KnmaTviFva http://…","id":"637284212106756096","possibly_sensitive":false,"created_at":"2015-08-28T15:22:50.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":67,"end":72,"probability":0.9773,"type":"Place","normalized_text":"Riyadh"}],"hashtags":[{"start":25,"end":30,"tag":"MERS"}],"urls":[{"start":107,"end":129,"url":"http://t.co/KVeWhpZrTa","expanded_url":"http://bit.ly/1F2WgjC","display_url":"bit.ly/1F2WgjC"}]},"conversation_id":"637283903045242880","source":"TweetDeck","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"637280421659680768"}],"lang":"en","text":"RT @ECDC_Flu: Almost all #MERS cases in August so far have been in Riyadh. ECDC's updated risk assessment: http://t.co/KVeWhpZrTa http://t.…","id":"637283903045242880","possibly_sensitive":false,"created_at":"2015-08-28T15:21:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":39,"end":48,"tag":"Brussels"},{"start":73,"end":76,"tag":"EU"},{"start":77,"end":84,"tag":"Pharma"},{"start":97,"end":108,"tag":"EUPharma50"}],"urls":[{"start":109,"end":131,"url":"http://t.co/5G836iSBre","expanded_url":"http://europa.eu/!nF67dj","display_url":"europa.eu/!nF67dj"}]},"conversation_id":"637258102765699072","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"637248473016991744"}],"lang":"en","text":"RT @EU_Health: Happening in a month in #Brussels: conference on 50 years #EU #Pharma legislation #EUPharma50 http://t.co/5G836iSBre http://…","id":"637258102765699072","possibly_sensitive":false,"created_at":"2015-08-28T13:39:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":39,"end":49,"tag":"guideline"}],"urls":[{"start":110,"end":132,"url":"http://t.co/rYsPf2IR8D","expanded_url":"http://bit.ly/1JAPCCc","display_url":"bit.ly/1JAPCCc"}]},"conversation_id":"637210677132849152","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two weeks left to send comments on our #guideline on the processing of renewals in the centralised procedure: http://t.co/rYsPf2IR8D","id":"637210677132849152","possibly_sensitive":false,"created_at":"2015-08-28T10:30:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":73,"end":89,"username":"Eurosurveillanc","id":"455839750"}],"annotations":[{"start":46,"end":47,"probability":0.4307,"type":"Place","normalized_text":"EU"},{"start":53,"end":58,"probability":0.9105,"type":"Place","normalized_text":"Norway"}],"hashtags":[{"start":21,"end":25,"tag":"OTC"},{"start":26,"end":38,"tag":"antibiotics"},{"start":114,"end":118,"tag":"AMR"}],"urls":[{"start":91,"end":113,"url":"http://t.co/kmwDKEvlfD","expanded_url":"http://bit.ly/1KdlzqS","display_url":"bit.ly/1KdlzqS"}]},"conversation_id":"637198293597057024","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":6,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Analysis of licensed #OTC #antibiotics in the EU and Norway published by @Eurosurveillanc: http://t.co/kmwDKEvlfD #AMR","id":"637198293597057024","possibly_sensitive":false,"created_at":"2015-08-28T09:41:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":86,"end":102,"probability":0.5159,"type":"Organization","normalized_text":"CoE Member States"}],"hashtags":[{"start":15,"end":21,"tag":"blood"}],"urls":[{"start":105,"end":127,"url":"http://t.co/egzRf7RsHt","expanded_url":"http://bit.ly/1Hv349e","display_url":"bit.ly/1Hv349e"}]},"conversation_id":"637193649005199361","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"637183248666378240"}],"lang":"en","text":"RT @edqm_news: #blood Transfusion : Latest report allows comparison of trends amongst CoE Member States  http://t.co/egzRf7RsHt","id":"637193649005199361","possibly_sensitive":false,"created_at":"2015-08-28T09:22:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":{},"urls":[{"start":94,"end":116,"url":"http://t.co/cbJeAvOvd5","expanded_url":"http://bit.ly/1wgrWCr","display_url":"bit.ly/1wgrWCr"}]},"conversation_id":"637193484366139392","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"637168994215198720"}],"lang":"en","text":"RT @edqm_news: New edition of the Technical Guide for the Elaboration of Monographs released: http://t.co/cbJeAvOvd5","id":"637193484366139392","possibly_sensitive":false,"created_at":"2015-08-28T09:22:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"annotations":{},"hashtags":[{"start":12,"end":25,"tag":"animalhealth"},{"start":52,"end":60,"tag":"Estonia"},{"start":67,"end":77,"tag":"Lithuania"},{"start":120,"end":131,"tag":"swinefever"}],"urls":{}},"conversation_id":"636897404030205952","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"636897286346424321"}],"lang":"en","text":"RT @EURLex: #animalhealth: updated list of areas in #Estonia &amp; #Lithuania with control measures relating to African #swinefever - http://t.…","id":"636897404030205952","possibly_sensitive":false,"created_at":"2015-08-27T13:45:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":16,"username":"battlesuperbugs","id":"3288561903"}],"annotations":{},"hashtags":{},"urls":[{"start":75,"end":97,"url":"http://t.co/dSnAY5ZxAO","expanded_url":"http://bit.ly/1Lybd1X","display_url":"bit.ly/1Lybd1X"}]},"conversation_id":"636872173366419456","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"636872173366419456"}],"lang":"en","text":"@battlesuperbugs: Comments on our draft guideline can be sent until 31 Aug http://t.co/dSnAY5ZxAO","id":"636892995183353856","possibly_sensitive":false,"created_at":"2015-08-27T13:28:17.000Z","author_id":"116716199","in_reply_to_user_id":"3288561903","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":21,"end":31,"tag":"Medicines"}],"urls":[{"start":83,"end":105,"url":"http://t.co/6RrXDkSJ3i","expanded_url":"http://bit.ly/1EYMLBO","display_url":"bit.ly/1EYMLBO"}]},"conversation_id":"636863886499651584","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Committee for Orphan #Medicines: agenda for the September meeting is now available http://t.co/6RrXDkSJ3i","id":"636863886499651584","possibly_sensitive":false,"created_at":"2015-08-27T11:32:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":24,"end":34,"tag":"medicines"},{"start":35,"end":42,"tag":"online"},{"start":54,"end":59,"tag":"quiz"},{"start":113,"end":126,"tag":"EUPharmaLogo"}],"urls":[{"start":90,"end":112,"url":"http://t.co/1Gj6u79ngx","expanded_url":"http://bit.ly/1RhKooO","display_url":"bit.ly/1RhKooO"}]},"conversation_id":"636863145852731392","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"636861233199718400"}],"lang":"en","text":"RT @EUlondonrep: Buying #medicines #online? Take this #quiz to find out how to stay safe: http://t.co/1Gj6u79ngx\n#EUPharmaLogo http://t.co/…","id":"636863145852731392","possibly_sensitive":false,"created_at":"2015-08-27T11:29:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":32,"end":38,"tag":"Ebola"}],"urls":[{"start":73,"end":95,"url":"http://t.co/9sXPqiEbJj","expanded_url":"http://goo.gl/fhbBVs","display_url":"goo.gl/fhbBVs"},{"start":96,"end":118,"url":"http://t.co/UDYKO20lID","expanded_url":"https://twitter.com/WHO/status/636578866182684672/photo/1","display_url":"pic.twitter.com/UDYKO20lID"}]},"conversation_id":"636581911264120833","source":"TweetDeck","public_metrics":{"retweet_count":192,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"636578866182684672"}],"lang":"en","text":"RT @WHO: Here is the latest WHO #Ebola situation report (26 August 2015) http://t.co/9sXPqiEbJj http://t.co/UDYKO20lID","id":"636581911264120833","possibly_sensitive":false,"created_at":"2015-08-26T16:52:09.000Z","author_id":"116716199","attachments":{"media_keys":["3_636578864156684288"]}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":26,"end":40,"tag":"ITspecialists"}],"urls":[{"start":41,"end":63,"url":"http://t.co/eRvGnx0kJJ","expanded_url":"http://bit.ly/1zp7JIe","display_url":"bit.ly/1zp7JIe"}]},"conversation_id":"636562919057149952","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We are looking to recruit #ITspecialists http://t.co/eRvGnx0kJJ","id":"636562919057149952","possibly_sensitive":false,"created_at":"2015-08-26T15:36:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":22,"end":33,"tag":"adrenaline"}],"urls":[{"start":63,"end":85,"url":"http://t.co/zLLwDxPCz2","expanded_url":"http://bit.ly/1WSfeVk","display_url":"bit.ly/1WSfeVk"},{"start":87,"end":110,"url":"https://t.co/TWdpookRc6","expanded_url":"https://twitter.com/EMA_News/status/615802756293525504","display_url":"twitter.com/EMA_News/statu…"}]},"conversation_id":"636538119521705984","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"615802756293525504"}],"lang":"en","text":"Assessment report for #adrenaline auto-injectors now available http://t.co/zLLwDxPCz2\n https://t.co/TWdpookRc6","id":"636538119521705984","possibly_sensitive":false,"created_at":"2015-08-26T13:58:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":71,"end":85,"tag":"Pharmacopoeia"}],"urls":{}},"conversation_id":"636529577821634560","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"636528321292038144"}],"lang":"en","text":"RT @edqm_news: Registrations are now open for the 8th Edition European #Pharmacopoeia Training Session (Chemicals) in December 2015 http://…","id":"636529577821634560","possibly_sensitive":false,"created_at":"2015-08-26T13:24:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"EUEnvironment","id":"22362552"}],"annotations":{},"hashtags":[{"start":131,"end":136,"tag":"SOER"}],"urls":[{"start":108,"end":130,"url":"http://t.co/yGqnrPDJhp","expanded_url":"http://goo.gl/4jzs6W","display_url":"goo.gl/4jzs6W"}]},"conversation_id":"636508754675138560","source":"TweetDeck","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"636500929425108992"}],"lang":"en","text":"RT @EUEnvironment: Around 25 % of the burden of disease and deaths is attributable to environmental causes. http://t.co/yGqnrPDJhp #SOER ht…","id":"636508754675138560","possibly_sensitive":false,"created_at":"2015-08-26T12:01:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":28,"end":33,"tag":"SMEs"},{"start":41,"end":56,"tag":"pharmaceutical"},{"start":74,"end":81,"tag":"survey"}],"urls":[{"start":82,"end":104,"url":"http://t.co/PIJYHx0Lrj","expanded_url":"http://svy.mk/1WDXiNY","display_url":"svy.mk/1WDXiNY"}]},"conversation_id":"636474436124807168","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Are we meeting the needs of #SMEs in the #pharmaceutical sector? Take our #survey http://t.co/PIJYHx0Lrj","id":"636474436124807168","possibly_sensitive":false,"created_at":"2015-08-26T09:45:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":16,"end":27,"probability":0.9631,"type":"Person","normalized_text":"Sierra Leone"}],"hashtags":[{"start":91,"end":97,"tag":"Ebola"}],"urls":{}},"conversation_id":"636453186254041088","source":"TweetDeck","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"636450008057909248"}],"lang":"en","text":"RT @WHO_Europe: Sierra Leone has passed a milestone: There are no people being treated for #Ebola &amp; no confirmed cases in the country http:…","id":"636453186254041088","possibly_sensitive":false,"created_at":"2015-08-26T08:20:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/Ggtjp54VoB","expanded_url":"http://bit.ly/1fDwj3a","display_url":"bit.ly/1fDwj3a"}]},"conversation_id":"636156662265565184","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Workshop by our committee for advanced therapies (CAT) and the International Society for Cellular Therapy (ISCT): http://t.co/Ggtjp54VoB","id":"636156662265565184","possibly_sensitive":false,"created_at":"2015-08-25T12:42:22.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":97,"end":109,"tag":"recruitment"}],"urls":[{"start":74,"end":96,"url":"http://t.co/mKhFKF2ZJG","expanded_url":"http://bit.ly/1IbZh16","display_url":"bit.ly/1IbZh16"}]},"conversation_id":"636130078355755008","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We're seeking an Enterprise Architect, Information Technology. Apply now: http://t.co/mKhFKF2ZJG #recruitment","id":"636130078355755008","possibly_sensitive":false,"created_at":"2015-08-25T10:56:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":119,"end":131,"tag":"recruitment"}],"urls":[{"start":96,"end":118,"url":"http://t.co/uGjr8L9Fqo","expanded_url":"http://bit.ly/1Pw9TNR","display_url":"bit.ly/1Pw9TNR"}]},"conversation_id":"636129640457891840","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We're recruiting an Extract, Transform and Load Developer, Information Technology. For details: http://t.co/uGjr8L9Fqo #recruitment","id":"636129640457891840","possibly_sensitive":false,"created_at":"2015-08-25T10:54:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":112,"end":124,"tag":"recruitment"}],"urls":[{"start":89,"end":111,"url":"http://t.co/VK9NWuzicv","expanded_url":"http://bit.ly/1Jj38gQ","display_url":"bit.ly/1Jj38gQ"}]},"conversation_id":"636129098084012032","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Apply now for our position as Solution Architect/Technical Lead, Information Technology: http://t.co/VK9NWuzicv #recruitment","id":"636129098084012032","possibly_sensitive":false,"created_at":"2015-08-25T10:52:50.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":127,"end":139,"tag":"recruitment"}],"urls":[{"start":104,"end":126,"url":"http://t.co/l78NOSSohd","expanded_url":"http://bit.ly/1haYHL8","display_url":"bit.ly/1haYHL8"}]},"conversation_id":"636128602057261056","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We're looking for a Human Resources Management Specialist to join our Learning and Development Service: http://t.co/l78NOSSohd #recruitment","id":"636128602057261056","possibly_sensitive":false,"created_at":"2015-08-25T10:50:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":112,"end":124,"tag":"recruitment"}],"urls":[{"start":89,"end":111,"url":"http://t.co/9k9wqY6CHk","expanded_url":"http://bit.ly/1JwAPNi","display_url":"bit.ly/1JwAPNi"}]},"conversation_id":"636127950245597185","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We’re recruiting a Data Architect, Information Technology. Full details on our website:  http://t.co/9k9wqY6CHk #recruitment","id":"636127950245597185","possibly_sensitive":false,"created_at":"2015-08-25T10:48:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":9,"username":"parkesh_","id":"955002667"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"636077071756881920","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"636077071756881920"}],"lang":"en","text":"@parkesh_ Thank you for your tweet. EMA press office has already been in contact.","id":"636104888829743104","possibly_sensitive":false,"created_at":"2015-08-25T09:16:38.000Z","author_id":"116716199","in_reply_to_user_id":"955002667","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"635825281908015104","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"635800329410453504"}],"lang":"en","text":"RT @EU_ECHA: Do you have information on alternatives to the use of 1,2-dichloroethane (EDC)? Send your comments by 07/10 http://t.co/RD2Jh5…","id":"635825281908015104","possibly_sensitive":false,"created_at":"2015-08-24T14:45:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":28,"end":38,"tag":"guideline"}],"urls":[{"start":95,"end":117,"url":"http://t.co/9mnyufT51u","expanded_url":"http://bit.ly/1LA46sM","display_url":"bit.ly/1LA46sM"}]},"conversation_id":"635754114236944385","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Last week to comment on the #guideline on poorly extractable \nand/or radiolabelled substances: http://t.co/9mnyufT51u","id":"635754114236944385","possibly_sensitive":false,"created_at":"2015-08-24T10:02:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":36,"end":46,"tag":"guideline"},{"start":80,"end":96,"tag":"advancedtherapy"}],"urls":[{"start":98,"end":120,"url":"http://t.co/yivh9Iq1yp","expanded_url":"http://bit.ly/1DZkS1r","display_url":"bit.ly/1DZkS1r"}]},"conversation_id":"635753712921767936","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"1 week left to comment on our draft #guideline on development of gene therapies #advancedtherapy: http://t.co/yivh9Iq1yp","id":"635753712921767936","possibly_sensitive":false,"created_at":"2015-08-24T10:01:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":49,"end":55,"tag":"Salix"},{"start":61,"end":68,"tag":"herbal"}],"urls":[{"start":70,"end":92,"url":"http://t.co/NpuVG616uy","expanded_url":"http://bit.ly/1LLyqgG","display_url":"bit.ly/1LLyqgG"}]},"conversation_id":"635753332854910976","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"8 days to submit data for review of monograph on #Salix bark #herbal: http://t.co/NpuVG616uy","id":"635753332854910976","possibly_sensitive":false,"created_at":"2015-08-24T09:59:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":21,"end":31,"tag":"guideline"},{"start":71,"end":85,"tag":"antimicrobial"}],"urls":[{"start":117,"end":139,"url":"http://t.co/ibJlGmUosK","expanded_url":"http://bit.ly/1JlPQ6n","display_url":"bit.ly/1JlPQ6n"}]},"conversation_id":"635753027329216512","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"1 week to comment on #guideline on assessing risk of resistance due to #antimicrobial use in food-producing animals: http://t.co/ibJlGmUosK","id":"635753027329216512","possibly_sensitive":false,"created_at":"2015-08-24T09:58:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":34,"end":41,"tag":"herbal"},{"start":61,"end":67,"tag":"Piper"}],"urls":[{"start":81,"end":103,"url":"http://t.co/P6iZAlDdHJ","expanded_url":"http://bit.ly/1QcuXrX","display_url":"bit.ly/1QcuXrX"}]},"conversation_id":"635752621098299392","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"One more week to submit data \nfor #herbal assessment work\non #Piper methysticum: http://t.co/P6iZAlDdHJ","id":"635752621098299392","possibly_sensitive":false,"created_at":"2015-08-24T09:56:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":38,"end":48,"tag":"guideline"},{"start":52,"end":59,"tag":"herbal"},{"start":60,"end":70,"tag":"medicines"}],"urls":[{"start":72,"end":94,"url":"http://t.co/oXNqcnVSIp","expanded_url":"http://bit.ly/1AIYvLZ","display_url":"bit.ly/1AIYvLZ"}]},"conversation_id":"635752229463543808","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"8 days left to comment on the quality #guideline on #herbal #medicines: http://t.co/oXNqcnVSIp","id":"635752229463543808","possibly_sensitive":false,"created_at":"2015-08-24T09:55:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":53,"end":60,"tag":"herbal"},{"start":61,"end":71,"tag":"medicines"}],"urls":[{"start":73,"end":95,"url":"http://t.co/pp2AU6Z6Ri","expanded_url":"http://bit.ly/1K4Gytv","display_url":"bit.ly/1K4Gytv"}]},"conversation_id":"635749871400714240","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"One week left to comment on the testing guideline on #herbal #medicines: http://t.co/pp2AU6Z6Ri","id":"635749871400714240","possibly_sensitive":false,"created_at":"2015-08-24T09:45:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":61,"end":83,"url":"http://t.co/7zPeS3E1rJ","expanded_url":"http://bit.ly/1Lv37tA","display_url":"bit.ly/1Lv37tA"}]},"conversation_id":"634988759759589376","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"634988759759589376"}],"lang":"en","text":"@MrsTeepot Please our website here for complete information: http://t.co/7zPeS3E1rJ","id":"635731963333214208","possibly_sensitive":false,"created_at":"2015-08-24T08:34:46.000Z","author_id":"116716199","in_reply_to_user_id":"173111183","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":{},"hashtags":[{"start":60,"end":66,"tag":"polio"}],"urls":{}},"conversation_id":"634736699587862528","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"634733569932460032"}],"lang":"en","text":"RT @WHO_Europe_VPI: IHR Emergency Committee: intl spread of #polio still a global concern, but strong progress being made http://t.co/DCoa6…","id":"634736699587862528","possibly_sensitive":false,"created_at":"2015-08-21T14:39:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":44,"end":57,"tag":"Consultation"}],"urls":[{"start":86,"end":108,"url":"http://t.co/zAZ12Zr5X6","expanded_url":"http://bit.ly/1EH40Yj","display_url":"bit.ly/1EH40Yj"}]},"conversation_id":"634724780491571201","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Updated guidance on good clinical practice. #Consultation open until 3 February 2016: http://t.co/zAZ12Zr5X6","id":"634724780491571201","possibly_sensitive":false,"created_at":"2015-08-21T13:52:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":43,"end":52,"tag":"guidance"},{"start":70,"end":80,"tag":"medicines"},{"start":105,"end":118,"tag":"consultation"}],"urls":[{"start":82,"end":104,"url":"http://t.co/Ocb0ektYyH","expanded_url":"http://bit.ly/1JbsIEU","display_url":"bit.ly/1JbsIEU"}]},"conversation_id":"634723101788504064","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"One more week to send your comments on new #guidance for importers of #medicines: http://t.co/Ocb0ektYyH #consultation","id":"634723101788504064","possibly_sensitive":false,"created_at":"2015-08-21T13:45:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"urls":[{"start":117,"end":139,"url":"http://t.co/zAZ12Zr5X6","expanded_url":"http://bit.ly/1EH40Yj","display_url":"bit.ly/1EH40Yj"}]},"conversation_id":"634660228018143232","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation opens on addendum on the ICH E6 (R2) guideline on good clinical practice. Comments by 3 February 2016: http://t.co/zAZ12Zr5X6","id":"634660228018143232","possibly_sensitive":false,"created_at":"2015-08-21T09:36:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":51,"end":61,"tag":"chemicals"}],"urls":[{"start":71,"end":93,"url":"http://t.co/D6ayrqWLCg","expanded_url":"http://bit.ly/1HZfw1t","display_url":"bit.ly/1HZfw1t"}]},"conversation_id":"634655981293727744","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"634651165997826048"}],"lang":"en","text":"RT @EFSA_EU: How we assess risks posed by multiple #chemicals in food? http://t.co/D6ayrqWLCg","id":"634655981293727744","possibly_sensitive":false,"created_at":"2015-08-21T09:19:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eu2015lv","id":"3217949032"}],"annotations":{},"hashtags":[{"start":94,"end":103,"tag":"eu2015lv"}],"urls":[{"start":111,"end":134,"url":"https://t.co/D2srlEsttf","expanded_url":"https://eu2015.lv/images/news/EU2015LV_results_en.pdf","display_url":"eu2015.lv/images/news/EU…"}]},"conversation_id":"634655398440632320","source":"TweetDeck","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"634640022017343488"}],"lang":"en","text":"RT @eu2015lv: For your summer reading pleasure - print &amp; read the full 116 page report of #eu2015lv here - https://t.co/D2srlEsttf http://t…","id":"634655398440632320","possibly_sensitive":false,"created_at":"2015-08-21T09:16:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":52,"end":61,"tag":"guidance"},{"start":79,"end":89,"tag":"medicines"},{"start":114,"end":127,"tag":"consultation"}],"urls":[{"start":91,"end":113,"url":"http://t.co/Ocb0ektYyH","expanded_url":"http://bit.ly/1JbsIEU","display_url":"bit.ly/1JbsIEU"}]},"conversation_id":"634650005484273668","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"One week to go to comment on a concept paper on new #guidance for importers of #medicines: http://t.co/Ocb0ektYyH #consultation","id":"634650005484273668","possibly_sensitive":false,"created_at":"2015-08-21T08:55:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":87,"end":95,"tag":"BigData"},{"start":96,"end":106,"tag":"Alzheimer"},{"start":107,"end":114,"tag":"cancer"},{"start":115,"end":126,"tag":"toxicology"},{"start":127,"end":139,"tag":"respiratory"}],"urls":[{"start":64,"end":86,"url":"http://t.co/RK3L6gVEUv","expanded_url":"http://bit.ly/futuretopics","display_url":"bit.ly/futuretopics"}]},"conversation_id":"634640242197274624","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"634638353955205120"}],"lang":"en","text":"RT @IMI_JU: Draft texts of future Call topics are now online at http://t.co/RK3L6gVEUv #BigData #Alzheimer #cancer #toxicology #respiratory","id":"634640242197274624","possibly_sensitive":false,"created_at":"2015-08-21T08:16:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":61,"end":67,"tag":"PhEur"},{"start":107,"end":111,"tag":"ISO"}],"urls":{}},"conversation_id":"634382733515603970","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"634377372188450816"}],"lang":"en","text":"RT @edqm_news: At final stage of publishing leaflets for all #PhEur Reference Standards in accordance with #ISO Guide 34 principles http://…","id":"634382733515603970","possibly_sensitive":false,"created_at":"2015-08-20T15:13:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":15,"end":27,"tag":"Pharmeuropa"},{"start":65,"end":79,"tag":"Pharmacopoeia"}],"urls":{}},"conversation_id":"634382682647097344","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"634377308883820544"}],"lang":"en","text":"RT @edqm_news: #Pharmeuropa Issue 27.3 is complete. The European #Pharmacopoeia Commission awaits your comments by 30 September http://t.co…","id":"634382682647097344","possibly_sensitive":false,"created_at":"2015-08-20T15:13:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":6,"end":17,"tag":"paediatric"}],"urls":[{"start":64,"end":86,"url":"http://t.co/yXw1XCZLb3","expanded_url":"http://bit.ly/1J6TFJh","display_url":"bit.ly/1J6TFJh"},{"start":87,"end":109,"url":"http://t.co/yXw1XCZLb3","expanded_url":"http://bit.ly/1J6TFJh","display_url":"bit.ly/1J6TFJh"}]},"conversation_id":"634371917412220929","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"3 new #paediatric investigation plans  agreed by PDCO in August http://t.co/yXw1XCZLb3 http://t.co/yXw1XCZLb3","id":"634371917412220929","possibly_sensitive":false,"created_at":"2015-08-20T14:30:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{},"hashtags":[{"start":93,"end":102,"tag":"EU_REACH"}],"urls":{}},"conversation_id":"634368591417221120","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"634353266978123777"}],"lang":"en","text":"RT @EU_ECHA: Are you aware of new methods that can be used to replace animal testing in many #EU_REACH registrations? Have a look http://t.…","id":"634368591417221120","possibly_sensitive":false,"created_at":"2015-08-20T14:17:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"annotations":{},"hashtags":[{"start":12,"end":23,"tag":"innovation"},{"start":25,"end":31,"tag":"H2020"},{"start":36,"end":40,"tag":"SME"}],"urls":[{"start":116,"end":138,"url":"http://t.co/BgmrPDnx52","expanded_url":"http://ow.ly/R8w76","display_url":"ow.ly/R8w76"}]},"conversation_id":"634320863890939904","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"634319332391165952"}],"lang":"en","text":"RT @EURLex: #innovation: #H2020 new #SME Instrument most popular scheme in 2014 with more than 8,100 applications - http://t.co/BgmrPDnx52","id":"634320863890939904","possibly_sensitive":false,"created_at":"2015-08-20T11:07:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":16,"end":19,"tag":"EU"},{"start":40,"end":55,"tag":"CourtOfJustice"}],"urls":[{"start":109,"end":131,"url":"http://t.co/FDXLMlFY85","expanded_url":"http://bit.ly/1B7ll0t","display_url":"bit.ly/1B7ll0t"}]},"conversation_id":"634298038471786496","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"634259148897669120"}],"lang":"en","text":"RT @eubookshop: #EU What is exactly the #CourtOfJustice? It's explained in this free booklet! download here: http://t.co/FDXLMlFY85 @EUCour…","id":"634298038471786496","possibly_sensitive":false,"created_at":"2015-08-20T09:36:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":13,"end":27,"username":"EU_Commission","id":"157981564"},{"start":104,"end":118,"username":"EU_ScienceHub","id":"2754681001"}],"annotations":{},"hashtags":[{"start":83,"end":86,"tag":"EU"},{"start":97,"end":103,"tag":"H2020"}],"urls":{}},"conversation_id":"634043205953146880","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"634010566068146176"}],"lang":"en","text":"RT @EURLex: .@EU_Commission Annual Report on Research &amp; Tech Activities of the #EU in 2014 - #H2020 @EU_ScienceHub and more - http://t.co/5…","id":"634043205953146880","possibly_sensitive":false,"created_at":"2015-08-19T16:44:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":22,"end":43,"tag":"ChemicalContaminants"},{"start":68,"end":80,"tag":"infographic"}],"urls":[{"start":45,"end":67,"url":"http://t.co/irkPEIA75C","expanded_url":"http://bit.ly/1KvCUp2","display_url":"bit.ly/1KvCUp2"},{"start":81,"end":103,"url":"http://t.co/M41nq0MKZH","expanded_url":"https://twitter.com/EFSA_EU/status/633971692667338752/photo/1","display_url":"pic.twitter.com/M41nq0MKZH"}]},"conversation_id":"634041955626942465","source":"TweetDeck","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633971692667338752"}],"lang":"en","text":"RT @EFSA_EU: What are #ChemicalContaminants? http://t.co/irkPEIA75C #infographic http://t.co/M41nq0MKZH","id":"634041955626942465","possibly_sensitive":false,"created_at":"2015-08-19T16:39:16.000Z","author_id":"116716199","attachments":{"media_keys":["3_633971692562481152"]}},{"entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":112,"end":120,"username":"eu_echo","id":"470099591"}],"annotations":[{"start":23,"end":24,"probability":0.4397,"type":"Organization","normalized_text":"EU"}],"hashtags":[{"start":81,"end":89,"tag":"WHD2015"},{"start":90,"end":111,"tag":"WorldHumanitarianDay"}],"urls":[{"start":56,"end":78,"url":"http://t.co/cQpkHtTe8e","expanded_url":"http://europa.eu/!Wk63pM","display_url":"europa.eu/!Wk63pM"}]},"conversation_id":"633955084771135492","source":"TweetDeck","public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633945670987157505"}],"lang":"en","text":"RT @EU_Commission: The EU supports humanitarian action: http://t.co/cQpkHtTe8e | #WHD2015 #WorldHumanitarianDay @eu_echo","id":"633955084771135492","possibly_sensitive":false,"created_at":"2015-08-19T10:54:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":40,"end":44,"tag":"SME"}],"urls":[{"start":101,"end":123,"url":"http://t.co/iirhmvux5J","expanded_url":"http://bit.ly/1E2MV0f","display_url":"bit.ly/1E2MV0f"}]},"conversation_id":"633925021744922624","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We are looking for your feedback on our #SME initiative. Complete our online survey by 25 September: http://t.co/iirhmvux5J","id":"633925021744922624","possibly_sensitive":false,"created_at":"2015-08-19T08:54:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":91,"end":96,"probability":0.996,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":15,"end":21,"tag":"blood"}],"urls":[{"start":100,"end":122,"url":"http://t.co/egzRf7RsHt","expanded_url":"http://bit.ly/1Hv349e","display_url":"bit.ly/1Hv349e"}]},"conversation_id":"633923056487006208","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633922496723611648"}],"lang":"en","text":"RT @edqm_news: #blood Transfusion : Latest report provides an insight into developments in Europe   http://t.co/egzRf7RsHt","id":"633923056487006208","possibly_sensitive":false,"created_at":"2015-08-19T08:46:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":19,"end":25,"tag":"PhEur"}],"urls":{}},"conversation_id":"633922973410398208","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633922421943324672"}],"lang":"en","text":"RT @edqm_news: The #PhEur Commission published its implementation strategy for the ICH\nQ3D guideline for elemental impurities http://t.co/t…","id":"633922973410398208","possibly_sensitive":false,"created_at":"2015-08-19T08:46:29.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":117,"end":126,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":25,"end":28,"tag":"EU"},{"start":29,"end":42,"tag":"HorizonPrize"},{"start":53,"end":64,"tag":"antibiotic"},{"start":127,"end":131,"tag":"AMR"}],"urls":[{"start":69,"end":91,"url":"http://t.co/SIE4YjFb90","expanded_url":"http://europa.eu/!cU34FC","display_url":"europa.eu/!cU34FC"},{"start":94,"end":116,"url":"http://t.co/CvhqYm0OO2","expanded_url":"http://europa.eu/!nY78JF","display_url":"europa.eu/!nY78JF"}]},"conversation_id":"633680179517366272","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633624269679951872"}],"lang":"en","text":"RT @EU_Health: €1million #EU #HorizonPrize to reduce #antibiotic use http://t.co/SIE4YjFb90 / http://t.co/CvhqYm0OO2 @EU_H2020 #AMR http://…","id":"633680179517366272","possibly_sensitive":false,"created_at":"2015-08-18T16:41:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":40,"end":100,"probability":0.6747,"type":"Organization","normalized_text":"Head of Regulatory, Science and Innovation Support Department"}],"hashtags":[{"start":127,"end":139,"tag":"recruitment"}],"urls":[{"start":103,"end":125,"url":"http://t.co/2949i1v7Ri","expanded_url":"http://bit.ly/1IfXj4v","display_url":"bit.ly/1IfXj4v"}]},"conversation_id":"633630535823306752","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Deadline extended to apply for a job as Head of Regulatory, Science and Innovation Support Department: http://t.co/2949i1v7Ri  #recruitment","id":"633630535823306752","possibly_sensitive":false,"created_at":"2015-08-18T13:24:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"Vaccine"},{"start":79,"end":92,"tag":"immunization"},{"start":127,"end":142,"tag":"immunizeEurope"}],"urls":[{"start":104,"end":126,"url":"http://t.co/de29QuIRqu","expanded_url":"http://www.who.int/immunization/en/","display_url":"who.int/immunization/e…"}]},"conversation_id":"633614098979266560","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633607833444069376"}],"lang":"en","text":"RT @WHO_Europe_VPI: #Vaccine hesitancy is a growing &amp; global challenge for #immunization programmes http://t.co/de29QuIRqu\n#immunizeEurope …","id":"633614098979266560","possibly_sensitive":false,"created_at":"2015-08-18T12:19:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":[{"start":62,"end":73,"tag":"antibiotic"}],"urls":[{"start":86,"end":108,"url":"http://t.co/Len0e5uskX","expanded_url":"http://www.nice.org.uk/guidance/ng15","display_url":"nice.org.uk/guidance/ng15"}]},"conversation_id":"633565902815019008","source":"TweetDeck","public_metrics":{"retweet_count":70,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633530110952534016"}],"lang":"en","text":"RT @NICEcomms: Read our guideline for the best ways to reduce #antibiotic resistance: http://t.co/Len0e5uskX","id":"633565902815019008","possibly_sensitive":false,"created_at":"2015-08-18T09:07:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":79,"end":88,"probability":0.4665,"type":"Place","normalized_text":"CPhI India"}],"hashtags":[{"start":59,"end":64,"tag":"CPhI"}],"urls":[{"start":114,"end":136,"url":"http://t.co/ybxtlmEMm4","expanded_url":"http://bit.ly/1tPVlAV","display_url":"bit.ly/1tPVlAV"}]},"conversation_id":"633562950029180928","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633561046343622656"}],"lang":"en","text":"RT @edqm_news: Did you know the EDQM will be exhibiting at #CPhI Worldwide and CPhI India? More information here: http://t.co/ybxtlmEMm4","id":"633562950029180928","possibly_sensitive":false,"created_at":"2015-08-18T08:55:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":58,"end":61,"tag":"EU"},{"start":62,"end":69,"tag":"public"},{"start":70,"end":77,"tag":"health"},{"start":78,"end":87,"tag":"consumer"},{"start":88,"end":95,"tag":"safety"},{"start":96,"end":108,"tag":"environment"}],"urls":[{"start":109,"end":131,"url":"http://t.co/chwHgh0qh0","expanded_url":"http://europa.eu/!MR67JQ","display_url":"europa.eu/!MR67JQ"}]},"conversation_id":"633316663522394112","source":"TweetDeck","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633290332831092736"}],"lang":"en","text":"RT @EU_Health: Scientist? Join our Scientific Committees! #EU #public #health #consumer #safety #environment http://t.co/chwHgh0qh0 http://…","id":"633316663522394112","possibly_sensitive":false,"created_at":"2015-08-17T16:37:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"annotations":{},"hashtags":[{"start":12,"end":24,"tag":"Horizon2020"},{"start":80,"end":89,"tag":"Research"}],"urls":{}},"conversation_id":"633316211972030464","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633298556305207297"}],"lang":"en","text":"RT @EURLex: #Horizon2020: Proposals and related activities invited for European #Research Council Work Programme 2016 - http://t.co/fHq2Q2z…","id":"633316211972030464","possibly_sensitive":false,"created_at":"2015-08-17T16:35:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":42,"end":53,"tag":"paediatric"}],"urls":[{"start":90,"end":112,"url":"http://t.co/wX5hTS6iEM","expanded_url":"http://bit.ly/1JbWsO9","display_url":"bit.ly/1JbWsO9"}]},"conversation_id":"633278304020205568","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"The #minutes from the July meeting of our #paediatric committee (PDCO) are now available: http://t.co/wX5hTS6iEM","id":"633278304020205568","possibly_sensitive":false,"created_at":"2015-08-17T14:04:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":77,"end":85,"tag":"quality"},{"start":86,"end":96,"tag":"medicines"}],"urls":[{"start":98,"end":120,"url":"http://t.co/qcpxU4t9ft","expanded_url":"http://bit.ly/1gQk3xl","display_url":"bit.ly/1gQk3xl"}]},"conversation_id":"633277148762112000","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We have published the results of the sampling and testing programme for 2013 #quality #medicines: http://t.co/qcpxU4t9ft","id":"633277148762112000","possibly_sensitive":false,"created_at":"2015-08-17T14:00:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":82,"end":88,"tag":"video"}],"urls":[{"start":89,"end":111,"url":"http://t.co/c9TjNrhIgR","expanded_url":"http://bit.ly/1HRtAK8","display_url":"bit.ly/1HRtAK8"}]},"conversation_id":"633261226244599808","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633246920136359936"}],"lang":"en","text":"RT @EFSA_EU: How is antimicrobial resistance related to food safety? Watch EFSA's #video http://t.co/c9TjNrhIgR","id":"633261226244599808","possibly_sensitive":false,"created_at":"2015-08-17T12:56:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":15,"end":21,"tag":"blood"}],"urls":[{"start":112,"end":134,"url":"http://t.co/egzRf7RsHt","expanded_url":"http://bit.ly/1Hv349e","display_url":"bit.ly/1Hv349e"}]},"conversation_id":"633208828092383232","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633195457733337088"}],"lang":"en","text":"RT @edqm_news: #blood Transfusion : New Trend Analysis Report covering a full decade now available to download  http://t.co/egzRf7RsHt","id":"633208828092383232","possibly_sensitive":false,"created_at":"2015-08-17T09:28:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":21,"end":45,"tag":"AntimicrobialResistance"},{"start":70,"end":82,"tag":"infographic"}],"urls":[{"start":47,"end":69,"url":"http://t.co/uR7xbPL15A","expanded_url":"http://bit.ly/1PgWCs8","display_url":"bit.ly/1PgWCs8"},{"start":83,"end":105,"url":"http://t.co/B2HAdIXCjM","expanded_url":"https://twitter.com/EFSA_EU/status/633201625822326784/photo/1","display_url":"pic.twitter.com/B2HAdIXCjM"}]},"conversation_id":"633208723327070208","source":"TweetDeck","public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"633201625822326784"}],"lang":"en","text":"RT @EFSA_EU: What is #AntimicrobialResistance? http://t.co/uR7xbPL15A #infographic http://t.co/B2HAdIXCjM","id":"633208723327070208","possibly_sensitive":false,"created_at":"2015-08-17T09:28:18.000Z","author_id":"116716199","attachments":{"media_keys":["3_633201625721651200"]}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":39,"end":49,"tag":"guideline"},{"start":83,"end":99,"tag":"advancedtherapy"}],"urls":[{"start":101,"end":123,"url":"http://t.co/yivh9Iq1yp","expanded_url":"http://bit.ly/1DZkS1r","display_url":"bit.ly/1DZkS1r"}]},"conversation_id":"633207183086342144","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":6,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two weeks left to comment on our draft #guideline on development of gene therapies #advancedtherapy: http://t.co/yivh9Iq1yp","id":"633207183086342144","possibly_sensitive":false,"created_at":"2015-08-17T09:22:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":50,"end":56,"tag":"Salix"},{"start":62,"end":69,"tag":"herbal"}],"urls":[{"start":71,"end":93,"url":"http://t.co/NpuVG616uy","expanded_url":"http://bit.ly/1LLyqgG","display_url":"bit.ly/1LLyqgG"}]},"conversation_id":"633205745270550528","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"15 days to submit data for review of monograph on #Salix bark #herbal: http://t.co/NpuVG616uy","id":"633205745270550528","possibly_sensitive":false,"created_at":"2015-08-17T09:16:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":22,"end":32,"tag":"guideline"},{"start":72,"end":86,"tag":"antimicrobial"}],"urls":[{"start":118,"end":140,"url":"http://t.co/ibJlGmUosK","expanded_url":"http://bit.ly/1JlPQ6n","display_url":"bit.ly/1JlPQ6n"}]},"conversation_id":"633204552515330048","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"2 weeks to comment on #guideline on assessing risk of resistance due to #antimicrobial use in food-producing animals: http://t.co/ibJlGmUosK","id":"633204552515330048","possibly_sensitive":false,"created_at":"2015-08-17T09:11:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":35,"end":42,"tag":"herbal"},{"start":62,"end":68,"tag":"Piper"}],"urls":[{"start":82,"end":104,"url":"http://t.co/P6iZAlDdHJ","expanded_url":"http://bit.ly/1QcuXrX","display_url":"bit.ly/1QcuXrX"}]},"conversation_id":"633201604729171968","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two weeks left to submit data \nfor #herbal assessment work\non #Piper methysticum: http://t.co/P6iZAlDdHJ","id":"633201604729171968","possibly_sensitive":false,"created_at":"2015-08-17T09:00:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":39,"end":49,"tag":"guideline"},{"start":53,"end":60,"tag":"herbal"},{"start":61,"end":71,"tag":"medicines"}],"urls":[{"start":73,"end":95,"url":"http://t.co/QfQJGPWIUk","expanded_url":"http://bit.ly/1gPvtkU","display_url":"bit.ly/1gPvtkU"}]},"conversation_id":"633200118892773376","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"15 days left to comment on the quality #guideline on #herbal #medicines: http://t.co/QfQJGPWIUk","id":"633200118892773376","possibly_sensitive":false,"created_at":"2015-08-17T08:54:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":54,"end":61,"tag":"herbal"},{"start":62,"end":72,"tag":"medicines"}],"urls":[{"start":74,"end":96,"url":"http://t.co/pp2AU6Z6Ri","expanded_url":"http://bit.ly/1K4Gytv","display_url":"bit.ly/1K4Gytv"}]},"conversation_id":"633199473213243392","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Last two weeks to comment on the testing guideline on #herbal #medicines: http://t.co/pp2AU6Z6Ri","id":"633199473213243392","possibly_sensitive":false,"created_at":"2015-08-17T08:51:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":33,"end":43,"tag":"guideline"}],"urls":[{"start":100,"end":122,"url":"http://t.co/9mnyufT51u","expanded_url":"http://bit.ly/1LA46sM","display_url":"bit.ly/1LA46sM"}]},"conversation_id":"633195995506061312","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Last two weeks to comment on the #guideline on poorly extractable \nand/or radiolabelled substances: http://t.co/9mnyufT51u","id":"633195995506061312","possibly_sensitive":false,"created_at":"2015-08-17T08:37:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":36,"end":39,"tag":"EU"},{"start":71,"end":81,"tag":"additives"},{"start":90,"end":98,"tag":"tobacco"}],"urls":{}},"conversation_id":"633189500508880896","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"632892231930806273"}],"lang":"en","text":"RT @EU_Health: Open consultation on #EU SCENIHR preliminary opinion on #additives used in #tobacco products. Send comments by 15.09 http://…","id":"633189500508880896","possibly_sensitive":false,"created_at":"2015-08-17T08:11:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":104,"end":116,"tag":"infographic"}],"urls":[{"start":81,"end":103,"url":"http://t.co/9NBTcVpgpt","expanded_url":"http://bit.ly/1TBA86E","display_url":"bit.ly/1TBA86E"},{"start":117,"end":139,"url":"http://t.co/u1YxCQ0E56","expanded_url":"https://twitter.com/EFSA_EU/status/632189948456738816/photo/1","display_url":"pic.twitter.com/u1YxCQ0E56"}]},"conversation_id":"632191564828266496","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"632189948456738816"}],"lang":"en","text":"RT @EFSA_EU: What are vector-borne diseases and what does EFSA do in this field? http://t.co/9NBTcVpgpt #infographic http://t.co/u1YxCQ0E56","id":"632191564828266496","possibly_sensitive":false,"created_at":"2015-08-14T14:06:29.000Z","author_id":"116716199","attachments":{"media_keys":["3_632189948322541568"]}},{"entities":{"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"},{"start":120,"end":128,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":13,"end":17,"tag":"DYK"},{"start":89,"end":94,"tag":"EFSA"},{"start":101,"end":119,"tag":"RiskCommunication"}],"urls":{}},"conversation_id":"632177144848846848","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"632161043163279360"}],"lang":"en","text":"RT @Food_EU: #DYK Communicating on risks associated with the food chain is a key part of #EFSA work? #RiskCommunication @EFSA_EU https://t.…","id":"632177144848846848","possibly_sensitive":false,"created_at":"2015-08-14T13:09:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":57,"end":66,"tag":"guidance"},{"start":84,"end":94,"tag":"medicines"},{"start":119,"end":132,"tag":"consultation"}],"urls":[{"start":96,"end":118,"url":"http://t.co/Ocb0ektYyH","expanded_url":"http://bit.ly/1JbsIEU","display_url":"bit.ly/1JbsIEU"}]},"conversation_id":"632176932046680064","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Only two weeks left to comment on a concept paper on new #guidance for importers of #medicines: http://t.co/Ocb0ektYyH #consultation","id":"632176932046680064","possibly_sensitive":false,"created_at":"2015-08-14T13:08:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":47,"end":56,"tag":"guidance"},{"start":108,"end":121,"tag":"consultation"}],"urls":[{"start":85,"end":107,"url":"http://t.co/Ocb0ektYyH","expanded_url":"http://bit.ly/1JbsIEU","display_url":"bit.ly/1JbsIEU"}]},"conversation_id":"632114451517427713","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two weeks to comment on a concept paper on new #guidance for importers of medicines: http://t.co/Ocb0ektYyH #consultation","id":"632114451517427713","possibly_sensitive":false,"created_at":"2015-08-14T09:00:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":82,"end":91,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/qJjfEq6Q2u","expanded_url":"http://europa.eu/!yQ93UB","display_url":"europa.eu/!yQ93UB"}]},"conversation_id":"631829483725717504","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631827804687101952"}],"lang":"en","text":"RT @EU_Health: Call for expression of interest: civil society representatives for @EMA_News Management Board http://t.co/qJjfEq6Q2u. Deadli…","id":"631829483725717504","possibly_sensitive":false,"created_at":"2015-08-13T14:07:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":13,"end":28,"tag":"AnimalDiseases"},{"start":57,"end":69,"tag":"infographic"}],"urls":[{"start":70,"end":92,"url":"http://t.co/yAWngr1svO","expanded_url":"http://bit.ly/1J63uIF","display_url":"bit.ly/1J63uIF"},{"start":93,"end":115,"url":"http://t.co/u2pZ0itLI8","expanded_url":"https://twitter.com/EFSA_EU/status/631827570338754560/photo/1","display_url":"pic.twitter.com/u2pZ0itLI8"}]},"conversation_id":"631829431301111808","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631827570338754560"}],"lang":"en","text":"RT @EFSA_EU: #AnimalDiseases. How do they affect humans. #infographic http://t.co/yAWngr1svO http://t.co/u2pZ0itLI8","id":"631829431301111808","possibly_sensitive":false,"created_at":"2015-08-13T14:07:29.000Z","author_id":"116716199","attachments":{"media_keys":["3_631827569906724864"]}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":33,"end":44,"tag":"foodsafety"}],"urls":[{"start":92,"end":114,"url":"http://t.co/cgUvQ4kQyE","expanded_url":"http://bit.ly/1DMqHiT","display_url":"bit.ly/1DMqHiT"}]},"conversation_id":"631807214857134080","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631797360973250560"}],"lang":"en","text":"RT @EFSA_EU: Want to learn about #foodsafety? Check out EFSA’s Understanding science videos http://t.co/cgUvQ4kQyE","id":"631807214857134080","possibly_sensitive":false,"created_at":"2015-08-13T12:39:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":58,"end":69,"tag":"paediatric"}],"urls":[{"start":88,"end":110,"url":"http://t.co/2Gh09XRud7","expanded_url":"http://bit.ly/1DM1qFv","display_url":"bit.ly/1DM1qFv"}]},"conversation_id":"631749601524097024","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the #agenda of this week's meeting of our #paediatric committee (PDCO): http://t.co/2Gh09XRud7","id":"631749601524097024","possibly_sensitive":false,"created_at":"2015-08-13T08:50:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":32,"end":38,"tag":"Ebola"},{"start":96,"end":110,"tag":"EbolaResponse"}],"urls":[{"start":73,"end":95,"url":"http://t.co/EHuaeXM4yO","expanded_url":"http://goo.gl/42KE2O","display_url":"goo.gl/42KE2O"},{"start":111,"end":133,"url":"http://t.co/LFJjSAgThX","expanded_url":"https://twitter.com/WHO/status/631495235000930304/photo/1","display_url":"pic.twitter.com/LFJjSAgThX"}]},"conversation_id":"631740846631723008","source":"TweetDeck","public_metrics":{"retweet_count":145,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631495235000930304"}],"lang":"en","text":"RT @WHO: Here is the latest WHO #Ebola situation report (12 August 2015) http://t.co/EHuaeXM4yO #EbolaResponse http://t.co/LFJjSAgThX","id":"631740846631723008","possibly_sensitive":false,"created_at":"2015-08-13T08:15:29.000Z","author_id":"116716199","attachments":{"media_keys":["3_631495233352548352"]}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":78,"end":84,"tag":"Ebola"},{"start":110,"end":124,"tag":"EbolaResponse"}],"urls":[{"start":85,"end":108,"url":"https://t.co/ugU8sDis9z","expanded_url":"https://goo.gl/d0PxNL","display_url":"goo.gl/d0PxNL"}]},"conversation_id":"631740276512571392","source":"TweetDeck","public_metrics":{"retweet_count":71,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631544163847282689"}],"lang":"en","text":"RT @WHO: Here is the 2nd situation report by the Interagency Collaboration on #Ebola https://t.co/ugU8sDis9z \n#EbolaResponse http://t.co/5z…","id":"631740276512571392","possibly_sensitive":false,"created_at":"2015-08-13T08:13:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":15,"end":21,"tag":"PhEur"}],"urls":{}},"conversation_id":"631404752803373056","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631403534542630912"}],"lang":"en","text":"RT @edqm_news: #PhEur Commission published its strategy for the Conference on Harmonization’s Q3D guideline for elemental impurities http:/…","id":"631404752803373056","possibly_sensitive":false,"created_at":"2015-08-12T09:59:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"EU_Careers","id":"81119708"}],"annotations":[{"start":35,"end":39,"probability":0.8082,"type":"Place","normalized_text":"Czech"},{"start":42,"end":49,"probability":0.3641,"type":"Place","normalized_text":"Croatian"}],"hashtags":[{"start":84,"end":97,"tag":"interpreters"}],"urls":{}},"conversation_id":"631403463746977792","source":"TweetDeck","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631395075650666497"}],"lang":"en","text":"RT @EU_Careers: We are looking for Czech, Croatian, Lithuanian and Maltese-speaking #interpreters. Apply by 18 Aug at http://t.co/jynYBodJK…","id":"631403463746977792","possibly_sensitive":false,"created_at":"2015-08-12T09:54:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"EU_ScienceHub","id":"2754681001"}],"annotations":{},"hashtags":[{"start":121,"end":132,"tag":"EUsci4PARL"}],"urls":[{"start":98,"end":120,"url":"http://t.co/m1pjMcmbu9","expanded_url":"http://europa.eu/!Kc93JD","display_url":"europa.eu/!Kc93JD"}]},"conversation_id":"631392816338341889","source":"TweetDeck","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631377427051216896"}],"lang":"en","text":"RT @EU_ScienceHub: How to improve existing communication between EU policymakers &amp; scientists?http://t.co/m1pjMcmbu9 #EUsci4PARL http://t.c…","id":"631392816338341889","possibly_sensitive":false,"created_at":"2015-08-12T09:12:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"},{"start":94,"end":104,"username":"HBSCStudy","id":"347761231"}],"annotations":[{"start":40,"end":45,"probability":0.9938,"type":"Place","normalized_text":"Europe"},{"start":51,"end":57,"probability":0.7793,"type":"Place","normalized_text":"America"}],"hashtags":[{"start":128,"end":137,"tag":"YouthDay"}],"urls":[{"start":105,"end":127,"url":"http://t.co/Os5ioWeQrM","expanded_url":"http://bit.ly/1EmAh6K","display_url":"bit.ly/1EmAh6K"}]},"conversation_id":"631392530693644288","source":"TweetDeck","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631384425083858944"}],"lang":"en","text":"RT @WHO_Europe: 18% of 15yr-olds across Europe &amp; N America rate their health as fair/poor @HBSCStudy http://t.co/Os5ioWeQrM #YouthDay http:…","id":"631392530693644288","possibly_sensitive":false,"created_at":"2015-08-12T09:11:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":71,"end":93,"url":"http://t.co/jZrYeQiKBY","expanded_url":"http://bit.ly/1J9AQZ7","display_url":"bit.ly/1J9AQZ7"}]},"conversation_id":"631390491708264448","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"EU Telematics Strategy and Implementation Roadmap 2015-2017 published: http://t.co/jZrYeQiKBY","id":"631390491708264448","possibly_sensitive":false,"created_at":"2015-08-12T09:03:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"annotations":{},"hashtags":[{"start":12,"end":22,"tag":"eurlextip"}],"urls":[{"start":107,"end":129,"url":"http://t.co/Dsfd6A4q6h","expanded_url":"http://ow.ly/PD6fk","display_url":"ow.ly/PD6fk"}]},"conversation_id":"631130055876460544","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631101883424329728"}],"lang":"en","text":"RT @EURLex: #eurlextip: National Implementing Measures now displayed in a separate tab for EU Directives - http://t.co/Dsfd6A4q6h http://t.…","id":"631130055876460544","possibly_sensitive":false,"created_at":"2015-08-11T15:48:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":22,"end":53,"probability":0.5887,"type":"Organization","normalized_text":"International Health Regulations"}],"hashtags":[{"start":90,"end":94,"tag":"IHR"}],"urls":[{"start":67,"end":89,"url":"http://t.co/re5bah2YRk","expanded_url":"http://goo.gl/LoewCG","display_url":"goo.gl/LoewCG"}]},"conversation_id":"631129748324896768","source":"TweetDeck","public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631119010520809472"}],"lang":"en","text":"RT @WHO: What are the International Health Regulations? Learn more http://t.co/re5bah2YRk #IHR","id":"631129748324896768","possibly_sensitive":false,"created_at":"2015-08-11T15:47:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":62,"end":67,"probability":0.9929,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":37,"end":46,"tag":"medicine"},{"start":47,"end":58,"tag":"regulation"}],"urls":[{"start":85,"end":107,"url":"http://t.co/jZrYeQAm0y","expanded_url":"http://bit.ly/1J9AQZ7","display_url":"bit.ly/1J9AQZ7"}]},"conversation_id":"631092964299771904","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"New road map to make IT services for #medicine #regulation in Europe more efficient: http://t.co/jZrYeQAm0y","id":"631092964299771904","possibly_sensitive":false,"created_at":"2015-08-11T13:21:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":23,"end":24,"probability":0.5813,"type":"Organization","normalized_text":"EU"}],"hashtags":[{"start":48,"end":61,"tag":"alternatives"},{"start":108,"end":118,"tag":"chemicals"}],"urls":{}},"conversation_id":"631062011510685696","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631059925884633088"}],"lang":"en","text":"RT @EU_ECHA: Check out EU resources for finding #alternatives to animal testing in the safety assessment of #chemicals. http://t.co/Y9PgIlg…","id":"631062011510685696","possibly_sensitive":false,"created_at":"2015-08-11T11:18:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":25,"end":35,"tag":"guideline"}],"urls":[{"start":112,"end":134,"url":"http://t.co/zGbrzdLOXp","expanded_url":"http://bit.ly/1N04HUo","display_url":"bit.ly/1N04HUo"}]},"conversation_id":"631026777410957312","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on revised #guideline on requirements for transmission of information on non-interventional PASS: http://t.co/zGbrzdLOXp","id":"631026777410957312","possibly_sensitive":false,"created_at":"2015-08-11T08:58:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":25,"end":35,"tag":"guideline"}],"urls":[{"start":109,"end":131,"url":"http://t.co/mrAt74VrrU","expanded_url":"http://bit.ly/1UAdAWh","display_url":"bit.ly/1UAdAWh"}]},"conversation_id":"631025756571877377","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on revised #guideline on good pharmacovigilance practices - post-authorisation safety studies: http://t.co/mrAt74VrrU","id":"631025756571877377","possibly_sensitive":false,"created_at":"2015-08-11T08:53:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":49,"end":62,"tag":"EUPharmaLogo"}],"urls":[{"start":112,"end":134,"url":"http://t.co/PbuUWIK0XS","expanded_url":"http://europa.eu/!Ru39xb","display_url":"europa.eu/!Ru39xb"}]},"conversation_id":"631020473795616768","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"631012191911682048"}],"lang":"en","text":"RT @EUlondonrep: Wrong click could be fatal: new #EUPharmaLogo to reassure the medicine you buy online is real: http://t.co/PbuUWIK0XS http…","id":"631020473795616768","possibly_sensitive":false,"created_at":"2015-08-11T08:32:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":41,"end":44,"tag":"EU"},{"start":45,"end":52,"tag":"Pharma"},{"start":65,"end":76,"tag":"EUPharma50"},{"start":103,"end":112,"tag":"Brussels"}],"urls":[{"start":77,"end":99,"url":"http://t.co/5G836iSBre","expanded_url":"http://europa.eu/!nF67dj","display_url":"europa.eu/!nF67dj"}]},"conversation_id":"630774659861057536","source":"TweetDeck","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"630772467787780096"}],"lang":"en","text":"RT @EU_Health: Conference on 50 Years of #EU #Pharma legislation #EUPharma50 http://t.co/5G836iSBre in #Brussels, 28.09 http://t.co/MzPH8YW…","id":"630774659861057536","possibly_sensitive":false,"created_at":"2015-08-10T16:16:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"}],"annotations":{},"hashtags":[{"start":44,"end":49,"tag":"Feed"},{"start":50,"end":60,"tag":"Additives"},{"start":84,"end":92,"tag":"animals"},{"start":93,"end":103,"tag":"nutrition"},{"start":104,"end":115,"tag":"foodsafety"},{"start":116,"end":119,"tag":"EU"}],"urls":[{"start":61,"end":83,"url":"http://t.co/zdV56NtIKv","expanded_url":"http://europa.eu/!Bv48CC","display_url":"europa.eu/!Bv48CC"}]},"conversation_id":"630771104408305665","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"630761732751925248"}],"lang":"en","text":"RT @Food_EU: The European Union Register of #Feed #Additives http://t.co/zdV56NtIKv #animals #nutrition #foodsafety #EU http://t.co/KXlsNRz…","id":"630771104408305665","possibly_sensitive":false,"created_at":"2015-08-10T16:02:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"630746695362605056","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"630739433424310272"}],"lang":"en","text":"RT @edqm_news: NHSs should recognise the importance of prescribing physical activity for transplanted patients, says Position Paper http://…","id":"630746695362605056","possibly_sensitive":false,"created_at":"2015-08-10T14:25:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":61,"end":67,"tag":"PhEur"},{"start":107,"end":111,"tag":"ISO"}],"urls":{}},"conversation_id":"630746540890583040","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"630739333675393024"}],"lang":"en","text":"RT @edqm_news: At final stage of publishing leaflets for all #PhEur Reference Standards in accordance with #ISO Guide 34 principles http://…","id":"630746540890583040","possibly_sensitive":false,"created_at":"2015-08-10T14:24:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"},{"start":37,"end":51,"username":"Helmholtz_HZI","id":"246235344"}],"annotations":{},"hashtags":[{"start":58,"end":68,"tag":"hepatitis"},{"start":122,"end":137,"tag":"immunizeEurope"}],"urls":[{"start":99,"end":121,"url":"http://t.co/oYH5Uj8xlu","expanded_url":"http://bit.ly/1MfIYX6","display_url":"bit.ly/1MfIYX6"}]},"conversation_id":"630746064933531648","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"630732924497850368"}],"lang":"en","text":"RT @WHO_Europe_VPI: Recent review of @Helmholtz_HZI shows #hepatitis B prevalence in 161 countries http://t.co/oYH5Uj8xlu\n#immunizeEurope","id":"630746064933531648","possibly_sensitive":false,"created_at":"2015-08-10T14:22:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":49,"tag":"Evotaz"},{"start":51,"end":62,"tag":"atazanavir"},{"start":65,"end":76,"tag":"cobicistat"},{"start":81,"end":85,"tag":"HIV"},{"start":86,"end":95,"tag":"medicine"}],"urls":[{"start":97,"end":119,"url":"http://t.co/IlNEnw82vj","expanded_url":"http://bit.ly/1Tf8UHT","display_url":"bit.ly/1Tf8UHT"}]},"conversation_id":"630744832902868992","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Evotaz (#atazanavir / #cobicistat) an #HIV #medicine: http://t.co/IlNEnw82vj","id":"630744832902868992","possibly_sensitive":false,"created_at":"2015-08-10T14:17:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":[{"start":15,"end":35,"probability":0.6183,"type":"Organization","normalized_text":"British Pharmacopoeia"}],"hashtags":{},"urls":[{"start":83,"end":105,"url":"http://t.co/0wUIyRKxtY","expanded_url":"http://ow.ly/QHiVv","display_url":"ow.ly/QHiVv"}]},"conversation_id":"630698437902778368","source":"TweetDeck","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"630678412936544256"}],"lang":"en","text":"RT @MHRApress: British Pharmacopoeia launches new integrated user-friendly website http://t.co/0wUIyRKxtY","id":"630698437902778368","possibly_sensitive":false,"created_at":"2015-08-10T11:13:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{},"hashtags":[{"start":100,"end":104,"tag":"EDC"}],"urls":[{"start":105,"end":127,"url":"http://t.co/VFNbI771V9","expanded_url":"http://bit.ly/1DakwVg","display_url":"bit.ly/1DakwVg"}]},"conversation_id":"630698210043019264","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"630694340126461953"}],"lang":"en","text":"RT @EU_ECHA: Do you know what endocrine disruptors are and how they affect you and the environment? #EDC http://t.co/VFNbI771V9 http://t.co…","id":"630698210043019264","possibly_sensitive":false,"created_at":"2015-08-10T11:12:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"WEBRADR","id":"2797520425"},{"start":13,"end":21,"username":"WEBRADR","id":"2797520425"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"629686619851853824","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629669257069101057"}],"lang":"en","text":"RT @WEBRADR: @WEBRADR Yellow Card App is a working prototype, help us improve. Send your feedback to web-radr@mhra.gsi.gov.uk","id":"629686619851853824","possibly_sensitive":false,"created_at":"2015-08-07T16:12:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":10,"username":"eliadosom","id":"77272175"}],"annotations":{},"hashtags":[{"start":70,"end":88,"tag":"pharmacovigilance"}],"urls":{}},"conversation_id":"629645855881068544","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"629647413633019904"}],"lang":"en","text":"@eliadosom there is no PRAC in August; next meeting is 7-10 September #pharmacovigilance","id":"629654626036531200","possibly_sensitive":false,"created_at":"2015-08-07T14:05:35.000Z","author_id":"116716199","in_reply_to_user_id":"77272175","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":91,"end":100,"tag":"medicine"},{"start":101,"end":119,"tag":"pharmacovigilance"}],"urls":[{"start":68,"end":90,"url":"http://t.co/GVHtSGbf0y","expanded_url":"http://bit.ly/1gijaNU","display_url":"bit.ly/1gijaNU"}]},"conversation_id":"629645855881068544","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We have just published PRAC's July 2015 recommendations on signals: http://t.co/GVHtSGbf0y #medicine #pharmacovigilance","id":"629645855881068544","possibly_sensitive":false,"created_at":"2015-08-07T13:30:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":80,"end":89,"username":"EMA_News","id":"116716199"},{"start":90,"end":97,"username":"US_FDA","id":"208120290"},{"start":98,"end":106,"username":"EU_ECHA","id":"331604970"}],"annotations":[{"start":73,"end":77,"probability":0.9413,"type":"Place","normalized_text":"Parma"}],"hashtags":[{"start":107,"end":121,"tag":"Nanomaterials"}],"urls":{}},"conversation_id":"629639796034551808","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629623043476848640"}],"lang":"en","text":"RT @EFSA_EU: EFSA to host international meeting on regulatory science in Parma. @EMA_News @US_FDA @EU_ECHA #Nanomaterials http://t.co/0sBEb…","id":"629639796034551808","possibly_sensitive":false,"created_at":"2015-08-07T13:06:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"629608510809079808","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629590991884931073"}],"lang":"en","text":"RT @ICH_news: ICH M4E(R2) draft revised Guideline reaches Step 2b of the ICH Process and enters the consultation period. See http://t.co/Do…","id":"629608510809079808","possibly_sensitive":false,"created_at":"2015-08-07T11:02:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":15,"end":20,"tag":"EDQM"},{"start":48,"end":55,"tag":"Plasma"}],"urls":[{"start":81,"end":103,"url":"http://t.co/bfYYDFuzMu","expanded_url":"http://bit.ly/1KI2NT0","display_url":"bit.ly/1KI2NT0"}]},"conversation_id":"629608181489135616","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629596094499037184"}],"lang":"en","text":"RT @edqm_news: #EDQM organising a Symposium on  #Plasma for Direct Clinical Use  http://t.co/bfYYDFuzMu","id":"629608181489135616","possibly_sensitive":false,"created_at":"2015-08-07T11:01:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":21,"end":32,"tag":"veterinary"},{"start":101,"end":111,"tag":"guideline"}],"urls":[{"start":113,"end":135,"url":"http://t.co/3VHuLRQwL7","expanded_url":"http://bit.ly/1BEOCIR","display_url":"bit.ly/1BEOCIR"}]},"conversation_id":"629586879634120704","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Evaluating safety of #veterinary medicines residues in human food - one more week to comment on VICH #guideline: http://t.co/3VHuLRQwL7","id":"629586879634120704","possibly_sensitive":false,"created_at":"2015-08-07T09:36:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":35,"end":47,"tag":"recruitment"}],"urls":[{"start":72,"end":94,"url":"http://t.co/l8xqrmKi8y","expanded_url":"http://bit.ly/1M0QYg8","display_url":"bit.ly/1M0QYg8"}]},"conversation_id":"629585472474456064","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Senior scientific administrator -  #recruitment open for one more week: http://t.co/l8xqrmKi8y","id":"629585472474456064","possibly_sensitive":false,"created_at":"2015-08-07T09:30:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":81,"end":93,"tag":"recruitment"}],"urls":[{"start":58,"end":80,"url":"http://t.co/LZaWD78gqZ","expanded_url":"http://bit.ly/1eFg9Gi","display_url":"bit.ly/1eFg9Gi"}]},"conversation_id":"629584700911296512","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"One week to go to apply for a job  as Scientific Officer: http://t.co/LZaWD78gqZ #recruitment","id":"629584700911296512","possibly_sensitive":false,"created_at":"2015-08-07T09:27:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{},"urls":[{"start":97,"end":119,"url":"http://t.co/IrtySoCOmD","expanded_url":"http://www.emcdda.europa.eu/topics/pods/psychosocial-interventions","display_url":"emcdda.europa.eu/topics/pods/ps…"}]},"conversation_id":"629583125715243008","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629563058034212865"}],"lang":"en","text":"RT @EMCDDA: European Drug Report 2015: The role of psychosocial interventions in drug treatment: http://t.co/IrtySoCOmD http://t.co/1B85cxH…","id":"629583125715243008","possibly_sensitive":false,"created_at":"2015-08-07T09:21:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{},"urls":[{"start":88,"end":110,"url":"http://t.co/czcLqhD6Cm","expanded_url":"http://www.emcdda.europa.eu/topics/pods/drug-consumption-rooms","display_url":"emcdda.europa.eu/topics/pods/dr…"},{"start":111,"end":133,"url":"http://t.co/XpxBf2Bet9","expanded_url":"https://twitter.com/EMCDDA/status/629565302582456320/photo/1","display_url":"pic.twitter.com/XpxBf2Bet9"}]},"conversation_id":"629582578970980352","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629565302582456320"}],"lang":"en","text":"RT @EMCDDA: European Drug Report 2015: Drug consumption rooms — provision and evidence: http://t.co/czcLqhD6Cm http://t.co/XpxBf2Bet9","id":"629582578970980352","possibly_sensitive":false,"created_at":"2015-08-07T09:19:18.000Z","author_id":"116716199","attachments":{"media_keys":["3_629565299545780224"]}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{},"hashtags":[{"start":39,"end":49,"tag":"chemicals"}],"urls":{}},"conversation_id":"629582541738127360","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629565760524939264"}],"lang":"en","text":"RT @EU_ECHA: New strategy to track how #chemicals behave in the human body from @EURL_ECVAM http://t.co/ot2Xr8Uynk #toxicity","id":"629582541738127360","possibly_sensitive":false,"created_at":"2015-08-07T09:19:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":70,"end":73,"probability":0.9201,"type":"Place","normalized_text":"Asia"},{"start":78,"end":83,"probability":0.9818,"type":"Place","normalized_text":"Europe"}],"hashtags":{},"urls":[{"start":85,"end":107,"url":"http://t.co/3dlEUQwCKU","expanded_url":"http://www.emcdda.europa.eu/topics/pods/opioid-trafficking-routes","display_url":"emcdda.europa.eu/topics/pods/op…"},{"start":108,"end":130,"url":"http://t.co/YRIfVXClvu","expanded_url":"https://twitter.com/EMCDDA/status/629566498995048448/photo/1","display_url":"pic.twitter.com/YRIfVXClvu"}]},"conversation_id":"629582513694986241","source":"TweetDeck","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629566498995048448"}],"lang":"en","text":"RT @EMCDDA: European Drug Report 2015: Opioid trafficking routes from Asia to Europe http://t.co/3dlEUQwCKU http://t.co/YRIfVXClvu","id":"629582513694986241","possibly_sensitive":false,"created_at":"2015-08-07T09:19:02.000Z","author_id":"116716199","attachments":{"media_keys":["3_629566496004444160"]}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":71,"end":89,"tag":"decriminalisation"}],"urls":[{"start":100,"end":122,"url":"http://t.co/G4UPCqhrt2","expanded_url":"http://www.emcdda.europa.eu/topics/pods/legal-supply-of-cannabis#panel2","display_url":"emcdda.europa.eu/topics/pods/le…"}]},"conversation_id":"629582292235722752","source":"TweetDeck","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629569039803752448"}],"lang":"en","text":"RT @EMCDDA: EMCDDA: European Drug Report 2015: a short fun video about #decriminalisation of drugs: http://t.co/G4UPCqhrt2 http://t.co/CwCN…","id":"629582292235722752","possibly_sensitive":false,"created_at":"2015-08-07T09:18:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{},"urls":[{"start":62,"end":84,"url":"http://t.co/6PKZo8nmBF","expanded_url":"http://www.emcdda.europa.eu/video/2015/european-drug-report-2015-get-the-facts","display_url":"emcdda.europa.eu/video/2015/eur…"},{"start":85,"end":107,"url":"http://t.co/y3esHuKH2a","expanded_url":"https://twitter.com/EMCDDA/status/606434786039762944/photo/1","display_url":"pic.twitter.com/y3esHuKH2a"}]},"conversation_id":"629582252784111617","source":"TweetDeck","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629570147938869249"}],"lang":"en","text":"RT @EMCDDA: European Drug Report 2015: Video — Get the facts: http://t.co/6PKZo8nmBF http://t.co/y3esHuKH2a","id":"629582252784111617","possibly_sensitive":false,"created_at":"2015-08-07T09:18:00.000Z","author_id":"116716199","attachments":{"media_keys":["3_606434784903069696"]}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":{},"urls":[{"start":88,"end":110,"url":"http://t.co/EinIde2m4x","expanded_url":"http://www.emcdda.europa.eu/edr2015","display_url":"emcdda.europa.eu/edr2015"},{"start":111,"end":133,"url":"http://t.co/3fzJnYKKd6","expanded_url":"https://twitter.com/EMCDDA/status/606426949020483584/photo/1","display_url":"pic.twitter.com/3fzJnYKKd6"}]},"conversation_id":"629582010042974208","source":"TweetDeck","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629570728317296640"}],"lang":"en","text":"RT @EMCDDA: European Drug Report 2015 Trends and Developments: EU drug use at a glance: http://t.co/EinIde2m4x http://t.co/3fzJnYKKd6","id":"629582010042974208","possibly_sensitive":false,"created_at":"2015-08-07T09:17:02.000Z","author_id":"116716199","attachments":{"media_keys":["3_606426948106092544"]}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":15,"end":20,"tag":"EDQM"},{"start":74,"end":80,"tag":"blood"},{"start":87,"end":93,"tag":"blood"}],"urls":[{"start":123,"end":146,"url":"https://t.co/RVphGBM0Tt","expanded_url":"https://www.edqm.eu/en/blood-transfusion-reports-70.html","display_url":"edqm.eu/en/blood-trans…"}]},"conversation_id":"629580700392521728","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629575057988284416"}],"lang":"en","text":"RT @edqm_news: #EDQM publishes Trends &amp; Observations Report on use of #blood &amp; #blood components from 2001 to 2011 https://t.co/RVphGBM0Tt","id":"629580700392521728","possibly_sensitive":false,"created_at":"2015-08-07T09:11:50.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":13,"end":32,"tag":"PublicConsultation"},{"start":57,"end":71,"tag":"Picoxystrobin"}],"urls":[{"start":73,"end":95,"url":"http://t.co/8cDcTrrIX1","expanded_url":"http://bit.ly/1K5aiD1","display_url":"bit.ly/1K5aiD1"}]},"conversation_id":"629314216340680704","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629290851412389888"}],"lang":"en","text":"RT @EFSA_EU: #PublicConsultation on the active substance #Picoxystrobin. http://t.co/8cDcTrrIX1","id":"629314216340680704","possibly_sensitive":false,"created_at":"2015-08-06T15:32:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{},"hashtags":[{"start":28,"end":48,"tag":"PublicConsultations"},{"start":100,"end":110,"tag":"chemicals"}],"urls":{}},"conversation_id":"629314160292184064","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629299411210911744"}],"lang":"en","text":"RT @EU_ECHA: Respond to our #PublicConsultations. It's your chance to contribute to the safe use of #chemicals in the EU http://t.co/3Y42oV…","id":"629314160292184064","possibly_sensitive":false,"created_at":"2015-08-06T15:32:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"IAPOvoice","id":"180728609"}],"annotations":{},"hashtags":[{"start":47,"end":58,"tag":"Membership"}],"urls":[{"start":99,"end":121,"url":"http://t.co/xslrQmDnZJ","expanded_url":"http://bit.ly/1gdlVQs","display_url":"bit.ly/1gdlVQs"}]},"conversation_id":"629314019669708800","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629276839605891073"}],"lang":"en","text":"RT @IAPOvoice: We're excited to launch our new #Membership Guide! Find out why you should join us! http://t.co/xslrQmDnZJ http://t.co/vjeYB…","id":"629314019669708800","possibly_sensitive":false,"created_at":"2015-08-06T15:32:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{},"hashtags":{},"urls":[{"start":75,"end":97,"url":"http://t.co/ShxnwWkQJI","expanded_url":"http://1.usa.gov/1KRkmF8","display_url":"1.usa.gov/1KRkmF8"}]},"conversation_id":"629248954014822400","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629002725263572993"}],"lang":"en","text":"RT @FDAanimalhealth: Animal Drug Approvals August 2015 Update (Green Book) http://t.co/ShxnwWkQJI","id":"629248954014822400","possibly_sensitive":false,"created_at":"2015-08-06T11:13:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":75,"end":82,"probability":0.4901,"type":"Organization","normalized_text":"CEP News"}],"hashtags":[{"start":38,"end":52,"tag":"certification"}],"urls":[{"start":94,"end":116,"url":"http://t.co/NmMi3hvvEh","expanded_url":"http://bit.ly/1tcIZ4q","display_url":"bit.ly/1tcIZ4q"}]},"conversation_id":"629248615219920896","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629226545610117120"}],"lang":"en","text":"RT @edqm_news: Did you see the latest #certification monthly report? Check CEP News published http://t.co/NmMi3hvvEh","id":"629248615219920896","possibly_sensitive":false,"created_at":"2015-08-06T11:12:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":109,"end":125,"username":"DigitalAgendaEU","id":"2894539229"}],"annotations":{},"hashtags":{},"urls":[{"start":82,"end":104,"url":"http://t.co/hlrBXpPAss","expanded_url":"http://europa.eu/!Kp66Wx","display_url":"europa.eu/!Kp66Wx"}]},"conversation_id":"629248587306782720","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629228112878903296"}],"lang":"es","text":"RT @myCORDIS: Open Data Portals | Digital Agenda for Europe | European Commission http://t.co/hlrBXpPAss via @DigitalAgendaEU","id":"629248587306782720","possibly_sensitive":false,"created_at":"2015-08-06T11:12:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":15,"end":27,"tag":"Pharmeuropa"},{"start":65,"end":79,"tag":"Pharmacopoeia"}],"urls":{}},"conversation_id":"629248528645234689","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629232577208025088"}],"lang":"en","text":"RT @edqm_news: #Pharmeuropa Issue 27.3 is complete. The European #Pharmacopoeia Commission awaits your comments by 30 September http://t.co…","id":"629248528645234689","possibly_sensitive":false,"created_at":"2015-08-06T11:11:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"},{"start":24,"end":28,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":93,"end":106,"tag":"immunization"}],"urls":[{"start":115,"end":137,"url":"http://t.co/3fM4h6We7e","expanded_url":"http://bit.ly/1NbXUUB","display_url":"bit.ly/1NbXUUB"}]},"conversation_id":"629248381546795008","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"629246749702533120"}],"lang":"en","text":"RT @WHO_Europe_VPI: New @WHO guidelines will help improve the design &amp; use of home-based #immunization records http://t.co/3fM4h6We7e http:…","id":"629248381546795008","possibly_sensitive":false,"created_at":"2015-08-06T11:11:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"},{"start":13,"end":24,"username":"_himanshus","id":"68667045"}],"annotations":{},"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/uCzclnboTC","expanded_url":"http://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm397791.htm","display_url":"fda.gov/aboutfda/cente…"}]},"conversation_id":"628973843441299456","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628968720031973380"}],"lang":"en","text":"RT @US_FDA: .@_himanshus The Guidance for Industry\nInternet/Social Media Platforms draft document can be found here: http://t.co/uCzclnboTC","id":"628973843441299456","possibly_sensitive":false,"created_at":"2015-08-05T17:00:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":117,"end":132,"username":"thomsonreuters","id":"14412844"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"628971017604608000","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628967584159936513"}],"lang":"en","text":"RT @EuropaBio: The n° of innovative medicines launched globally in 2014 hit a 17-year high of 46, up from 29 in 2013 @thomsonreuters http:/…","id":"628971017604608000","possibly_sensitive":false,"created_at":"2015-08-05T16:49:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":15,"tag":"EudraVigilance"},{"start":16,"end":25,"tag":"training"},{"start":77,"end":84,"tag":"safety"}],"urls":[{"start":112,"end":134,"url":"http://t.co/J1tcdFAnF2","expanded_url":"http://bit.ly/1KOMKF8","display_url":"bit.ly/1KOMKF8"}]},"conversation_id":"628966366071103489","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#EudraVigilance #training courses on electronic reporting of individual case #safety reports: 6 more this year: http://t.co/J1tcdFAnF2","id":"628966366071103489","possibly_sensitive":false,"created_at":"2015-08-05T16:30:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":25,"end":40,"tag":"EudraVigilance"},{"start":70,"end":79,"tag":"training"}],"urls":[{"start":89,"end":111,"url":"http://t.co/By57xKAZrx","expanded_url":"http://bit.ly/1VYZOy0","display_url":"bit.ly/1VYZOy0"},{"start":113,"end":135,"url":"http://t.co/98yfAJ2Mvb","expanded_url":"http://bit.ly/1ONbheA","display_url":"bit.ly/1ONbheA"}]},"conversation_id":"628966266611625985","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Sign up for our eXtended #EudraVigilance medicinal product dictionary #training courses: http://t.co/By57xKAZrx  http://t.co/98yfAJ2Mvb","id":"628966266611625985","possibly_sensitive":false,"created_at":"2015-08-05T16:30:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":102,"end":109,"tag":"synbio"}],"urls":[{"start":110,"end":132,"url":"http://t.co/OiNUceJasZ","expanded_url":"http://europa.eu/!Pb63hk","display_url":"europa.eu/!Pb63hk"}]},"conversation_id":"628961860289732608","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628957003646402560"}],"lang":"fr","text":"RT @EU_Health: Plain language science factsheet on synthetic biology now available in DE, FR &amp; ES #synbio http://t.co/OiNUceJasZ http://t.c…","id":"628961860289732608","possibly_sensitive":false,"created_at":"2015-08-05T16:12:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"628960803417378816","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628924310296657921"}],"lang":"en","text":"RT @NICESciAdvice: Our next scientific advice seminar looks at early engagement for regenerative medicine and cell therapy developers https…","id":"628960803417378816","possibly_sensitive":false,"created_at":"2015-08-05T16:08:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{},"hashtags":[{"start":42,"end":57,"tag":"classification"},{"start":64,"end":74,"tag":"labelling"},{"start":75,"end":89,"tag":"consultations"}],"urls":[{"start":91,"end":113,"url":"http://t.co/57rfHrVa9j","expanded_url":"http://bit.ly/1DAnzCd","display_url":"bit.ly/1DAnzCd"},{"start":114,"end":136,"url":"http://t.co/EWuQnZeAGA","expanded_url":"https://twitter.com/EU_ECHA/status/628917388122189824/photo/1","display_url":"pic.twitter.com/EWuQnZeAGA"}]},"conversation_id":"628960669489086464","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628917388122189824"}],"lang":"en","text":"RT @EU_ECHA: Contribute to our harmonised #classification &amp; #labelling #consultations. http://t.co/57rfHrVa9j http://t.co/EWuQnZeAGA","id":"628960669489086464","possibly_sensitive":false,"created_at":"2015-08-05T16:08:03.000Z","author_id":"116716199","attachments":{"media_keys":["3_628917387199250432"]}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":112,"end":114,"probability":0.8093,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/h8KnbhdXwt","expanded_url":"http://www.fda.gov/ForPatients/About/ucm413492.htm","display_url":"fda.gov/ForPatients/Ab…"}]},"conversation_id":"628960651818438656","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628917387111362561"}],"lang":"en","text":"RT @US_FDA: Here is the latest bi-weekly Patient Network Newsletter with a variety of recent health topics from FDA. http://t.co/h8KnbhdXwt","id":"628960651818438656","possibly_sensitive":false,"created_at":"2015-08-05T16:07:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":54,"end":66,"tag":"infographic"},{"start":84,"end":94,"tag":"medicines"},{"start":95,"end":98,"tag":"EU"},{"start":99,"end":106,"tag":"safety"}],"urls":[{"start":107,"end":129,"url":"http://t.co/vCffWjvWoq","expanded_url":"http://europa.eu/!Pm34NM","display_url":"europa.eu/!Pm34NM"}]},"conversation_id":"628960543852875776","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628914810789494788"}],"lang":"en","text":"RT @EU_Health: What is the Life of Pill? Our animated #infographic tells the story! #medicines #EU #safety http://t.co/vCffWjvWoq http://t.…","id":"628960543852875776","possibly_sensitive":false,"created_at":"2015-08-05T16:07:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"628960425548324864","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628912844034015236"}],"lang":"en","text":"RT @NICEcomms: Our next scientific advice seminar looks at early engagement for regenerative medicine and cell therapy developers https://t…","id":"628960425548324864","possibly_sensitive":false,"created_at":"2015-08-05T16:07:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":25,"end":37,"tag":"infographic"},{"start":41,"end":56,"tag":"AnimalDiseases"}],"urls":[{"start":85,"end":107,"url":"http://t.co/DE6GwCALvh","expanded_url":"http://bit.ly/1N9M5hJ","display_url":"bit.ly/1N9M5hJ"},{"start":108,"end":130,"url":"http://t.co/UEdytDXFgD","expanded_url":"https://twitter.com/EFSA_EU/status/628911140211458048/photo/1","display_url":"pic.twitter.com/UEdytDXFgD"}]},"conversation_id":"628960406992736256","source":"TweetDeck","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628911140211458048"}],"lang":"en","text":"RT @EFSA_EU: Interactive #infographic on #AnimalDiseases. How do they affect humans. http://t.co/DE6GwCALvh http://t.co/UEdytDXFgD","id":"628960406992736256","possibly_sensitive":false,"created_at":"2015-08-05T16:07:01.000Z","author_id":"116716199","attachments":{"media_keys":["3_628911140148510721"]}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"},{"start":77,"end":92,"username":"HepBFoundation","id":"87017466"}],"annotations":{},"hashtags":[{"start":24,"end":35,"tag":"4000voices"},{"start":46,"end":64,"tag":"WorldHepatitisDay"}],"urls":[{"start":116,"end":138,"url":"http://t.co/GtwonYTMpW","expanded_url":"http://goo.gl/MAIoce","display_url":"goo.gl/MAIoce"}]},"conversation_id":"628960102188470272","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628907461781659649"}],"lang":"en","text":"RT @Hep_Alliance: Tweet #4000voices with your #WorldHepatitisDay photos like @HepBFoundation &amp; upload them here http://t.co/GtwonYTMpW http…","id":"628960102188470272","possibly_sensitive":false,"created_at":"2015-08-05T16:05:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"annotations":{},"hashtags":[{"start":14,"end":22,"tag":"codeine"},{"start":23,"end":30,"tag":"survey"},{"start":31,"end":42,"tag":"researcheu"},{"start":43,"end":47,"tag":"FP7"},{"start":48,"end":59,"tag":"MarieCurie"}],"urls":[{"start":60,"end":83,"url":"https://t.co/gKaXstV1Ci","expanded_url":"https://twitter.com/CODEMISUSED/status/625622980127813636","display_url":"twitter.com/CODEMISUSED/st…"}]},"conversation_id":"628960036652478465","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628905049092190208"}],"lang":"und","text":"RT @myCORDIS: #codeine #survey #researcheu #FP7 #MarieCurie https://t.co/gKaXstV1Ci","id":"628960036652478465","possibly_sensitive":false,"created_at":"2015-08-05T16:05:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":13,"username":"ZAAAlexander","id":"2343847004"},{"start":14,"end":18,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/PXIKAnRU3w","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}]},"conversation_id":"628884527725809664","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"628884527725809664"}],"lang":"en","text":"@ZAAAlexander @WHO If you have a specific query, please send it to us at http://t.co/PXIKAnRU3w so that we can reply in full.","id":"628902686772084736","possibly_sensitive":false,"created_at":"2015-08-05T12:17:39.000Z","author_id":"116716199","in_reply_to_user_id":"2343847004","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":14,"username":"MorrisSBerrie","id":"23423648"},{"start":15,"end":23,"username":"BBCTech","id":"621583"},{"start":24,"end":31,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":{},"urls":[{"start":64,"end":86,"url":"http://t.co/PXIKAnRU3w","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}]},"conversation_id":"628534762324512768","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"628587466904236032"}],"lang":"en","text":"@MorrisSBerrie @BBCTech @US_FDA Please send your query to us at http://t.co/PXIKAnRU3w so that we can reply in full.","id":"628902403346169856","possibly_sensitive":false,"created_at":"2015-08-05T12:16:32.000Z","author_id":"116716199","in_reply_to_user_id":"23423648","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":16,"end":34,"tag":"pharmacovigilance"},{"start":78,"end":85,"tag":"safety"}],"urls":[{"start":95,"end":117,"url":"http://t.co/RFIzxeN2KC","expanded_url":"http://bit.ly/1K1JSSB","display_url":"bit.ly/1K1JSSB"},{"start":118,"end":140,"url":"http://t.co/t3AMv8uSUD","expanded_url":"http://bit.ly/1UkrH1I","display_url":"bit.ly/1UkrH1I"}]},"conversation_id":"628597431861661696","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Introduction to #pharmacovigilance and expedited reporting of individual case #safety reports: http://t.co/RFIzxeN2KC http://t.co/t3AMv8uSUD","id":"628597431861661696","possibly_sensitive":false,"created_at":"2015-08-04T16:04:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":39,"end":49,"tag":"guideline"}],"urls":[{"start":83,"end":105,"url":"http://t.co/bpnB2OtY3D","expanded_url":"http://bit.ly/1KOLG4i","display_url":"bit.ly/1KOLG4i"}]},"conversation_id":"628597346281103360","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on Q3C (R6): Impurities: #guideline for residual solvents - Step 2b: http://t.co/bpnB2OtY3D","id":"628597346281103360","possibly_sensitive":false,"created_at":"2015-08-04T16:04:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":39,"end":49,"tag":"guideline"}],"urls":[{"start":116,"end":138,"url":"http://t.co/96fwbytHyT","expanded_url":"http://bit.ly/1M8O3BX","display_url":"bit.ly/1M8O3BX"}]},"conversation_id":"628597309002117120","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on application of ICH M7 #guideline to calculation of compound-specific acceptable intakes - Step 2b: http://t.co/96fwbytHyT","id":"628597309002117120","possibly_sensitive":false,"created_at":"2015-08-04T16:04:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":17,"end":27,"tag":"guideline"},{"start":98,"end":102,"tag":"GCP"}],"urls":[{"start":75,"end":97,"url":"http://t.co/VMeNaS0O4S","expanded_url":"http://bit.ly/1N6WDON","display_url":"bit.ly/1N6WDON"}]},"conversation_id":"628597276676620289","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on #guideline for good clinical practice E6(R2) 4 - Step 2b: http://t.co/VMeNaS0O4S #GCP","id":"628597276676620289","possibly_sensitive":false,"created_at":"2015-08-04T16:04:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":63,"end":73,"tag":"guideline"},{"start":77,"end":88,"tag":"excipients"}],"urls":[{"start":119,"end":141,"url":"http://t.co/sjiu9qBXRH","expanded_url":"http://bit.ly/1ePIvh9","display_url":"bit.ly/1ePIvh9"}]},"conversation_id":"628597134586179585","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation: Q&amp;A on boric acid in context of revision of #guideline on #excipients in label and package leaflet: http://t.co/sjiu9qBXRH","id":"628597134586179585","possibly_sensitive":false,"created_at":"2015-08-04T16:03:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":62,"end":72,"tag":"guideline"},{"start":76,"end":87,"tag":"excipients"}],"urls":[{"start":118,"end":140,"url":"http://t.co/uml1MP45BD","expanded_url":"http://bit.ly/1N6Mfq4","display_url":"bit.ly/1N6Mfq4"}]},"conversation_id":"628597074502795264","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation: Q&amp;A on sodium laurilsulfate in revision of #guideline on #excipients in label and package leaflet: http://t.co/uml1MP45BD","id":"628597074502795264","possibly_sensitive":false,"created_at":"2015-08-04T16:03:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/IV1T7cqUBG","expanded_url":"http://www.nice.org.uk/news/blog/out-for-consultation","display_url":"nice.org.uk/news/blog/out-…"}]},"conversation_id":"628596827533758466","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628567083429670912"}],"lang":"en","text":"RT @NICEcomms: Blog: our Chair discusses the importance of the consultation process in our guidance development http://t.co/IV1T7cqUBG","id":"628596827533758466","possibly_sensitive":false,"created_at":"2015-08-04T16:02:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{},"hashtags":{},"urls":[{"start":45,"end":67,"url":"http://t.co/JE1OycE8Cv","expanded_url":"http://ow.ly/QsKen","display_url":"ow.ly/QsKen"}]},"conversation_id":"628596590584987648","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628582397903282176"}],"lang":"en","text":"RT @MHRAgovuk: Latest Inspectorate blog post http://t.co/JE1OycE8Cv blood compliance report assessment process","id":"628596590584987648","possibly_sensitive":false,"created_at":"2015-08-04T16:01:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}],"annotations":{},"hashtags":[{"start":116,"end":125,"tag":"EPHA2015"},{"start":126,"end":133,"tag":"ROMAEU"}],"urls":{}},"conversation_id":"628596339367112705","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628596105576599552"}],"lang":"en","text":"RT @EPHA_EU: July-August EPHA 2015 Newsletter - Is a Union for Health already within reach? - articles &amp; events #EPHA2015 #ROMAEU ▶http://t…","id":"628596339367112705","possibly_sensitive":false,"created_at":"2015-08-04T16:00:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":{},"urls":[{"start":95,"end":117,"url":"http://t.co/VIZyPX0i8B","expanded_url":"http://www.nice.org.uk/news/article/call-for-healthcare-professionals-to-join-nice-board","display_url":"nice.org.uk/news/article/c…"},{"start":118,"end":140,"url":"http://t.co/ejtC6pUUM9","expanded_url":"https://twitter.com/NICEcomms/status/628565075486502912/photo/1","display_url":"pic.twitter.com/ejtC6pUUM9"}]},"conversation_id":"628565569881669632","source":"TweetDeck","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628565075486502912"}],"lang":"en","text":"RT @NICEcomms: NICE needs you! We're looking for two Non-Executive Directors to join our Board http://t.co/VIZyPX0i8B http://t.co/ejtC6pUUM9","id":"628565569881669632","possibly_sensitive":false,"created_at":"2015-08-04T13:58:04.000Z","author_id":"116716199","attachments":{"media_keys":["3_628565074597253120"]}},{"entities":{"mentions":[{"start":0,"end":9,"username":"maloxi75","id":"71639666"}],"annotations":{},"hashtags":{},"urls":[{"start":107,"end":129,"url":"http://t.co/5AK9J9YrfK","expanded_url":"http://bit.ly/1JK2F8Y","display_url":"bit.ly/1JK2F8Y"}]},"conversation_id":"628544032717807616","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"628560388083335168"}],"lang":"en","text":"@maloxi75 Kindly read 'How to pay' on our website and use the contact details provided if you have issues: http://t.co/5AK9J9YrfK","id":"628564847337279489","possibly_sensitive":false,"created_at":"2015-08-04T13:55:12.000Z","author_id":"116716199","in_reply_to_user_id":"71639666","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":9,"end":24,"tag":"EudraVigilance"},{"start":25,"end":34,"tag":"training"},{"start":96,"end":103,"tag":"safety"}],"urls":[{"start":113,"end":135,"url":"http://t.co/J1tcdFAnF2","expanded_url":"http://bit.ly/1KOMKF8","display_url":"bit.ly/1KOMKF8"}]},"conversation_id":"628561374008971264","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Six more #EudraVigilance #training courses this year on electronic reporting of individual case #safety reports: http://t.co/J1tcdFAnF2","id":"628561374008971264","possibly_sensitive":false,"created_at":"2015-08-04T13:41:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":9,"end":24,"tag":"EudraVigilance"},{"start":67,"end":76,"tag":"training"}],"urls":[{"start":86,"end":108,"url":"http://t.co/By57xKAZrx","expanded_url":"http://bit.ly/1VYZOy0","display_url":"bit.ly/1VYZOy0"},{"start":109,"end":131,"url":"http://t.co/98yfAJ2Mvb","expanded_url":"http://bit.ly/1ONbheA","display_url":"bit.ly/1ONbheA"}]},"conversation_id":"628559147378851840","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"eXtended #EudraVigilance medicinal product dictionary face-to-face #training courses:\nhttp://t.co/By57xKAZrx http://t.co/98yfAJ2Mvb","id":"628559147378851840","possibly_sensitive":false,"created_at":"2015-08-04T13:32:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":9,"username":"maloxi75","id":"71639666"}],"annotations":{},"hashtags":{},"urls":[{"start":74,"end":96,"url":"http://t.co/PXIKAnRU3w","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}]},"conversation_id":"628544032717807616","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"628544032717807616"}],"lang":"en","text":"@maloxi75 Please send us your request officially so we can reply in full: http://t.co/PXIKAnRU3w","id":"628550124562722816","possibly_sensitive":false,"created_at":"2015-08-04T12:56:42.000Z","author_id":"116716199","in_reply_to_user_id":"71639666","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":16,"end":34,"tag":"pharmacovigilance"},{"start":78,"end":85,"tag":"safety"}],"urls":[{"start":95,"end":117,"url":"http://t.co/RFIzxeN2KC","expanded_url":"http://bit.ly/1K1JSSB","display_url":"bit.ly/1K1JSSB"},{"start":118,"end":140,"url":"http://t.co/t3AMv8uSUD","expanded_url":"http://bit.ly/1UkrH1I","display_url":"bit.ly/1UkrH1I"}]},"conversation_id":"628519163221438464","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Introduction to #pharmacovigilance and expedited reporting of individual case #safety reports: http://t.co/RFIzxeN2KC http://t.co/t3AMv8uSUD","id":"628519163221438464","possibly_sensitive":false,"created_at":"2015-08-04T10:53:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":39,"end":49,"tag":"guideline"}],"urls":[{"start":83,"end":105,"url":"http://t.co/bpnB2OtY3D","expanded_url":"http://bit.ly/1KOLG4i","display_url":"bit.ly/1KOLG4i"}]},"conversation_id":"628518041651908608","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on Q3C (R6): Impurities: #guideline for residual solvents - Step 2b: http://t.co/bpnB2OtY3D","id":"628518041651908608","possibly_sensitive":false,"created_at":"2015-08-04T10:49:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":39,"end":49,"tag":"guideline"}],"urls":[{"start":116,"end":138,"url":"http://t.co/96fwbytHyT","expanded_url":"http://bit.ly/1M8O3BX","display_url":"bit.ly/1M8O3BX"}]},"conversation_id":"628517722712862721","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on application of ICH M7 #guideline to calculation of compound-specific acceptable intakes - Step 2b: http://t.co/96fwbytHyT","id":"628517722712862721","possibly_sensitive":false,"created_at":"2015-08-04T10:47:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":17,"end":27,"tag":"guideline"},{"start":98,"end":102,"tag":"GCP"}],"urls":[{"start":75,"end":97,"url":"http://t.co/VMeNaS0O4S","expanded_url":"http://bit.ly/1N6WDON","display_url":"bit.ly/1N6WDON"}]},"conversation_id":"628517275973341185","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on #guideline for good clinical practice E6(R2) 4 - Step 2b: http://t.co/VMeNaS0O4S #GCP","id":"628517275973341185","possibly_sensitive":false,"created_at":"2015-08-04T10:46:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":65,"end":75,"tag":"guideline"},{"start":79,"end":90,"tag":"excipients"}],"urls":[{"start":121,"end":143,"url":"http://t.co/sjiu9qBXRH","expanded_url":"http://bit.ly/1ePIvh9","display_url":"bit.ly/1ePIvh9"}]},"conversation_id":"628497716667129857","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on Q&amp;A on boric acid in context of revision of #guideline on #excipients in label and package leaflet: http://t.co/sjiu9qBXRH","id":"628497716667129857","possibly_sensitive":false,"created_at":"2015-08-04T09:28:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":64,"end":74,"tag":"guideline"},{"start":78,"end":89,"tag":"excipients"}],"urls":[{"start":120,"end":142,"url":"http://t.co/uml1MP45BD","expanded_url":"http://bit.ly/1N6Mfq4","display_url":"bit.ly/1N6Mfq4"}]},"conversation_id":"628497179875930112","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on Q&amp;A on sodium laurilsulfate in revision of #guideline on #excipients in label and package leaflet: http://t.co/uml1MP45BD","id":"628497179875930112","possibly_sensitive":false,"created_at":"2015-08-04T09:26:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":99,"end":114,"tag":"anticoagulants"}],"urls":[{"start":116,"end":138,"url":"http://t.co/4rVkTqfuOP","expanded_url":"http://bit.ly/1OKp19S","display_url":"bit.ly/1OKp19S"}]},"conversation_id":"628481433628225536","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Workshop on the role of pharmacokinetic and pharmacodynamic measurements in the use of direct oral #anticoagulants: http://t.co/4rVkTqfuOP","id":"628481433628225536","possibly_sensitive":false,"created_at":"2015-08-04T08:23:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":32,"end":40,"tag":"Repatha"},{"start":42,"end":53,"tag":"evolocumab"},{"start":58,"end":67,"tag":"medicine"},{"start":77,"end":99,"tag":"hypercholesterolaemia"}],"urls":[{"start":101,"end":123,"url":"http://t.co/JNS4yH0wAB","expanded_url":"http://bit.ly/1IU6eL7","display_url":"bit.ly/1IU6eL7"}]},"conversation_id":"628481350832640001","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Assessment report published for #Repatha (#evolocumab), a #medicine to treat #hypercholesterolaemia: http://t.co/JNS4yH0wAB","id":"628481350832640001","possibly_sensitive":false,"created_at":"2015-08-04T08:23:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":54,"end":73,"tag":"referencestandards"}],"urls":[{"start":107,"end":129,"url":"http://t.co/C3zzcZsGGl","expanded_url":"http://bit.ly/1KtRvXu","display_url":"bit.ly/1KtRvXu"}]},"conversation_id":"628238392086675456","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628201472937865216"}],"lang":"en","text":"RT @edqm_news: Chemical hazard re-classifications for #referencestandards Jan-July 2015 are now accessible http://t.co/C3zzcZsGGl","id":"628238392086675456","possibly_sensitive":false,"created_at":"2015-08-03T16:17:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":15,"end":26,"tag":"Employment"},{"start":122,"end":128,"tag":"Pheur"}],"urls":[{"start":99,"end":121,"url":"http://t.co/J5AzSbqi0S","expanded_url":"http://bit.ly/1J0a1oC","display_url":"bit.ly/1J0a1oC"}]},"conversation_id":"628238274478350336","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628207811143565312"}],"lang":"en","text":"RT @edqm_news: #Employment opportunities - 2 weeks left to apply for the EDQM 's latest vacancies  http://t.co/J5AzSbqi0S #Pheur","id":"628238274478350336","possibly_sensitive":false,"created_at":"2015-08-03T16:17:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"}],"annotations":{},"hashtags":[{"start":82,"end":85,"tag":"EU"},{"start":125,"end":138,"tag":"animalhealth"}],"urls":[{"start":102,"end":124,"url":"http://t.co/Q2Hq6fEzuh","expanded_url":"http://europa.eu/!my87dj","display_url":"europa.eu/!my87dj"}]},"conversation_id":"628238011529068544","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628235288440098816"}],"lang":"en","text":"RT @Food_EU: What is African swine fever, what's the current situation &amp; what #EU measures taken? http://t.co/Q2Hq6fEzuh #animalhealth #foo…","id":"628238011529068544","possibly_sensitive":false,"created_at":"2015-08-03T16:16:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":31,"end":38,"tag":"herbal"},{"start":39,"end":49,"tag":"medicines"}],"urls":[{"start":102,"end":124,"url":"http://t.co/ZlGqxi6W14","expanded_url":"http://bit.ly/1VWkKFS","display_url":"bit.ly/1VWkKFS"}]},"conversation_id":"628237810571603968","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Public-friendly information on #herbal #medicines now available to help people make informed choices: http://t.co/ZlGqxi6W14","id":"628237810571603968","possibly_sensitive":false,"created_at":"2015-08-03T16:15:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":32,"end":40,"tag":"Repatha"},{"start":42,"end":53,"tag":"evolocumab"},{"start":58,"end":67,"tag":"medicine"},{"start":77,"end":99,"tag":"hypercholesterolaemia"}],"urls":[{"start":101,"end":123,"url":"http://t.co/JNS4yH0wAB","expanded_url":"http://bit.ly/1IU6eL7","display_url":"bit.ly/1IU6eL7"}]},"conversation_id":"628237447726563329","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Assessment report published for #Repatha (#evolocumab), a #medicine to treat #hypercholesterolaemia: http://t.co/JNS4yH0wAB","id":"628237447726563329","possibly_sensitive":false,"created_at":"2015-08-03T16:14:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":9,"username":"f_oregan","id":"212292092"},{"start":10,"end":22,"username":"egagenerics","id":"1229029034"}],"annotations":{},"hashtags":{},"urls":[{"start":121,"end":143,"url":"http://t.co/UdEOIym863","expanded_url":"http://bit.ly/1DkLHNr","display_url":"bit.ly/1DkLHNr"}]},"conversation_id":"627086809839742976","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"627093901174829056"}],"lang":"en","text":"@f_oregan @egagenerics That is correct, please see sections 5 &amp; 6 of the European Commission's Notice to Applicants: http://t.co/UdEOIym863","id":"628218640450605056","possibly_sensitive":false,"created_at":"2015-08-03T14:59:30.000Z","author_id":"116716199","in_reply_to_user_id":"212292092","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"},{"start":79,"end":87,"username":"EU_ECHA","id":"331604970"},{"start":88,"end":96,"username":"baua_de","id":"27054980"},{"start":97,"end":103,"username":"Cefic","id":"59902639"},{"start":104,"end":115,"username":"Eurometaux","id":"1964392818"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"628198409166561282","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628196637731479552"}],"lang":"en","text":"RT @EU_ECHA: Workshop on applications for authorisation for\"process chemicals\" @EU_ECHA @baua_de @Cefic @Eurometaux Register 07/09 http://t…","id":"628198409166561282","possibly_sensitive":false,"created_at":"2015-08-03T13:39:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":14,"username":"oconnellbrian","id":"108597502"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"627134711438143489","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"627182936538894336"}],"lang":"en","text":"@oconnellbrian We understand our press office is in touch with you, thanks.","id":"628171713163960320","possibly_sensitive":false,"created_at":"2015-08-03T11:53:01.000Z","author_id":"116716199","in_reply_to_user_id":"108597502","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":14,"username":"KarenShipley7","id":"3239762386"},{"start":15,"end":30,"username":"TheDukeDigital","id":"2374087363"},{"start":31,"end":44,"username":"CarterCenter","id":"81163402"},{"start":45,"end":50,"username":"gavi","id":"97219875"},{"start":51,"end":59,"username":"DukeGHI","id":"58636516"}],"annotations":{},"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/0k8I8PDWUK","expanded_url":"http://bit.ly/1elljqI","display_url":"bit.ly/1elljqI"}]},"conversation_id":"625649815184109569","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"627419999766974464"}],"lang":"en","text":"@KarenShipley7 @TheDukeDigital @CarterCenter @gavi @DukeGHI It has only been used in trials until now. Main results: http://t.co/0k8I8PDWUK","id":"628169458201325568","possibly_sensitive":false,"created_at":"2015-08-03T11:44:04.000Z","author_id":"116716199","in_reply_to_user_id":"3239762386","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":35,"end":50,"username":"V_Andriukaitis","id":"575269517"}],"annotations":[{"start":29,"end":32,"probability":0.3908,"type":"Person","normalized_text":"Cssr"}],"hashtags":[{"start":64,"end":72,"tag":"chronic"},{"start":73,"end":82,"tag":"diseases"},{"start":83,"end":94,"tag":"prevention"},{"start":101,"end":112,"tag":"lifestyles"}],"urls":[{"start":114,"end":136,"url":"http://t.co/om2GdbsV2Q","expanded_url":"http://europa.eu/!kg79gd","display_url":"europa.eu/!kg79gd"}]},"conversation_id":"628168271158734848","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627407250341167104"}],"lang":"en","text":"RT @EU_Health: Have you seen Cssr. @V_Andriukaitis blog post on #chronic #diseases #prevention &amp; #lifestyles? http://t.co/om2GdbsV2Q http:/…","id":"628168271158734848","possibly_sensitive":false,"created_at":"2015-08-03T11:39:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"annotations":{},"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/Cc9wa5YTtf","expanded_url":"http://ow.ly/QlaIv","display_url":"ow.ly/QlaIv"}]},"conversation_id":"628168212572696576","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627434035913052160"}],"lang":"en","text":"RT @EuropeanLung: We're looking for people with experience of rare lung cancers to help us develop a new factsheet http://t.co/Cc9wa5YTtf #…","id":"628168212572696576","possibly_sensitive":false,"created_at":"2015-08-03T11:39:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":91,"end":94,"tag":"EU"}],"urls":[{"start":107,"end":129,"url":"http://t.co/ugubAojsmW","expanded_url":"http://ow.ly/QkZ9p","display_url":"ow.ly/QkZ9p"}]},"conversation_id":"628168034079887364","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627830112587788288"}],"lang":"en","text":"RT @EU_Health: Pilot project on the promotion of self-care systems for chronic diseases in #EU Ddl: 4.9.15 http://t.co/ugubAojsmW #EUtender…","id":"628168034079887364","possibly_sensitive":false,"created_at":"2015-08-03T11:38:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":32,"end":79,"probability":0.2753,"type":"Organization","normalized_text":"Global Coalition for Regulatory Science Research"}],"hashtags":{},"urls":[{"start":101,"end":123,"url":"http://t.co/tYrWvYErRk","expanded_url":"http://bit.ly/1N3LEFF","display_url":"bit.ly/1N3LEFF"}]},"conversation_id":"628167847001391104","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628128185637576708"}],"lang":"en","text":"RT @EFSA_EU: EFSA will host the Global Coalition for Regulatory Science Research meeting in October. http://t.co/tYrWvYErRk @USA_FDA #Bioin…","id":"628167847001391104","possibly_sensitive":false,"created_at":"2015-08-03T11:37:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{},"hashtags":[{"start":16,"end":22,"tag":"Ebola"}],"urls":{}},"conversation_id":"628167793767264257","source":"TweetDeck","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628140625368588288"}],"lang":"en","text":"RT @ECDC_EU: An #Ebola vaccine will not eradicate the disease but will likely be a key tool in future outbreaks. Read ECDC comment http://t…","id":"628167793767264257","possibly_sensitive":false,"created_at":"2015-08-03T11:37:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"annotations":[{"start":80,"end":89,"probability":0.7919,"type":"Place","normalized_text":"Luxembourg"}],"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/mH525mOG9y","expanded_url":"http://goo.gl/DoOndN","display_url":"goo.gl/DoOndN"}]},"conversation_id":"628167754198200321","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628142617579122689"}],"lang":"en","text":"RT @AlzheimerEurope: In our July newsletter: 1 July - Dementia is a priority of Luxembourg's EU Presidency term http://t.co/mH525mOG9y http…","id":"628167754198200321","possibly_sensitive":false,"created_at":"2015-08-03T11:37:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":99,"end":114,"tag":"anticoagulants"}],"urls":[{"start":116,"end":138,"url":"http://t.co/4rVkTqfuOP","expanded_url":"http://bit.ly/1OKp19S","display_url":"bit.ly/1OKp19S"}]},"conversation_id":"628164033556934656","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Workshop on the role of pharmacokinetic and pharmacodynamic measurements in the use of direct oral #anticoagulants: http://t.co/4rVkTqfuOP","id":"628164033556934656","possibly_sensitive":false,"created_at":"2015-08-03T11:22:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":31,"end":38,"tag":"herbal"},{"start":39,"end":49,"tag":"medicines"}],"urls":[{"start":65,"end":87,"url":"http://t.co/ZlGqxiowSC","expanded_url":"http://bit.ly/1VWkKFS","display_url":"bit.ly/1VWkKFS"}]},"conversation_id":"628124662946377729","source":"Bitly","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Public-friendly information on #herbal #medicines now available: http://t.co/ZlGqxiowSC","id":"628124662946377729","possibly_sensitive":false,"created_at":"2015-08-03T08:46:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"H2020SME","id":"874591855626858496"},{"start":94,"end":101,"username":"EEN_EU","id":"304972712"}],"annotations":{},"hashtags":[{"start":31,"end":42,"tag":"innovation"},{"start":109,"end":123,"tag":"SMEinstrument"}],"urls":{}},"conversation_id":"628123601506562048","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628113606488498176"}],"lang":"en","text":"RT @H2020SME: A range of other #innovation support activities and services can be offered via @EEN_EU during #SMEinstrument phase3 http://t…","id":"628123601506562048","possibly_sensitive":false,"created_at":"2015-08-03T08:41:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":79,"end":94,"username":"profpaulgately","id":"96441928"},{"start":95,"end":109,"username":"oxfamgbpolicy","id":"385331513"}],"annotations":[{"start":13,"end":16,"probability":0.5018,"type":"Organization","normalized_text":"EPHA"}],"hashtags":[{"start":69,"end":74,"tag":"TTIP"}],"urls":[{"start":46,"end":68,"url":"http://t.co/VoOGSlsBpq","expanded_url":"http://paper.li/EPHA_EU/1423042601?edition_id=5ec53c00-39bb-11e5-84b7-0cc47a0d15fd","display_url":"paper.li/EPHA_EU/142304…"}]},"conversation_id":"628123541125361668","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"628123405687103488"}],"lang":"en","text":"RT @EPHA_EU: EPHA weekly news roundup is out! http://t.co/VoOGSlsBpq #TTIP Via @profpaulgately @oxfamgbpolicy","id":"628123541125361668","possibly_sensitive":false,"created_at":"2015-08-03T08:41:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":53,"tag":"Pregabalin"},{"start":70,"end":78,"tag":"generic"},{"start":79,"end":88,"tag":"medicine"},{"start":92,"end":99,"tag":"Lyrica"}],"urls":[{"start":101,"end":123,"url":"http://t.co/vxDoWFQioJ","expanded_url":"http://bit.ly/1I7i4Ou","display_url":"bit.ly/1I7i4Ou"}]},"conversation_id":"628122171479601152","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Pregabalin Mylan Pharma, a #generic #medicine of #Lyrica: http://t.co/vxDoWFQioJ","id":"628122171479601152","possibly_sensitive":false,"created_at":"2015-08-03T08:36:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":53,"tag":"Pregabalin"},{"start":63,"end":71,"tag":"generic"},{"start":72,"end":81,"tag":"medicine"},{"start":85,"end":92,"tag":"Lyrica"}],"urls":[{"start":94,"end":116,"url":"http://t.co/0iB4HNw0Tg","expanded_url":"http://bit.ly/1MXAjH8","display_url":"bit.ly/1MXAjH8"}]},"conversation_id":"628122130106982400","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Pregabalin Mylan, a #generic #medicine of #Lyrica: http://t.co/0iB4HNw0Tg","id":"628122130106982400","possibly_sensitive":false,"created_at":"2015-08-03T08:36:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"},{"start":93,"end":104,"username":"CTCatapult","id":"940559888266219520"}],"annotations":{},"hashtags":[{"start":70,"end":87,"tag":"healthinnovation"}],"urls":{}},"conversation_id":"627167625827758080","source":"Twitter for iPhone","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627158736830889984"}],"lang":"en","text":"RT @MHRAgovuk: Induced Pluripotent Stem Cells (iPS) – ground-breaking #healthinnovation from @CTCatapult – read our case study http://t.co/…","id":"627167625827758080","possibly_sensitive":false,"created_at":"2015-07-31T17:23:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"},{"start":40,"end":49,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":83,"end":94,"tag":"veterinary"},{"start":110,"end":115,"tag":"food"}],"urls":[{"start":117,"end":139,"url":"http://t.co/WjgBvQ0KC4","expanded_url":"http://bit.ly/1BEOCIR","display_url":"bit.ly/1BEOCIR"}]},"conversation_id":"627154256009785345","source":"Twitter for iPhone","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627151930473730050"}],"lang":"en","text":"RT @Food_EU: Last 2 weeks to comment on @EMA_News guideline: safety of residues of #veterinary drugs in human #food: http://t.co/WjgBvQ0KC4…","id":"627154256009785345","possibly_sensitive":false,"created_at":"2015-07-31T16:30:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":53,"tag":"Pregabalin"},{"start":63,"end":71,"tag":"generic"},{"start":72,"end":81,"tag":"medicine"},{"start":85,"end":92,"tag":"Lyrica"}],"urls":[{"start":94,"end":116,"url":"http://t.co/0iB4HNw0Tg","expanded_url":"http://bit.ly/1MXAjH8","display_url":"bit.ly/1MXAjH8"}]},"conversation_id":"627134711438143489","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Pregabalin Mylan, a #generic #medicine of #Lyrica: http://t.co/0iB4HNw0Tg","id":"627134711438143489","possibly_sensitive":false,"created_at":"2015-07-31T15:12:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":53,"tag":"Pregabalin"},{"start":70,"end":78,"tag":"generic"},{"start":79,"end":88,"tag":"medicine"},{"start":92,"end":99,"tag":"Lyrica"}],"urls":[{"start":101,"end":123,"url":"http://t.co/vxDoWFQioJ","expanded_url":"http://bit.ly/1I7i4Ou","display_url":"bit.ly/1I7i4Ou"}]},"conversation_id":"627134159761330176","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Pregabalin Mylan Pharma, a #generic #medicine of #Lyrica: http://t.co/vxDoWFQioJ","id":"627134159761330176","possibly_sensitive":false,"created_at":"2015-07-31T15:10:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"Online"},{"start":8,"end":19,"tag":"pharmacies"}],"urls":[{"start":61,"end":84,"url":"https://t.co/uxealP3utM","expanded_url":"https://twitter.com/Aifa_ufficiale/status/627121900829995008","display_url":"twitter.com/Aifa_ufficiale…"}]},"conversation_id":"627132447327670272","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"627121900829995008"}],"lang":"en","text":"#Online #pharmacies: social campaign of the European project https://t.co/uxealP3utM","id":"627132447327670272","possibly_sensitive":false,"created_at":"2015-07-31T15:03:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":87,"end":110,"url":"https://t.co/CmG5bjf84V","expanded_url":"https://twitter.com/INFARMED_IP/status/627117263632637952","display_url":"twitter.com/INFARMED_IP/st…"}]},"conversation_id":"627132202921426944","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"627117263632637952"}],"lang":"en","text":"International seminar \"Rational Use of Pharmaceuticals - The Environment Perspective\"  https://t.co/CmG5bjf84V","id":"627132202921426944","possibly_sensitive":false,"created_at":"2015-07-31T15:02:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":9,"end":15,"probability":0.9299,"type":"Person","normalized_text":"Dr Chan"}],"hashtags":[{"start":103,"end":109,"tag":"Ebola"}],"urls":{}},"conversation_id":"627116038879092736","source":"TweetDeck","public_metrics":{"retweet_count":92,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627102858735915008"}],"lang":"en","text":"RT @WHO: Dr Chan: An effective vaccine will be another very important tool for both current and future #Ebola outbreaks http://t.co/2WlAbAM…","id":"627116038879092736","possibly_sensitive":false,"created_at":"2015-07-31T13:58:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{},"hashtags":[{"start":111,"end":123,"tag":"EGAgenerics"}],"urls":[{"start":88,"end":110,"url":"http://t.co/RGObhUdg9o","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"}]},"conversation_id":"627088334192558080","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627086809839742976"}],"lang":"en","text":"RT @egagenerics: Can generic medicines manufacturers use data from branded equivalents? http://t.co/RGObhUdg9o #EGAgenerics","id":"627088334192558080","possibly_sensitive":false,"created_at":"2015-07-31T12:08:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":[{"start":77,"end":82,"probability":0.7028,"type":"Place","normalized_text":"London"}],"hashtags":{},"urls":[{"start":92,"end":115,"url":"https://t.co/4ZPR3wZlUX","expanded_url":"https://www.jobs.nhs.uk/xi/vacancy/455ee05f8886deed910edff8d5169982/?vac_ref=913853522","display_url":"jobs.nhs.uk/xi/vacancy/455…"}]},"conversation_id":"627085483261198337","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627082905165107200"}],"lang":"en","text":"RT @NICEcomms: We're looking for a Public Involvement Advisor to work in our London office: https://t.co/4ZPR3wZlUX","id":"627085483261198337","possibly_sensitive":false,"created_at":"2015-07-31T11:56:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":66,"end":77,"tag":"veterinary"},{"start":93,"end":98,"tag":"food"},{"start":124,"end":137,"tag":"consultation"}],"urls":[{"start":100,"end":122,"url":"http://t.co/3VHuLRQwL7","expanded_url":"http://bit.ly/1BEOCIR","display_url":"bit.ly/1BEOCIR"}]},"conversation_id":"627073444493045760","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Last 2 weeks to comment on the guideline on safety of residues of #veterinary drugs in human #food: http://t.co/3VHuLRQwL7  #consultation","id":"627073444493045760","possibly_sensitive":false,"created_at":"2015-07-31T11:08:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":90,"end":102,"tag":"recruitment"}],"urls":[{"start":66,"end":88,"url":"http://t.co/LZaWD78gqZ","expanded_url":"http://bit.ly/1eFg9Gi","display_url":"bit.ly/1eFg9Gi"}]},"conversation_id":"627072440276025344","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two more weeks to apply for our vacancy for a Scientific Officer: http://t.co/LZaWD78gqZ  #recruitment","id":"627072440276025344","possibly_sensitive":false,"created_at":"2015-07-31T11:04:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":97,"end":109,"tag":"recruitment"}],"urls":[{"start":73,"end":95,"url":"http://t.co/l8xqrmKi8y","expanded_url":"http://bit.ly/1M0QYg8","display_url":"bit.ly/1M0QYg8"}]},"conversation_id":"627072371665563648","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two more weeks to apply for our vacancy for a senior Scientific Officer: http://t.co/l8xqrmKi8y  #recruitment","id":"627072371665563648","possibly_sensitive":false,"created_at":"2015-07-31T11:04:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":46,"end":56,"username":"EAHPtweet","id":"203357203"}],"annotations":{},"hashtags":[{"start":96,"end":105,"tag":"pharmacy"},{"start":106,"end":116,"tag":"medicines"}],"urls":{}},"conversation_id":"627062738926325761","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627058778526101504"}],"lang":"en","text":"RT @EAHPtweet: Hot off the press! This week's @EAHPtweet EU Monitor looks at an ECJ judgment on #pharmacy #medicines production http://t.co…","id":"627062738926325761","possibly_sensitive":false,"created_at":"2015-07-31T10:26:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":62,"end":68,"tag":"PhEur"},{"start":115,"end":125,"tag":"monograph"}],"urls":{}},"conversation_id":"627062694592520192","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627058582605950976"}],"lang":"en","text":"RT @edqm_news: Iron sucrose concentrated solution (2753): The #PhEur needs your support for the elaboration of the #monograph http://t.co/N…","id":"627062694592520192","possibly_sensitive":false,"created_at":"2015-07-31T10:26:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":15,"end":17,"probability":0.536,"type":"Organization","normalized_text":"PDG"}],"hashtags":[{"start":113,"end":124,"tag":"impurities"}],"urls":{}},"conversation_id":"627062658265706497","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627058552121782272"}],"lang":"en","text":"RT @edqm_news: PDG confirm their commitment to harmonise the general chapter on testing procedures for elemental #impurities http://t.co/0n…","id":"627062658265706497","possibly_sensitive":false,"created_at":"2015-07-31T10:26:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":90,"end":104,"username":"Sandoz_Global","id":"223508480"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"626745452830965760","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"627053871999938560"}],"lang":"en","text":"@tobyg_epg It's up to the company to decide on what to apply for. You may wish to contact @Sandoz_Global to find out more.","id":"627056233657290752","possibly_sensitive":false,"created_at":"2015-07-31T10:00:30.000Z","author_id":"116716199","in_reply_to_user_id":"2902360799","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":32,"end":37,"probability":0.4804,"type":"Person","normalized_text":"Lyrica"}],"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/Txabp2lyU8","expanded_url":"http://bit.ly/1JA4JAz","display_url":"bit.ly/1JA4JAz"}]},"conversation_id":"626745452830965760","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"626745452830965760"}],"lang":"en","text":"@tobyg_epg They are generics of Lyrica, which has 3 indications, but the applicant for P.S. GmbH only applied for 2: http://t.co/Txabp2lyU8","id":"627053117528481792","possibly_sensitive":false,"created_at":"2015-07-31T09:48:07.000Z","author_id":"116716199","in_reply_to_user_id":"2902360799","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":[{"start":52,"end":70,"probability":0.5443,"type":"Other","normalized_text":"World Hepatitis Day"}],"hashtags":[{"start":118,"end":129,"tag":"4000voices"}],"urls":{}},"conversation_id":"627045818655244289","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627042465325928448"}],"lang":"en","text":"RT @Hep_Alliance: If you want to add a photo to our World Hepatitis Day gallery you can do so by tweeting the hashtag #4000voices http://t.…","id":"627045818655244289","possibly_sensitive":false,"created_at":"2015-07-31T09:19:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":67,"end":78,"tag":"veterinary"},{"start":94,"end":99,"tag":"food"},{"start":124,"end":137,"tag":"consultation"}],"urls":[{"start":101,"end":123,"url":"http://t.co/3VHuLRQwL7","expanded_url":"http://bit.ly/1BEOCIR","display_url":"bit.ly/1BEOCIR"}]},"conversation_id":"627037374820782080","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two weeks to comment on the guideline on the safety of residues of #veterinary drugs in human #food: http://t.co/3VHuLRQwL7 #consultation","id":"627037374820782080","possibly_sensitive":false,"created_at":"2015-07-31T08:45:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":89,"end":101,"tag":"recruitment"}],"urls":[{"start":66,"end":88,"url":"http://t.co/LZaWD78gqZ","expanded_url":"http://bit.ly/1eFg9Gi","display_url":"bit.ly/1eFg9Gi"}]},"conversation_id":"627034422777413632","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two weeks left to apply for our vacancy for a Scientific Officer: http://t.co/LZaWD78gqZ #recruitment","id":"627034422777413632","possibly_sensitive":false,"created_at":"2015-07-31T08:33:50.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":96,"end":108,"tag":"recruitment"}],"urls":[{"start":73,"end":95,"url":"http://t.co/l8xqrmKi8y","expanded_url":"http://bit.ly/1M0QYg8","display_url":"bit.ly/1M0QYg8"}]},"conversation_id":"627033414399602688","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two weeks left to apply for our vacancy for a senior Scientific Officer: http://t.co/l8xqrmKi8y #recruitment","id":"627033414399602688","possibly_sensitive":false,"created_at":"2015-07-31T08:29:50.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{},"hashtags":[{"start":66,"end":75,"tag":"vaccines"},{"start":76,"end":84,"tag":"malaria"}],"urls":[{"start":43,"end":65,"url":"http://t.co/o2VNTG6QO3","expanded_url":"http://ow.ly/QjBLL","display_url":"ow.ly/QjBLL"},{"start":103,"end":125,"url":"http://t.co/71wBV5hRX7","expanded_url":"http://ow.ly/QjC9d","display_url":"ow.ly/QjC9d"}]},"conversation_id":"627032127444504576","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627026954118676480"}],"lang":"en","text":"RT @EFPIA: EFPIA weekly newsletter is out! http://t.co/o2VNTG6QO3 #vaccines #malaria  \nSubscribe here: http://t.co/71wBV5hRX7 http://t.co/O…","id":"627032127444504576","possibly_sensitive":false,"created_at":"2015-07-31T08:24:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/blY0UM6Ft7","expanded_url":"http://bit.ly/1OEHyo8","display_url":"bit.ly/1OEHyo8"}]},"conversation_id":"627031996200521728","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"627022297535225856"}],"lang":"en","text":"RT @ECDC_Flu: Future directions for the European influenza reference laboratory network in influenza surveillance http://t.co/blY0UM6Ft7","id":"627031996200521728","possibly_sensitive":false,"created_at":"2015-07-31T08:24:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":29,"end":42,"tag":"Aripiprazole"},{"start":54,"end":63,"tag":"medicine"},{"start":68,"end":82,"tag":"schizophrenia"},{"start":87,"end":95,"tag":"bipolar"}],"urls":[{"start":108,"end":130,"url":"http://t.co/hf2x38kw3f","expanded_url":"http://bit.ly/1H5CQtX","display_url":"bit.ly/1H5CQtX"}]},"conversation_id":"626786424092782592","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the EPAR for #Aripiprazole Zentiva, a #medicine for #schizophrenia and #bipolar I disorder: http://t.co/hf2x38kw3f","id":"626786424092782592","possibly_sensitive":false,"created_at":"2015-07-30T16:08:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":18,"end":27,"username":"EU_H2020","id":"920249612329504768"}],"annotations":[{"start":54,"end":61,"probability":0.5562,"type":"Other","normalized_text":"Info Day"}],"hashtags":[{"start":80,"end":87,"tag":"Health"},{"start":123,"end":129,"tag":"H2020"}],"urls":{}},"conversation_id":"626735469167013888","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626733878707900416"}],"lang":"en","text":"RT @EU_Health: RT @EU_H2020 Registration now open for Info Day, Horizon 2020 - '#Health, demographic change and wellbeing' #H2020  http://t…","id":"626735469167013888","possibly_sensitive":false,"created_at":"2015-07-30T12:45:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":32,"end":45,"tag":"Aripiprazole"},{"start":57,"end":66,"tag":"medicine"},{"start":71,"end":85,"tag":"schizophrenia"},{"start":90,"end":98,"tag":"bipolar"}],"urls":[{"start":111,"end":133,"url":"http://t.co/hf2x38kw3f","expanded_url":"http://bit.ly/1H5CQtX","display_url":"bit.ly/1H5CQtX"}]},"conversation_id":"626702882373533696","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Assessment report published for #Aripiprazole Zentiva, a #medicine for #schizophrenia and #bipolar I disorder: http://t.co/hf2x38kw3f","id":"626702882373533696","possibly_sensitive":false,"created_at":"2015-07-30T10:36:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":13,"end":32,"tag":"PublicConsultation"}],"urls":[{"start":91,"end":113,"url":"http://t.co/StZ6ghk35Y","expanded_url":"http://bit.ly/1MzdkW2","display_url":"bit.ly/1MzdkW2"}]},"conversation_id":"626701632722575361","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626678640122662912"}],"lang":"en","text":"RT @EFSA_EU: #PublicConsultation on the active substance Coniothyrium minitans CON M/91/08 http://t.co/StZ6ghk35Y","id":"626701632722575361","possibly_sensitive":false,"created_at":"2015-07-30T10:31:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"annotations":{},"hashtags":[{"start":74,"end":81,"tag":"ribfp7"}],"urls":[{"start":51,"end":73,"url":"http://t.co/UL6q4i6roe","expanded_url":"http://bit.ly/1H5nQMD","display_url":"bit.ly/1H5nQMD"}]},"conversation_id":"626701586027401216","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626682886146494467"}],"lang":"en","text":"RT @myCORDIS: Recovering from spinal cord injuries http://t.co/UL6q4i6roe #ribfp7","id":"626701586027401216","possibly_sensitive":false,"created_at":"2015-07-30T10:31:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":80,"end":98,"tag":"immunosuppressive"}],"urls":{}},"conversation_id":"626701414128087040","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626688195737055236"}],"lang":"en","text":"RT @edqm_news: This highlights importance of prescribing physical activity with #immunosuppressive therapy for transplanted patients http:/…","id":"626701414128087040","possibly_sensitive":false,"created_at":"2015-07-30T10:30:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":99,"end":113,"tag":"Pharmacopoeia"}],"urls":{}},"conversation_id":"626701391252340736","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626688234479878144"}],"lang":"en","text":"RT @edqm_news: New items were recently added to or deleted from the work programme of the European #Pharmacopoeia Commission http://t.co/U6…","id":"626701391252340736","possibly_sensitive":false,"created_at":"2015-07-30T10:30:29.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":41,"end":55,"tag":"EUHealthAward"},{"start":60,"end":65,"tag":"NGOs"},{"start":75,"end":81,"tag":"Ebola"},{"start":105,"end":119,"tag":"EbolaResponse"}],"urls":[{"start":82,"end":104,"url":"http://t.co/AsiOjaIzkC","expanded_url":"http://europa.eu/!tU77tD","display_url":"europa.eu/!tU77tD"}]},"conversation_id":"626701247878426625","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626696767631958016"}],"lang":"en","text":"RT @EU_Health: Tomorrow is the deadline! #EUHealthAward for #NGOs fighting #Ebola http://t.co/AsiOjaIzkC #EbolaResponse http://t.co/9rLzjij…","id":"626701247878426625","possibly_sensitive":false,"created_at":"2015-07-30T10:29:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":52,"end":74,"url":"http://t.co/vAbERRD5lC","expanded_url":"http://bit.ly/1JvvPsk","display_url":"bit.ly/1JvvPsk"}]},"conversation_id":"626700703424212992","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Our rules on fees are being revised as of 1 August: http://t.co/vAbERRD5lC","id":"626700703424212992","possibly_sensitive":false,"created_at":"2015-07-30T10:27:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":64,"end":66,"probability":0.7945,"type":"Organization","normalized_text":"FDA"},{"start":100,"end":102,"probability":0.6408,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":{}},"conversation_id":"626436476797108224","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626433972487225345"}],"lang":"en","text":"RT @US_FDA: \"Report illustrates 8 years of dramatic advances in FDA regulatory science programs.\" --FDA’s Acting Chief Scientist http://t.c…","id":"626436476797108224","possibly_sensitive":false,"created_at":"2015-07-29T16:57:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":52,"end":74,"url":"http://t.co/vAbERRD5lC","expanded_url":"http://bit.ly/1JvvPsk","display_url":"bit.ly/1JvvPsk"}]},"conversation_id":"626433231601143808","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Our rules on fees are being revised as of 1 August: http://t.co/vAbERRD5lC","id":"626433231601143808","possibly_sensitive":false,"created_at":"2015-07-29T16:44:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{},"hashtags":[{"start":113,"end":125,"tag":"EGAgenerics"}],"urls":[{"start":90,"end":112,"url":"http://t.co/Lax4Cu5zG2","expanded_url":"http://bit.ly/1vdtjee","display_url":"bit.ly/1vdtjee"}]},"conversation_id":"626431990821224448","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626422683861782528"}],"lang":"en","text":"RT @egagenerics: Pharmacovigilance and Generic Medicines: Ensuring Ongoing Patient Safety http://t.co/Lax4Cu5zG2 #EGAgenerics","id":"626431990821224448","possibly_sensitive":false,"created_at":"2015-07-29T16:39:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"626431958151733249","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626419219706609664"}],"lang":"en","text":"RT @FDAMedia: Did you know that many of the presentations from today's Science Board meeting are now online? Check them out here: http://t.…","id":"626431958151733249","possibly_sensitive":false,"created_at":"2015-07-29T16:39:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"annotations":[{"start":30,"end":46,"probability":0.3881,"type":"Organization","normalized_text":"FDA Science Board"}],"hashtags":{},"urls":{}},"conversation_id":"626431905366454272","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626418896506101760"}],"lang":"en","text":"RT @FDAMedia: Wanted to cover FDA Science Board meeting but couldn't make it in person? Remember, you can sign into the webcast: https://t.…","id":"626431905366454272","possibly_sensitive":false,"created_at":"2015-07-29T16:39:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"annotations":[{"start":52,"end":54,"probability":0.649,"type":"Organization","normalized_text":"FDA"},{"start":73,"end":75,"probability":0.5776,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":89,"end":111,"url":"http://t.co/2N64RlVB3t","expanded_url":"http://go.usa.gov/37Stm","display_url":"go.usa.gov/37Stm"}]},"conversation_id":"626431781990961152","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626415239194673152"}],"lang":"en","text":"RT @FDAMedia: Times They Are a Changin’ – And So is FDA. Read the latest FDA Voice Blog: http://t.co/2N64RlVB3t re how agency is \"Moving Sc…","id":"626431781990961152","possibly_sensitive":false,"created_at":"2015-07-29T16:39:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":[{"start":28,"end":74,"probability":0.3885,"type":"Organization","normalized_text":"European Medicines Agency Scientific Committees"}],"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/GzfkxcpFSL","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002383.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}]},"conversation_id":"626431590697160704","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626401099763855360"}],"lang":"en","text":"RT @EAHPtweet: Vacancies on European Medicines Agency Scientific Committees open to hospital pharmacist applications http://t.co/GzfkxcpFSL…","id":"626431590697160704","possibly_sensitive":false,"created_at":"2015-07-29T16:38:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":91,"end":100,"username":"Parlimag","id":"21223877"}],"annotations":{},"hashtags":[{"start":22,"end":29,"tag":"cancer"}],"urls":[{"start":68,"end":90,"url":"http://t.co/HmbzXnTrc6","expanded_url":"http://ow.ly/Q27sH","display_url":"ow.ly/Q27sH"}]},"conversation_id":"626431548619886592","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626399769888444416"}],"lang":"en","text":"RT @EuropaBio: Global #cancer research era offers patients new hope http://t.co/HmbzXnTrc6 @Parlimag","id":"626431548619886592","possibly_sensitive":false,"created_at":"2015-07-29T16:38:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":88,"end":97,"username":"DRIVE_AB","id":"3061562807"}],"annotations":{},"hashtags":[{"start":30,"end":40,"tag":"economics"},{"start":44,"end":55,"tag":"antibiotic"}],"urls":{}},"conversation_id":"626431243199074304","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626396063486857216"}],"lang":"en","text":"RT @IMI_JU: Interested in the #economics of #antibiotic dvpt &amp; responsible use? Our @DRIVE_AB project wants to hear from you http://t.co/6m…","id":"626431243199074304","possibly_sensitive":false,"created_at":"2015-07-29T16:37:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":54,"end":77,"url":"https://t.co/LdaogTZcSn","expanded_url":"https://twitter.com/luca__pani/status/626391668271484932","display_url":"twitter.com/luca__pani/sta…"}]},"conversation_id":"626430939447619585","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"626391668271484932"}],"lang":"en","text":"International WHO day for the prevention of hepatitis https://t.co/LdaogTZcSn","id":"626430939447619585","possibly_sensitive":false,"created_at":"2015-07-29T16:35:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{},"hashtags":{},"urls":[{"start":93,"end":115,"url":"http://t.co/S4Zqq8SjEc","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002382.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}]},"conversation_id":"626430764863913984","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626390274311344128"}],"lang":"en","text":"RT @GCessak: EMA to encourage use of scientific advice for post-authorisation safety studies http://t.co/S4Zqq8SjEc","id":"626430764863913984","possibly_sensitive":false,"created_at":"2015-07-29T16:35:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":33,"end":42,"username":"UBIOPRED","id":"453922574"}],"annotations":{},"hashtags":[{"start":70,"end":78,"tag":"patient"},{"start":94,"end":103,"tag":"research"}],"urls":[{"start":104,"end":126,"url":"http://t.co/6m6F3Zyg4G","expanded_url":"http://bit.ly/1K70gCq","display_url":"bit.ly/1K70gCq"}]},"conversation_id":"626430626049196032","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626386060700946432"}],"lang":"en","text":"RT @IMI_JU: IMI project success: @UBIOPRED gives advice on meaningful #patient involvement in #research http://t.co/6m6F3Zyg4G #patientsinv…","id":"626430626049196032","possibly_sensitive":false,"created_at":"2015-07-29T16:34:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":[{"start":14,"end":16,"probability":0.6433,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":70,"end":92,"url":"http://t.co/vMLFnqy6tB","expanded_url":"http://ht.ly/QdVXQ","display_url":"ht.ly/QdVXQ"}]},"conversation_id":"626373153816768512","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626373084577181698"}],"lang":"en","text":"RT @FDA_MCMi: FDA Science Board meeting starts 9 am EDT. Stream live: http://t.co/vMLFnqy6tB View materials (more added): http://t.co/BGB7v…","id":"626373153816768512","possibly_sensitive":false,"created_at":"2015-07-29T12:46:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/CxdjuzZiAf","expanded_url":"http://bit.ly/1JuzneC","display_url":"bit.ly/1JuzneC"}]},"conversation_id":"626370992512876544","source":"Twitter Web Client","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Want to represent civil society on our scientific committees? Call for expression of interest open to 30 September: http://t.co/CxdjuzZiAf","id":"626370992512876544","possibly_sensitive":false,"created_at":"2015-07-29T12:37:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":96,"end":103,"tag":"safety"}],"urls":[{"start":113,"end":135,"url":"http://t.co/87D1Qxgfrk","expanded_url":"http://bit.ly/1GYi1AA","display_url":"bit.ly/1GYi1AA"}]},"conversation_id":"626370132571516928","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've started a 12-month pilot to encourage the use of scientific advice for post-authorisation #safety studies: http://t.co/87D1Qxgfrk","id":"626370132571516928","possibly_sensitive":false,"created_at":"2015-07-29T12:34:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":123,"end":136,"tag":"consultation"}],"urls":[{"start":100,"end":122,"url":"http://t.co/CvZ7vOQ2Py","expanded_url":"http://bit.ly/1VLagsM","display_url":"bit.ly/1VLagsM"}]},"conversation_id":"626369269933207553","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Send us your comments on our #guideline on the processing of renewals in the centralised procedure: http://t.co/CvZ7vOQ2Py #consultation","id":"626369269933207553","possibly_sensitive":false,"created_at":"2015-07-29T12:30:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"626359721595928576","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626338870003671040"}],"lang":"en","text":"RT @EASDnews: Apply now for the 5th call of IMI 2 with a topic on diabetic kidney disease biomarkers. Deadline 13 October 2015 http://t.co/…","id":"626359721595928576","possibly_sensitive":false,"created_at":"2015-07-29T11:52:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":54,"end":60,"tag":"green"},{"start":71,"end":81,"tag":"chemicals"},{"start":114,"end":121,"tag":"pharma"}],"urls":{}},"conversation_id":"626359553450471424","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626331169861332992"}],"lang":"en","text":"RT @IMI_JU: IMI project success: CHEM21 scientists go #green to create #chemicals for an environmentally friendly #pharma sector http://t.c…","id":"626359553450471424","possibly_sensitive":false,"created_at":"2015-07-29T11:52:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"626359522077069313","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626330783897264128"}],"lang":"en","text":"RT @ICH_news: ICH Q3C(R6) (PDE for MIBK and for TEA) reaches Step 2b of the ICH Process and enters the consultation period. See http://t.co…","id":"626359522077069313","possibly_sensitive":false,"created_at":"2015-07-29T11:52:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{},"hashtags":[{"start":51,"end":69,"tag":"WorldHepatitisDay"}],"urls":{}},"conversation_id":"626359419329191937","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626328512996208640"}],"lang":"en","text":"RT @Hep_Alliance: nearly 900 people have taken the #WorldHepatitisDay Quiz but only 1 in 5 knew all the facts! Do you? http://t.co/m6ibmE11…","id":"626359419329191937","possibly_sensitive":false,"created_at":"2015-07-29T11:51:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":87,"end":93,"tag":"PhEur"},{"start":94,"end":104,"tag":"monograph"}],"urls":{}},"conversation_id":"626324679050047488","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626324556182102017"}],"lang":"en","text":"RT @edqm_news: If your company is interested in supporting the elaboration of this new #PhEur #monograph, please contact the EDQM http://t.…","id":"626324679050047488","possibly_sensitive":false,"created_at":"2015-07-29T09:33:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/CxdjuAgTrN","expanded_url":"http://bit.ly/1JuzneC","display_url":"bit.ly/1JuzneC"}]},"conversation_id":"626322588520726528","source":"Bitly","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Call for expressions of interest to represent civil society on two EMA scientific committees - apply by 30 September: http://t.co/CxdjuAgTrN","id":"626322588520726528","possibly_sensitive":false,"created_at":"2015-07-29T09:25:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":12,"end":14,"probability":0.7897,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":127,"end":132,"tag":"skin"},{"start":133,"end":140,"tag":"cancer"}],"urls":[{"start":104,"end":126,"url":"http://t.co/46mKrkIxiT","expanded_url":"http://ow.ly/QdA7i","display_url":"ow.ly/QdA7i"}]},"conversation_id":"626321107168194560","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626320073855238145"}],"lang":"en","text":"RT @myESMO: FDA approves sonidegib for treatment of patients with locally-advanced basal cell carcinoma http://t.co/46mKrkIxiT #skin #cancer","id":"626321107168194560","possibly_sensitive":false,"created_at":"2015-07-29T09:19:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":33,"end":41,"username":"WEBRADR","id":"2797520425"}],"annotations":{},"hashtags":[{"start":58,"end":62,"tag":"app"},{"start":67,"end":77,"tag":"medicines"},{"start":78,"end":85,"tag":"safety"}],"urls":[{"start":97,"end":119,"url":"http://t.co/6m6F3Zyg4G","expanded_url":"http://bit.ly/1K70gCq","display_url":"bit.ly/1K70gCq"}]},"conversation_id":"626317248190382080","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626310353991954432"}],"lang":"en","text":"RT @IMI_JU: IMI project success: @WEBRADR launches mobile #app for #medicines #safety monitoring http://t.co/6m6F3Zyg4G","id":"626317248190382080","possibly_sensitive":false,"created_at":"2015-07-29T09:04:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":110,"end":133,"url":"https://t.co/MvBPtEkjIy","expanded_url":"https://twitter.com/Aifa_ufficiale/status/626294126456217601","display_url":"twitter.com/Aifa_ufficiale…"}]},"conversation_id":"626317058750435328","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"626294126456217601"}],"lang":"en","text":"The EMA's CHMP recommends the approval of 10 new medicines and gives a positive opinion for a malaria vaccine https://t.co/MvBPtEkjIy","id":"626317058750435328","possibly_sensitive":false,"created_at":"2015-07-29T09:03:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":[{"start":41,"end":50,"tag":"melanoma"},{"start":74,"end":85,"tag":"skincancer"}],"urls":[{"start":86,"end":109,"url":"https://t.co/hPRsoVMmMl","expanded_url":"https://www.nice.org.uk/news/article/first-guideline-on-deadliest-form-of-skin-cancer-to-reduce-variation-in-care","display_url":"nice.org.uk/news/article/f…"},{"start":110,"end":132,"url":"http://t.co/OTBqZy6ck8","expanded_url":"https://twitter.com/NICEcomms/status/626293617749929984/photo/1","display_url":"pic.twitter.com/OTBqZy6ck8"}]},"conversation_id":"626316834506166272","source":"TweetDeck","public_metrics":{"retweet_count":47,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626293617749929984"}],"lang":"en","text":"RT @NICEcomms: New guidance published on #melanoma, the deadliest form of #skincancer\nhttps://t.co/hPRsoVMmMl http://t.co/OTBqZy6ck8","id":"626316834506166272","possibly_sensitive":false,"created_at":"2015-07-29T09:02:24.000Z","author_id":"116716199","attachments":{"media_keys":["3_626045360767639552"]}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":15,"end":27,"tag":"Call4Tender"},{"start":102,"end":107,"tag":"ERNs"},{"start":108,"end":115,"tag":"CHAFEA"}],"urls":[{"start":116,"end":138,"url":"http://t.co/r8lCvui7Hj","expanded_url":"http://europa.eu/!TQ66Kq","display_url":"europa.eu/!TQ66Kq"}]},"conversation_id":"626072696749715456","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626065905747927040"}],"lang":"en","text":"RT @EU_Health: #Call4Tender: Independent assessment/evaluation bodies for European Reference Networks #ERNs #CHAFEA http://t.co/r8lCvui7Hj.…","id":"626072696749715456","possibly_sensitive":false,"created_at":"2015-07-28T16:52:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{},"hashtags":[{"start":68,"end":77,"tag":"clinical"},{"start":89,"end":99,"tag":"Parkinson"}],"urls":[{"start":102,"end":124,"url":"http://t.co/TVVGVoBU4r","expanded_url":"http://www.epda.eu.com/en/research-papers/2015/prd/07-22-prelatdisord/","display_url":"epda.eu.com/en/research-pa…"}]},"conversation_id":"626054023540551683","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626017435427209217"}],"lang":"en","text":"RT @euparkinsons: Recruitment strategies &amp; patient selection in #clinical trials for #Parkinson's http://t.co/TVVGVoBU4r","id":"626054023540551683","possibly_sensitive":false,"created_at":"2015-07-28T15:38:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":118,"end":126,"username":"ECDC_EU","id":"204752573"}],"annotations":{},"hashtags":[{"start":39,"end":42,"tag":"EU"},{"start":64,"end":74,"tag":"hepatitis"},{"start":99,"end":117,"tag":"WorldHepatitisDay"}],"urls":{}},"conversation_id":"626053981329096704","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626018862585245696"}],"lang":"en","text":"RT @EU_Health: An estimated 10 million #EU citizens infected w. #hepatitis B &amp; C. Many unaware #WorldHepatitisDay @ECDC_EU http://t.co/oSpf…","id":"626053981329096704","possibly_sensitive":false,"created_at":"2015-07-28T15:37:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/EQm0MrSpB3","expanded_url":"http://bit.ly/IMInews","display_url":"bit.ly/IMInews"}]},"conversation_id":"626053955232137216","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626019048015437824"}],"lang":"en","text":"RT @IMI_JU: The July newsletter is out, feat. Call launches, planned Call topics, big data, plus project successes http://t.co/EQm0MrSpB3","id":"626053955232137216","possibly_sensitive":false,"created_at":"2015-07-28T15:37:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ESCAIDE","id":"2974549409"},{"start":117,"end":127,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":100,"end":107,"tag":"CHAFEA"}],"urls":{}},"conversation_id":"626053820473319425","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626019951812440064"}],"lang":"en","text":"RT @ESCAIDE: Register early to secure your spot at Bridging epidemiology &amp; public health policy #CHAFEA workshop @EU_Health http://t.co/1Kv…","id":"626053820473319425","possibly_sensitive":false,"created_at":"2015-07-28T15:37:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"626053768111628288","source":"TweetDeck","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626022308205957120"}],"lang":"en","text":"RT @US_FDA: Today we released a plan for a key set of measurements to help ensure manufacturers are producing quality medication http://t.c…","id":"626053768111628288","possibly_sensitive":false,"created_at":"2015-07-28T15:37:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"}],"annotations":{},"hashtags":[{"start":13,"end":32,"tag":"PublicConsultation"},{"start":94,"end":106,"tag":"HealthClaim"}],"urls":{}},"conversation_id":"626053612800749568","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626023365086683136"}],"lang":"en","text":"RT @Food_EU: #PublicConsultation on the draft general scientific guidance for stakeholders on #HealthClaim applications http://t.co/kK9jAuA…","id":"626053612800749568","possibly_sensitive":false,"created_at":"2015-07-28T15:36:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":38,"end":44,"tag":"PhEur"},{"start":114,"end":128,"tag":"animaltesting"}],"urls":{}},"conversation_id":"626053361314471936","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626027673396072449"}],"lang":"en","text":"RT @edqm_news: General Notices of the #PhEur have been updated with a view to reducing (and ultimately replacing) #animaltesting http://t.c…","id":"626053361314471936","possibly_sensitive":false,"created_at":"2015-07-28T15:35:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/GNhItcjwgK","expanded_url":"http://bit.ly/1rsSElA","display_url":"bit.ly/1rsSElA"}]},"conversation_id":"626053344860217344","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626027722846916609"}],"lang":"en","text":"RT @edqm_news: Reference Standards Database: List of new reference standards &amp; new batches is available : http://t.co/GNhItcjwgK","id":"626053344860217344","possibly_sensitive":false,"created_at":"2015-07-28T15:35:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"annotations":[{"start":83,"end":87,"probability":0.6712,"type":"Person","normalized_text":"Hep B"}],"hashtags":[{"start":23,"end":41,"tag":"WorldHepatitisDay"}],"urls":[{"start":96,"end":118,"url":"http://t.co/ihGV07fjp0","expanded_url":"http://go.usa.gov/3GBz9","display_url":"go.usa.gov/3GBz9"}]},"conversation_id":"626053296743182336","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626030745568546817"}],"lang":"en","text":"RT @FDAWomen: Today is #WorldHepatitisDay. Learn about FDA-approved treatments for Hep B and C. http://t.co/ihGV07fjp0","id":"626053296743182336","possibly_sensitive":false,"created_at":"2015-07-28T15:35:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":82,"end":88,"probability":0.9909,"type":"Place","normalized_text":"Romania"},{"start":101,"end":106,"probability":0.9868,"type":"Place","normalized_text":"Sweden"}],"hashtags":[{"start":13,"end":23,"tag":"Hepatitis"}],"urls":[{"start":111,"end":133,"url":"http://t.co/IjlyX3zj6v","expanded_url":"http://bit.ly/1KwaaPx","display_url":"bit.ly/1KwaaPx"}]},"conversation_id":"626053250706501636","source":"TweetDeck","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626035511736541184"}],"lang":"en","text":"RT @ECDC_EU: #Hepatitis B: &gt;13000 chronic cases in 2013. Rates from 0.1/100000 in Romania to 15.5 in Sweden http://t.co/IjlyX3zj6v http://t…","id":"626053250706501636","possibly_sensitive":false,"created_at":"2015-07-28T15:35:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":{},"hashtags":[{"start":90,"end":101,"tag":"4000voices"},{"start":102,"end":120,"tag":"WorldHepatitisDay"}],"urls":{}},"conversation_id":"626052352680796160","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626039522439110656"}],"lang":"en","text":"RT @WHO_Europe_VPI: 4000 deaths a day is 4000 too many. Preventing hepatitis is up to you\n#4000voices #WorldHepatitisDay http://t.co/x8ftIb…","id":"626052352680796160","possibly_sensitive":false,"created_at":"2015-07-28T15:31:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":[{"start":71,"end":73,"probability":0.8514,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":98,"end":120,"url":"http://t.co/9aZYXY5ea1","expanded_url":"http://ht.ly/Qbp2m","display_url":"ht.ly/Qbp2m"}]},"conversation_id":"626052294610698240","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626042246358503424"}],"lang":"en","text":"RT @FDA_MCMi: Background material for the July 29 Science Board to the FDA meeting now available: http://t.co/9aZYXY5ea1","id":"626052294610698240","possibly_sensitive":false,"created_at":"2015-07-28T15:31:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"}],"annotations":{},"hashtags":[{"start":87,"end":94,"tag":"safety"}],"urls":{}},"conversation_id":"626052155456266240","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626045275489087488"}],"lang":"en","text":"RT @NICESciAdvice: EMA encouraging the use of scientific advice for post-authorisation #safety studies through a 12-month pilot: http://t.c…","id":"626052155456266240","possibly_sensitive":false,"created_at":"2015-07-28T15:30:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":103,"end":108,"probability":0.9876,"type":"Place","normalized_text":"Europe"}],"hashtags":{},"urls":{}},"conversation_id":"626052073700913152","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626048024398163968"}],"lang":"en","text":"RT @HepatitisEurope: HBV &amp; HCV, serious asymptomatic infectious diseases, kill approx 120k citizens in Europe/year.  Let's fight epidemic  …","id":"626052073700913152","possibly_sensitive":false,"created_at":"2015-07-28T15:30:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{},"hashtags":[{"start":13,"end":23,"tag":"Hepatitis"}],"urls":[{"start":106,"end":128,"url":"http://t.co/mN4XUamiSI","expanded_url":"http://bit.ly/1OyTp7b","display_url":"bit.ly/1OyTp7b"}]},"conversation_id":"626052025692913664","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626048490393567232"}],"lang":"en","text":"RT @ECDC_EU: #Hepatitis C: from 2006-13, &gt;241000 infections were diagnosed. Rates show an upward trend http://t.co/mN4XUamiSI http://t.co/f…","id":"626052025692913664","possibly_sensitive":false,"created_at":"2015-07-28T15:30:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"626051966523834370","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"626049572301836289"}],"lang":"en","text":"RT @HepatitisEurope: Approx. 57% adv. liver disease cases &amp; 78% primary liver cancer cases relate to hep. B or C infection http://t.co/7ExQ…","id":"626051966523834370","possibly_sensitive":false,"created_at":"2015-07-28T15:29:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":33,"tag":"guideline"}],"urls":[{"start":94,"end":116,"url":"http://t.co/CvZ7vOQ2Py","expanded_url":"http://bit.ly/1VLagsM","display_url":"bit.ly/1VLagsM"}]},"conversation_id":"626035123104952320","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft #guideline on the processing of renewals in the centralised procedure: http://t.co/CvZ7vOQ2Py","id":"626035123104952320","possibly_sensitive":false,"created_at":"2015-07-28T14:22:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":70,"end":77,"tag":"safety"}],"urls":[{"start":112,"end":134,"url":"http://t.co/87D1Qxgfrk","expanded_url":"http://bit.ly/1GYi1AA","display_url":"bit.ly/1GYi1AA"}]},"conversation_id":"626030516836429824","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We're encouraging the use of scientific advice for post-authorisation #safety studies through a 12-month pilot: http://t.co/87D1Qxgfrk","id":"626030516836429824","possibly_sensitive":false,"created_at":"2015-07-28T14:04:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":26,"end":36,"tag":"guideline"},{"start":40,"end":52,"tag":"biosimilars"},{"start":64,"end":76,"tag":"recombinant"},{"start":77,"end":89,"tag":"granulocyte"}],"urls":[{"start":117,"end":139,"url":"http://t.co/NguyyBp1su","expanded_url":"http://bit.ly/1D5SF8T","display_url":"bit.ly/1D5SF8T"}]},"conversation_id":"625945953388859392","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on revising #guideline on #biosimilars containing #recombinant #granulocyte-colony stimulating factor: http://t.co/NguyyBp1su","id":"625945953388859392","possibly_sensitive":false,"created_at":"2015-07-28T08:28:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":25,"end":36,"tag":"guidelines"},{"start":62,"end":72,"tag":"medicines"}],"urls":[{"start":107,"end":129,"url":"http://t.co/P0xPCpdlA6","expanded_url":"http://bit.ly/1Owddb5","display_url":"bit.ly/1Owddb5"}]},"conversation_id":"625945919784153089","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on revised #guidelines on fast track routes for #medicines that address unmet medical needs: http://t.co/P0xPCpdlA6","id":"625945919784153089","possibly_sensitive":false,"created_at":"2015-07-28T08:28:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":52,"tag":"Nivolumab"},{"start":60,"end":69,"tag":"medicine"},{"start":98,"end":103,"tag":"lung"},{"start":104,"end":111,"tag":"cancer"}],"urls":[{"start":114,"end":136,"url":"http://t.co/wQXMs9awvA","expanded_url":"http://bit.ly/1IpIrR6","display_url":"bit.ly/1IpIrR6"}]},"conversation_id":"625945766327152640","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Nivolumab BMS, a #medicine for squamous non-small cell #lung #cancer:  http://t.co/wQXMs9awvA","id":"625945766327152640","possibly_sensitive":false,"created_at":"2015-07-28T08:27:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":53,"tag":"Pregabalin"},{"start":65,"end":74,"tag":"medicine"},{"start":79,"end":88,"tag":"epilepsy"},{"start":93,"end":101,"tag":"anxiety"}],"urls":[{"start":112,"end":134,"url":"http://t.co/txsrXCxJBA","expanded_url":"http://bit.ly/1KuX2wL","display_url":"bit.ly/1KuX2wL"}]},"conversation_id":"625945532272410624","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Pregabalin Zentiva, a #medicine for #epilepsy and #anxiety disorder: http://t.co/txsrXCxJBA","id":"625945532272410624","possibly_sensitive":false,"created_at":"2015-07-28T08:26:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":52,"tag":"Nivolumab"},{"start":60,"end":69,"tag":"medicine"},{"start":98,"end":103,"tag":"lung"},{"start":104,"end":111,"tag":"cancer"}],"urls":[{"start":114,"end":136,"url":"http://t.co/wQXMs9awvA","expanded_url":"http://bit.ly/1IpIrR6","display_url":"bit.ly/1IpIrR6"}]},"conversation_id":"625705596797501440","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Nivolumab BMS, a #medicine for squamous non-small cell #lung #cancer:  http://t.co/wQXMs9awvA","id":"625705596797501440","possibly_sensitive":false,"created_at":"2015-07-27T16:33:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":29,"end":40,"tag":"Bortezomib"},{"start":67,"end":75,"tag":"myeloma"},{"start":92,"end":101,"tag":"lymphoma"}],"urls":[{"start":103,"end":125,"url":"http://t.co/bv6u93TSo1","expanded_url":"http://bit.ly/1LNc4wB","display_url":"bit.ly/1LNc4wB"}]},"conversation_id":"625700398469414912","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the EPAR for #Bortezomib Accord, to treat multiple #myeloma and mantle cell #lymphoma: http://t.co/bv6u93TSo1","id":"625700398469414912","possibly_sensitive":false,"created_at":"2015-07-27T16:12:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"annotations":[{"start":64,"end":85,"probability":0.9076,"type":"Organization","normalized_text":"ICH Steering Committee"}],"hashtags":{},"urls":{}},"conversation_id":"625689744765243392","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625658059784876032"}],"lang":"en","text":"RT @ICH_news: Follow in details the main decisions taken by the ICH Steering Committee in June 2015. See the SC meeting report: \nhttp://t.c…","id":"625689744765243392","possibly_sensitive":false,"created_at":"2015-07-27T15:30:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"625689683390038016","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625662267611344896"}],"lang":"en","text":"RT @edqm_news: Two vacancies at the EDQM for a Scientific assistant and a Study director in Analytical chemistry - apply today! http://t.co…","id":"625689683390038016","possibly_sensitive":false,"created_at":"2015-07-27T15:30:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":57,"end":63,"tag":"PhEur"},{"start":112,"end":121,"tag":"european"},{"start":122,"end":136,"tag":"pharmacopoeia"}],"urls":[{"start":88,"end":110,"url":"http://t.co/CRekMrJMru","expanded_url":"http://bit.ly/1LtSeqD","display_url":"bit.ly/1LtSeqD"}]},"conversation_id":"625689666503753729","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625662373014151168"}],"lang":"en","text":"RT @edqm_news: Download the latest Work Programme of the #PhEur Commission (March 2015) http://t.co/CRekMrJMru  #european #pharmacopoeia","id":"625689666503753729","possibly_sensitive":false,"created_at":"2015-07-27T15:30:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":15,"end":17,"probability":0.536,"type":"Organization","normalized_text":"PDG"}],"hashtags":[{"start":113,"end":124,"tag":"impurities"}],"urls":{}},"conversation_id":"625689653400739840","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625662417700265984"}],"lang":"en","text":"RT @edqm_news: PDG confirm their commitment to harmonise the general chapter on testing procedures for elemental #impurities http://t.co/0n…","id":"625689653400739840","possibly_sensitive":false,"created_at":"2015-07-27T15:30:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"IAPOvoice","id":"180728609"},{"start":63,"end":73,"username":"IAPOvoice","id":"180728609"}],"annotations":[{"start":77,"end":98,"probability":0.5614,"type":"Organization","normalized_text":"WHO Regional Committee"}],"hashtags":{},"urls":{}},"conversation_id":"625689624350969856","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625663269706055680"}],"lang":"en","text":"RT @IAPOvoice: The deadline for apps from members to represent @IAPOvoice at WHO Regional Committee meetings is TODAY! Apply: http://t.co/k…","id":"625689624350969856","possibly_sensitive":false,"created_at":"2015-07-27T15:30:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":123,"end":128,"probability":0.9731,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":54,"end":59,"tag":"hepC"},{"start":92,"end":97,"tag":"hepB"},{"start":99,"end":104,"tag":"HepA"}],"urls":{}},"conversation_id":"625689514615435264","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625666026542362624"}],"lang":"en","text":"RT @ECDC_EU: Latest data on viral hepatitis: reported #hepC rate more than twice as high as #hepB. #HepA is re-emerging in Europe http://t.…","id":"625689514615435264","possibly_sensitive":false,"created_at":"2015-07-27T15:29:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"annotations":{},"hashtags":[{"start":40,"end":47,"tag":"asthma"}],"urls":{}},"conversation_id":"625689441496076288","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625676026824278016"}],"lang":"en","text":"RT @EuropeanLung: Are you interested in #asthma research? Tell us which topics you think should be prioritised in this survey. http://t.co/…","id":"625689441496076288","possibly_sensitive":false,"created_at":"2015-07-27T15:29:22.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{},"hashtags":[{"start":81,"end":85,"tag":"flu"},{"start":86,"end":95,"tag":"toxicity"},{"start":96,"end":100,"tag":"RSV"},{"start":101,"end":109,"tag":"BigData"},{"start":110,"end":120,"tag":"Alzheimer"},{"start":121,"end":128,"tag":"cancer"}],"urls":[{"start":58,"end":80,"url":"http://t.co/RK3L6gVEUv","expanded_url":"http://bit.ly/futuretopics","display_url":"bit.ly/futuretopics"}]},"conversation_id":"625689323963351040","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625681361345622016"}],"lang":"en","text":"RT @IMI_JU: Out now: early info on our autumn Call topics http://t.co/RK3L6gVEUv #flu #toxicity #RSV #BigData #Alzheimer #cancer #GetNetwor…","id":"625689323963351040","possibly_sensitive":false,"created_at":"2015-07-27T15:28:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":28,"end":34,"tag":"Blood"}],"urls":{}},"conversation_id":"625689242103083008","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625681910178648064"}],"lang":"en","text":"RT @edqm_news: 18th Edition #Blood guide: Why a European guide? Who is the guide designed for? What information does it contain?  http://t.…","id":"625689242103083008","possibly_sensitive":false,"created_at":"2015-07-27T15:28:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":13,"end":18,"probability":0.9829,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":44,"end":54,"tag":"hepatitis"},{"start":80,"end":98,"tag":"WorldHepatitisDay"}],"urls":{}},"conversation_id":"625689209903427584","source":"TweetDeck","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625684591051825152"}],"lang":"en","text":"RT @ECDC_EU: Europe reports 50 000 cases of #hepatitis B and C yearly. Ahead of #WorldHepatitisDay, learn why testing saves lives: http://t…","id":"625689209903427584","possibly_sensitive":false,"created_at":"2015-07-27T15:28:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{},"hashtags":[{"start":96,"end":106,"tag":"Parkinson"}],"urls":[{"start":110,"end":132,"url":"http://t.co/J14sPFX2bk","expanded_url":"http://www.epda.eu.com/en/research-papers/2015/mdj/07-22-movdisord/","display_url":"epda.eu.com/en/research-pa…"}]},"conversation_id":"625689170216910848","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625686863509094401"}],"lang":"en","text":"RT @euparkinsons: Gray&amp; white matter imaging: A biomarker for cognitive impairment in early #Parkinson's? http://t.co/J14sPFX2bk","id":"625689170216910848","possibly_sensitive":false,"created_at":"2015-07-27T15:28:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":26,"end":36,"tag":"guideline"},{"start":40,"end":52,"tag":"biosimilars"},{"start":64,"end":76,"tag":"recombinant"},{"start":77,"end":89,"tag":"granulocyte"}],"urls":[{"start":117,"end":139,"url":"http://t.co/NguyyBp1su","expanded_url":"http://bit.ly/1D5SF8T","display_url":"bit.ly/1D5SF8T"}]},"conversation_id":"625686642116923392","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on revising #guideline on #biosimilars containing #recombinant #granulocyte-colony stimulating factor: http://t.co/NguyyBp1su","id":"625686642116923392","possibly_sensitive":false,"created_at":"2015-07-27T15:18:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":25,"end":36,"tag":"guidelines"},{"start":62,"end":72,"tag":"medicines"}],"urls":[{"start":107,"end":129,"url":"http://t.co/P0xPCpdlA6","expanded_url":"http://bit.ly/1Owddb5","display_url":"bit.ly/1Owddb5","status":403,"unwound_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002381.jsp&mid=WC0b01ac058004d5c1"}]},"conversation_id":"625660036770058240","source":"Bitly","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on revised #guidelines on fast track routes for #medicines that address unmet medical needs: http://t.co/P0xPCpdlA6","id":"625660036770058240","possibly_sensitive":false,"created_at":"2015-07-27T13:32:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EUTenders","id":"294046348"},{"start":16,"end":30,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":47,"end":54,"tag":"Tender"}],"urls":{}},"conversation_id":"625623514599530496","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625623058959757312"}],"lang":"en","text":"RT @EUTenders: .@EU_Commission Chemical Agency #Tender on evaluation of biocidal disinfectants for the 2nd priority list Exp. 1.9.15 http:/…","id":"625623514599530496","possibly_sensitive":false,"created_at":"2015-07-27T11:07:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"},{"start":18,"end":27,"username":"EUnetHTA","id":"56493220"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"625618574456016896","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625618509352030208"}],"lang":"en","text":"RT @EUnetHTA: New @EUnetHTA public consultation on \"Core protocol Pilot for Additional Evidence Generation (AEG)\". Read more:http://t.co/kH…","id":"625618574456016896","possibly_sensitive":false,"created_at":"2015-07-27T10:47:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":83,"end":92,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":15,"end":27,"probability":0.6108,"type":"Organization","normalized_text":"Civil Society"}],"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/qJjfEq6Q2u","expanded_url":"http://europa.eu/!yQ93UB","display_url":"europa.eu/!yQ93UB"}]},"conversation_id":"625598065479675904","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624932227193942016"}],"lang":"en","text":"RT @EU_Health: Civil Society representatives: Call 4 expression of interest open 4 @EMA_News Management Board http://t.co/qJjfEq6Q2u Deadli…","id":"625598065479675904","possibly_sensitive":false,"created_at":"2015-07-27T09:26:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":41,"end":44,"tag":"EU"},{"start":45,"end":52,"tag":"Health"}],"urls":[{"start":104,"end":126,"url":"http://t.co/H6ySmMVz6I","expanded_url":"http://europa.eu/!HT94Km","display_url":"europa.eu/!HT94Km"}]},"conversation_id":"625597425680556032","source":"TweetDeck","public_metrics":{"retweet_count":121,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625235410202042368"}],"lang":"en","text":"RT @EU_Health: 2015 Annual Work Plan for #EU #Health Programme adopted. What priorities will be funded? http://t.co/H6ySmMVz6I http://t.co/…","id":"625597425680556032","possibly_sensitive":false,"created_at":"2015-07-27T09:23:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EUTenders","id":"294046348"},{"start":16,"end":23,"username":"EU_ENV","id":"366037745"}],"annotations":{},"hashtags":[{"start":24,"end":31,"tag":"Tender"}],"urls":[{"start":116,"end":138,"url":"http://t.co/bhEeu1QbWl","expanded_url":"http://ow.ly/PYqZ0","display_url":"ow.ly/PYqZ0"}]},"conversation_id":"625596453759647744","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625294674253750272"}],"lang":"en","text":"RT @EUTenders: .@EU_ENV #Tender Options for a strategic approach to pharmaceuticals in the environment Exp. 17.9.15 http://t.co/bhEeu1QbWl …","id":"625596453759647744","possibly_sensitive":false,"created_at":"2015-07-27T09:19:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":13,"end":32,"tag":"PublicConsultation"}],"urls":[{"start":105,"end":127,"url":"http://t.co/4lqclDFc12","expanded_url":"http://bit.ly/1Kt1VDJ","display_url":"bit.ly/1Kt1VDJ"}]},"conversation_id":"625596100783800320","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625576396023328768"}],"lang":"en","text":"RT @EFSA_EU: #PublicConsultation – assessment of products notified as food for special medical purposes  http://t.co/4lqclDFc12","id":"625596100783800320","possibly_sensitive":false,"created_at":"2015-07-27T09:18:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{},"hashtags":[{"start":24,"end":35,"tag":"HepatitisC"}],"urls":{}},"conversation_id":"625595997092212737","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"625591901794762752"}],"lang":"en","text":"RT @WHO_Europe: What is #HepatitisC ? transmission, prevention ... learn what u need to know about this bloodborne virus http://t.co/JsDrmf…","id":"625595997092212737","possibly_sensitive":false,"created_at":"2015-07-27T09:18:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":53,"tag":"Bortezomib"},{"start":80,"end":88,"tag":"myeloma"},{"start":105,"end":114,"tag":"lymphoma"}],"urls":[{"start":116,"end":138,"url":"http://t.co/bv6u93TSo1","expanded_url":"http://bit.ly/1LNc4wB","display_url":"bit.ly/1LNc4wB"}]},"conversation_id":"625590985649750016","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Bortezomib Accord, to treat multiple #myeloma and mantle cell #lymphoma: http://t.co/bv6u93TSo1","id":"625590985649750016","possibly_sensitive":false,"created_at":"2015-07-27T08:58:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":53,"end":63,"tag":"Valeriana"},{"start":87,"end":96,"tag":"valerian"}],"urls":[{"start":104,"end":126,"url":"http://t.co/EcyW3hOjnp","expanded_url":"http://bit.ly/1DBgRe0","display_url":"bit.ly/1DBgRe0"}]},"conversation_id":"625590305258098688","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft European Union list entry for #Valeriana officinalis L., radix (#valerian root): http://t.co/EcyW3hOjnp","id":"625590305258098688","possibly_sensitive":false,"created_at":"2015-07-27T08:55:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":44,"end":54,"tag":"Valeriana"},{"start":78,"end":87,"tag":"valerian"}],"urls":[{"start":95,"end":117,"url":"http://t.co/IWjjFU7ATs","expanded_url":"http://bit.ly/1OpX8DU","display_url":"bit.ly/1OpX8DU"}]},"conversation_id":"625590270051110913","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"fr","text":"#Consultation on draft #herbal monograph on #Valeriana officinalis L., radix (#valerian root): http://t.co/IWjjFU7ATs","id":"625590270051110913","possibly_sensitive":false,"created_at":"2015-07-27T08:55:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":45,"end":53,"tag":"Silybum"},{"start":91,"end":99,"tag":"thistle"}],"urls":[{"start":108,"end":130,"url":"http://t.co/Gq41y2Lg8J","expanded_url":"http://bit.ly/1MoWsQB","display_url":"bit.ly/1MoWsQB"}]},"conversation_id":"625590215143497728","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft #herbal monograph for #Silybum marianum (L.) Gaertn., fructus (milk #thistle fruit): http://t.co/Gq41y2Lg8J","id":"625590215143497728","possibly_sensitive":false,"created_at":"2015-07-27T08:55:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":45,"end":55,"tag":"Valeriana"},{"start":85,"end":94,"tag":"valerian"}],"urls":[{"start":111,"end":133,"url":"http://t.co/P9DTAONHgK","expanded_url":"http://bit.ly/1MroITy","display_url":"bit.ly/1MroITy"}]},"conversation_id":"625590184986439680","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft #herbal monograph for #Valeriana officinalis L., aetheroleum (#valerian essential oil): http://t.co/P9DTAONHgK","id":"625590184986439680","possibly_sensitive":false,"created_at":"2015-07-27T08:54:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":14,"end":23,"tag":"Inductos"},{"start":25,"end":36,"tag":"dibotermin"},{"start":63,"end":70,"tag":"spinal"},{"start":93,"end":103,"tag":"fractures"}],"urls":[{"start":105,"end":127,"url":"http://t.co/8jbWBfzbcD","expanded_url":"http://bit.ly/1Kp3Uf4","display_url":"bit.ly/1Kp3Uf4"}]},"conversation_id":"625590029977579521","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"EMA to review #Inductos (#dibotermin alfa), an implant used in #spinal disc problems and leg #fractures: http://t.co/8jbWBfzbcD","id":"625590029977579521","possibly_sensitive":false,"created_at":"2015-07-27T08:54:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.5017,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":59,"end":73,"tag":"hyperactivity"},{"start":107,"end":112,"tag":"ADHD"}],"urls":[{"start":84,"end":106,"url":"http://t.co/HunYUiktvN","expanded_url":"http://bit.ly/1IiKyBH","display_url":"bit.ly/1IiKyBH"}]},"conversation_id":"625589998742564864","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"EMA recommends approval of treatment for attention deficit #hyperactivity disorder: http://t.co/HunYUiktvN #ADHD","id":"625589998742564864","possibly_sensitive":false,"created_at":"2015-07-27T08:54:13.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":9,"tag":"Praluent"},{"start":11,"end":22,"tag":"alirocumab"},{"start":58,"end":70,"tag":"cholesterol"}],"urls":[{"start":72,"end":94,"url":"http://t.co/nZv5TTAQJD","expanded_url":"http://bit.ly/1Imz98x","display_url":"bit.ly/1Imz98x"}]},"conversation_id":"625589955482546176","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Praluent (#alirocumab) recommended for approval to lower #cholesterol: http://t.co/nZv5TTAQJD","id":"625589955482546176","possibly_sensitive":false,"created_at":"2015-07-27T08:54:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":66,"end":76,"tag":"medicines"}],"urls":[{"start":85,"end":107,"url":"http://t.co/cUkQh9ngl9","expanded_url":"http://bit.ly/1IiI1Yd","display_url":"bit.ly/1IiI1Yd"}]},"conversation_id":"625589922611757056","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the highlights of last week's committee for human #medicines (CHMP): http://t.co/cUkQh9ngl9","id":"625589922611757056","possibly_sensitive":false,"created_at":"2015-07-27T08:53:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":66,"end":76,"tag":"guideline"},{"start":94,"end":105,"tag":"anticancer"},{"start":106,"end":116,"tag":"medicines"}],"urls":[{"start":118,"end":140,"url":"http://t.co/KqqTWPrki1","expanded_url":"http://bit.ly/1Jbrbgn","display_url":"bit.ly/1Jbrbgn"}]},"conversation_id":"624600825134854146","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on reporting of safety data from trials in revising #guideline on evaluation of #anticancer #medicines: http://t.co/KqqTWPrki1","id":"624600825134854146","possibly_sensitive":false,"created_at":"2015-07-24T15:23:35.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":[{"start":35,"end":37,"probability":0.8931,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":90,"end":112,"url":"http://t.co/xbvQTYVJxi","expanded_url":"http://ht.ly/Q2eUg","display_url":"ht.ly/Q2eUg"}]},"conversation_id":"624600452043116545","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624567068524969988"}],"lang":"en","text":"RT @FDA_MCMi: Science Board to the FDA will meet July 29 (Silver Spring, MD and webcast): http://t.co/xbvQTYVJxi","id":"624600452043116545","possibly_sensitive":false,"created_at":"2015-07-24T15:22:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/BbWqETAM1O","expanded_url":"http://www.nice.org.uk/guidance/qs95","display_url":"nice.org.uk/guidance/qs95"}]},"conversation_id":"624600404446220288","source":"TweetDeck","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624575828823818240"}],"lang":"en","text":"RT @NICEcomms: Our new quality standard sets out priorities to help more adults with bipolar disorder access care http://t.co/BbWqETAM1O","id":"624600404446220288","possibly_sensitive":false,"created_at":"2015-07-24T15:21:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":23,"end":26,"probability":0.5836,"type":"Organization","normalized_text":"EFSA"}],"hashtags":{},"urls":[{"start":77,"end":99,"url":"http://t.co/eT1lcBHDfI","expanded_url":"http://bit.ly/1JiZsNv","display_url":"bit.ly/1JiZsNv"}]},"conversation_id":"624600336297123840","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624579810715639809"}],"lang":"en","text":"RT @EFSA_EU: Learn how EFSA establishes its Scientific Committee and Panels. http://t.co/eT1lcBHDfI","id":"624600336297123840","possibly_sensitive":false,"created_at":"2015-07-24T15:21:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":80,"end":98,"tag":"immunosuppressive"}],"urls":{}},"conversation_id":"624600256127242240","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624586205523521536"}],"lang":"en","text":"RT @edqm_news: This highlights importance of prescribing physical activity with #immunosuppressive therapy for transplanted patients http:/…","id":"624600256127242240","possibly_sensitive":false,"created_at":"2015-07-24T15:21:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{},"hashtags":[{"start":36,"end":46,"tag":"hepatitis"},{"start":97,"end":115,"tag":"WorldHepatitisDay"}],"urls":{}},"conversation_id":"624600240121778178","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624587004626350080"}],"lang":"en","text":"RT @Hep_Alliance: How many types of #hepatitis are there? Test your hepatitis knowledge with the #WorldHepatitisDay quiz! http://t.co/B9LkB…","id":"624600240121778178","possibly_sensitive":false,"created_at":"2015-07-24T15:21:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":{},"urls":[{"start":63,"end":85,"url":"http://t.co/pWgAXS6OIT","expanded_url":"http://bit.ly/1MphIFV","display_url":"bit.ly/1MphIFV"}]},"conversation_id":"624600223386484736","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624587352367890432"}],"lang":"en","text":"RT @EFSA_EU: Discover EFSA’s scientific process – step by step http://t.co/pWgAXS6OIT","id":"624600223386484736","possibly_sensitive":false,"created_at":"2015-07-24T15:21:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"WEBRADR","id":"2797520425"},{"start":13,"end":21,"username":"WEBRADR","id":"2797520425"}],"annotations":[{"start":61,"end":71,"probability":0.7664,"type":"Product","normalized_text":"Google Play"},{"start":100,"end":105,"probability":0.6323,"type":"Product","normalized_text":"iTunes"},{"start":135,"end":137,"probability":0.7654,"type":"Product","normalized_text":"iOS"}],"hashtags":{},"urls":[{"start":73,"end":96,"url":"https://t.co/3bl4cSyCnQ","expanded_url":"https://play.google.com/store/apps/details?id=uk.org.mhra.yellowcard&hl=en_GB","display_url":"play.google.com/store/apps/det…"},{"start":107,"end":130,"url":"https://t.co/6jxt8lH9YW","expanded_url":"https://itunes.apple.com/gb/app/yellow-card-mhra/id990237487?ls=1&mt=8or","display_url":"itunes.apple.com/gb/app/yellow-…"}]},"conversation_id":"624600091244924933","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624592462967783424"}],"lang":"en","text":"RT @WEBRADR: @WEBRADR Yellow Card App is LIVE! Download from Google Play https://t.co/3bl4cSyCnQ or iTunes https://t.co/6jxt8lH9YW for iOS/…","id":"624600091244924933","possibly_sensitive":false,"created_at":"2015-07-24T15:20:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{},"hashtags":{},"urls":[{"start":74,"end":96,"url":"http://t.co/6YveYA3Pfg","expanded_url":"http://go.usa.gov/3727d","display_url":"go.usa.gov/3727d"}]},"conversation_id":"624600070806114308","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624592497235202048"}],"lang":"en","text":"RT @FDA_Drug_Info: New! FDA Drug Safety Podcast on Proglycem (diazoxide): http://t.co/6YveYA3Pfg","id":"624600070806114308","possibly_sensitive":false,"created_at":"2015-07-24T15:20:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.5393,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":100,"end":108,"tag":"malaria"},{"start":109,"end":117,"tag":"vaccine"}],"urls":[{"start":77,"end":99,"url":"http://t.co/0k8I8Pmlwa","expanded_url":"http://bit.ly/1elljqI","display_url":"bit.ly/1elljqI"},{"start":118,"end":140,"url":"http://t.co/b24BsUfdvE","expanded_url":"https://twitter.com/EMA_News/status/624581058604838912/photo/1","display_url":"pic.twitter.com/b24BsUfdvE"}]},"conversation_id":"624581058604838912","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"EMA assessment can facilitate access to new medicines for people outside EU: http://t.co/0k8I8Pmlwa #malaria #vaccine http://t.co/b24BsUfdvE","id":"624581058604838912","possibly_sensitive":false,"created_at":"2015-07-24T14:05:03.000Z","author_id":"116716199","attachments":{"media_keys":["3_624580542139240448"]}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":14,"end":23,"tag":"Inductos"},{"start":25,"end":36,"tag":"dibotermin"},{"start":63,"end":70,"tag":"spinal"},{"start":93,"end":103,"tag":"fractures"}],"urls":[{"start":105,"end":127,"url":"http://t.co/8jbWBfzbcD","expanded_url":"http://bit.ly/1Kp3Uf4","display_url":"bit.ly/1Kp3Uf4"}]},"conversation_id":"624579888767496192","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"EMA to review #Inductos (#dibotermin alfa), an implant used in #spinal disc problems and leg #fractures: http://t.co/8jbWBfzbcD","id":"624579888767496192","possibly_sensitive":false,"created_at":"2015-07-24T14:00:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.5017,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":59,"end":73,"tag":"hyperactivity"},{"start":107,"end":112,"tag":"ADHD"}],"urls":[{"start":84,"end":106,"url":"http://t.co/HunYUiktvN","expanded_url":"http://bit.ly/1IiKyBH","display_url":"bit.ly/1IiKyBH"}]},"conversation_id":"624579572261093376","source":"Bitly","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"EMA recommends approval of treatment for attention deficit #hyperactivity disorder: http://t.co/HunYUiktvN #ADHD","id":"624579572261093376","possibly_sensitive":false,"created_at":"2015-07-24T13:59:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":9,"tag":"Praluent"},{"start":11,"end":22,"tag":"alirocumab"},{"start":58,"end":70,"tag":"cholesterol"}],"urls":[{"start":72,"end":94,"url":"http://t.co/nZv5TTAQJD","expanded_url":"http://bit.ly/1Imz98x","display_url":"bit.ly/1Imz98x","status":403,"unwound_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002377.jsp&mid=WC0b01ac058004d5c1"}]},"conversation_id":"624579306103177217","source":"Bitly","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Praluent (#alirocumab) recommended for approval to lower #cholesterol: http://t.co/nZv5TTAQJD","id":"624579306103177217","possibly_sensitive":false,"created_at":"2015-07-24T13:58:05.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":68,"end":78,"tag":"medicines"}],"urls":[{"start":87,"end":109,"url":"http://t.co/cUkQh9ngl9","expanded_url":"http://bit.ly/1IiI1Yd","display_url":"bit.ly/1IiI1Yd"}]},"conversation_id":"624579148888076288","source":"Bitly","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the highlights from this week's committee for human #medicines (CHMP): http://t.co/cUkQh9ngl9","id":"624579148888076288","possibly_sensitive":false,"created_at":"2015-07-24T13:57:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"IAPOvoice","id":"180728609"}],"annotations":{},"hashtags":{},"urls":[{"start":67,"end":89,"url":"http://t.co/zAhVlKVhLY","expanded_url":"http://bit.ly/1OBUJXn","display_url":"bit.ly/1OBUJXn"},{"start":90,"end":112,"url":"http://t.co/4upwhoY9EB","expanded_url":"https://twitter.com/IAPOvoice/status/624535763368189952/photo/1","display_url":"pic.twitter.com/4upwhoY9EB"}]},"conversation_id":"624539887442771968","source":"TweetDeck","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624535763368189952"}],"lang":"en","text":"RT @IAPOvoice: The world's first malaria vaccine gets green light: http://t.co/zAhVlKVhLY http://t.co/4upwhoY9EB","id":"624539887442771968","possibly_sensitive":false,"created_at":"2015-07-24T11:21:27.000Z","author_id":"116716199","attachments":{"media_keys":["3_624535762650861572"]}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":15,"end":22,"probability":0.8149,"type":"Organization","normalized_text":"PDG News"}],"hashtags":[{"start":62,"end":73,"tag":"monographs"},{"start":119,"end":133,"tag":"pharmacopoeia"},{"start":134,"end":140,"tag":"pheur"}],"urls":[{"start":95,"end":117,"url":"http://t.co/0naFEF8RH1","expanded_url":"http://bit.ly/1CUFE1O","display_url":"bit.ly/1CUFE1O"}]},"conversation_id":"624531712714899456","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624514514529206272"}],"lang":"en","text":"RT @edqm_news: PDG News: 29 general chapters and 48 excipient #monographs have been harmonised http://t.co/0naFEF8RH1  #pharmacopoeia #pheur","id":"624531712714899456","possibly_sensitive":false,"created_at":"2015-07-24T10:48:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":19,"end":27,"tag":"vacancy"}],"urls":{}},"conversation_id":"624531694306095104","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624514599426072576"}],"lang":"en","text":"RT @edqm_news: New #vacancy at the EDQM for a Principal Scientific Assistant to plan, implement and run selected laboratory studies http://…","id":"624531694306095104","possibly_sensitive":false,"created_at":"2015-07-24T10:48:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":113,"end":122,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":58,"end":66,"tag":"Malaria"}],"urls":{}},"conversation_id":"624531350763241472","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624505554094981121"}],"lang":"en","text":"RT @KGeorgievaEU: Huge hope for humanity as world's first #Malaria vaccine gets go-ahead from European regulator @EMA_News. Congrats for de…","id":"624531350763241472","possibly_sensitive":false,"created_at":"2015-07-24T10:47:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":53,"end":63,"tag":"Valeriana"},{"start":87,"end":96,"tag":"valerian"}],"urls":[{"start":104,"end":126,"url":"http://t.co/EcyW3hOjnp","expanded_url":"http://bit.ly/1DBgRe0","display_url":"bit.ly/1DBgRe0"}]},"conversation_id":"624526738438160384","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft European Union list entry for #Valeriana officinalis L., radix (#valerian root): http://t.co/EcyW3hOjnp","id":"624526738438160384","possibly_sensitive":false,"created_at":"2015-07-24T10:29:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":44,"end":54,"tag":"Valeriana"},{"start":78,"end":87,"tag":"valerian"}],"urls":[{"start":95,"end":117,"url":"http://t.co/IWjjFU7ATs","expanded_url":"http://bit.ly/1OpX8DU","display_url":"bit.ly/1OpX8DU"}]},"conversation_id":"624526319683018752","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"fr","text":"#Consultation on draft #herbal monograph on #Valeriana officinalis L., radix (#valerian root): http://t.co/IWjjFU7ATs","id":"624526319683018752","possibly_sensitive":false,"created_at":"2015-07-24T10:27:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":45,"end":53,"tag":"Silybum"},{"start":91,"end":99,"tag":"thistle"}],"urls":[{"start":108,"end":130,"url":"http://t.co/Gq41y2Lg8J","expanded_url":"http://bit.ly/1MoWsQB","display_url":"bit.ly/1MoWsQB"}]},"conversation_id":"624525774591275008","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft #herbal monograph for #Silybum marianum (L.) Gaertn., fructus (milk #thistle fruit): http://t.co/Gq41y2Lg8J","id":"624525774591275008","possibly_sensitive":false,"created_at":"2015-07-24T10:25:22.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":45,"end":55,"tag":"Valeriana"},{"start":85,"end":94,"tag":"valerian"}],"urls":[{"start":111,"end":133,"url":"http://t.co/P9DTAONHgK","expanded_url":"http://bit.ly/1MroITy","display_url":"bit.ly/1MroITy"}]},"conversation_id":"624525338442338304","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft #herbal monograph for #Valeriana officinalis L., aetheroleum (#valerian essential oil): http://t.co/P9DTAONHgK","id":"624525338442338304","possibly_sensitive":false,"created_at":"2015-07-24T10:23:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":95,"end":117,"url":"http://t.co/0k8I8PDWUK","expanded_url":"http://bit.ly/1elljqI","display_url":"bit.ly/1elljqI"},{"start":118,"end":140,"url":"http://t.co/HHjuR45plI","expanded_url":"https://twitter.com/EMA_News/status/624506657637302273/photo/1","display_url":"pic.twitter.com/HHjuR45plI"}]},"conversation_id":"624506657637302273","source":"TweetDeck","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Malaria vaccine reviewed by 'article 58' procedure, for medicines used outside European Union: http://t.co/0k8I8PDWUK http://t.co/HHjuR45plI","id":"624506657637302273","possibly_sensitive":false,"created_at":"2015-07-24T09:09:24.000Z","author_id":"116716199","attachments":{"media_keys":["3_624505884564168704"]}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":26,"end":36,"tag":"guideline"},{"start":54,"end":65,"tag":"anticancer"},{"start":66,"end":76,"tag":"medicines"}],"urls":[{"start":118,"end":140,"url":"http://t.co/KqqTWP9Jqt","expanded_url":"http://bit.ly/1Jbrbgn","display_url":"bit.ly/1Jbrbgn"}]},"conversation_id":"624500004112179200","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on revising #guideline on evaluation of #anticancer #medicines on reporting of safety data from trials: http://t.co/KqqTWP9Jqt","id":"624500004112179200","possibly_sensitive":false,"created_at":"2015-07-24T08:42:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":51,"end":82,"probability":0.5059,"type":"Organization","normalized_text":"Head of IT Operations Department"}],"hashtags":[{"start":108,"end":120,"tag":"recruitment"}],"urls":[{"start":85,"end":107,"url":"http://t.co/2HqaY0zRLh","expanded_url":"http://bit.ly/1R44uNO","display_url":"bit.ly/1R44uNO"}]},"conversation_id":"624497949456867328","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Deadline approaching to apply to our vacancy for a Head of IT Operations Department: http://t.co/2HqaY0zRLh #recruitment","id":"624497949456867328","possibly_sensitive":false,"created_at":"2015-07-24T08:34:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":31,"end":41,"tag":"medicines"},{"start":46,"end":55,"tag":"children"},{"start":80,"end":91,"tag":"paediatric"}],"urls":[{"start":57,"end":79,"url":"http://t.co/yjVNSizDN7","expanded_url":"http://bit.ly/1CWw2Ug","display_url":"bit.ly/1CWw2Ug"}]},"conversation_id":"624497167307264001","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Stimulating the development of #medicines for #children: http://t.co/yjVNSizDN7 #paediatric","id":"624497167307264001","possibly_sensitive":false,"created_at":"2015-07-24T08:31:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":6,"end":14,"tag":"malaria"},{"start":15,"end":23,"tag":"vaccine"}],"urls":[{"start":71,"end":93,"url":"http://t.co/0k8I8PDWUK","expanded_url":"http://bit.ly/1elljqI","display_url":"bit.ly/1elljqI"}]},"conversation_id":"624496841774788608","source":"Bitly","public_metrics":{"retweet_count":40,"reply_count":5,"like_count":13,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"First #malaria #vaccine receives positive scientific opinion from EMA: http://t.co/0k8I8PDWUK","id":"624496841774788608","possibly_sensitive":false,"created_at":"2015-07-24T08:30:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{},"hashtags":[{"start":16,"end":34,"tag":"WorldHepatitisDay"},{"start":98,"end":109,"tag":"4000voices"}],"urls":[{"start":75,"end":97,"url":"http://t.co/LHZFOF9Kji","expanded_url":"http://bit.ly/1Ozba6J","display_url":"bit.ly/1Ozba6J"},{"start":110,"end":132,"url":"http://t.co/3iPPhjfdgz","expanded_url":"https://twitter.com/WHO_Europe/status/624200221275357185/photo/1","display_url":"pic.twitter.com/3iPPhjfdgz"}]},"conversation_id":"624260597677432836","source":"TweetDeck","public_metrics":{"retweet_count":63,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624200221275357185"}],"lang":"en","text":"RT @WHO_Europe: #WorldHepatitisDay is July 28. Prevent Hepatitis. Act Now. http://t.co/LHZFOF9Kji #4000voices http://t.co/3iPPhjfdgz","id":"624260597677432836","possibly_sensitive":false,"created_at":"2015-07-23T16:51:39.000Z","author_id":"116716199","attachments":{"media_keys":["3_624200220272824320"]}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":97,"end":106,"username":"EJHP_BMJ","id":"3086481070"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"624174098457993216","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624141490277773312"}],"lang":"en","text":"RT @EAHPtweet: Latest EAHP EU Monitor includes updates on Falsified Meds Directive &amp; special @EJHP_BMJ edition on medication review http://…","id":"624174098457993216","possibly_sensitive":false,"created_at":"2015-07-23T11:07:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"DigitalAgendaEU","id":"2894539229"},{"start":89,"end":99,"username":"eurohumph","id":"318332175"}],"annotations":{},"hashtags":[{"start":123,"end":136,"tag":"mediafreedom"}],"urls":[{"start":100,"end":122,"url":"http://t.co/GaJKP4wDdw","expanded_url":"http://europa.eu/!Ug78wx","display_url":"europa.eu/!Ug78wx"}]},"conversation_id":"624174048981975040","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624143268482260992"}],"lang":"en","text":"RT @DigitalAgendaEU: Transparency of media ownership is particularly high on EU's agenda @eurohumph http://t.co/GaJKP4wDdw #mediafreedom ht…","id":"624174048981975040","possibly_sensitive":false,"created_at":"2015-07-23T11:07:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"escardio","id":"21572529"}],"annotations":{},"hashtags":[{"start":14,"end":25,"tag":"Cardiology"}],"urls":[{"start":95,"end":117,"url":"http://t.co/DYhihrH5Ys","expanded_url":"http://bit.ly/1MK08uk","display_url":"bit.ly/1MK08uk"}]},"conversation_id":"624173976512786432","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624144051848278016"}],"lang":"ro","text":"RT @escardio: #Cardiology Arrhythmogenic right ventricular cardiomyopathy and sports activity \nhttp://t.co/DYhihrH5Ys","id":"624173976512786432","possibly_sensitive":false,"created_at":"2015-07-23T11:07:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":20,"end":26,"tag":"Ebola"}],"urls":[{"start":44,"end":66,"url":"http://t.co/D0dNmiIpXb","expanded_url":"http://goo.gl/XUxNKq","display_url":"goo.gl/XUxNKq"},{"start":82,"end":104,"url":"http://t.co/v5BfQBgXnD","expanded_url":"https://twitter.com/WHO/status/624152006299676672/photo/1","display_url":"pic.twitter.com/v5BfQBgXnD"}]},"conversation_id":"624173906174324736","source":"TweetDeck","public_metrics":{"retweet_count":107,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624152006299676672"}],"lang":"en","text":"RT @WHO: Latest WHO #Ebola Situation Report http://t.co/D0dNmiIpXb (22 July 2015) http://t.co/v5BfQBgXnD","id":"624173906174324736","possibly_sensitive":false,"created_at":"2015-07-23T11:07:10.000Z","author_id":"116716199","attachments":{"media_keys":["3_624152004173148161"]}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":39,"end":50,"tag":"healthcare"}],"urls":[{"start":106,"end":128,"url":"http://t.co/QugufVYJpC","expanded_url":"http://europa.eu/!gM63nY","display_url":"europa.eu/!gM63nY"}]},"conversation_id":"624173893675274240","source":"TweetDeck","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624153382278823936"}],"lang":"en","text":"RT @EU_Health: Calling all specialised #healthcare providers - 2nd European Reference Networks conference http://t.co/QugufVYJpC http://t.c…","id":"624173893675274240","possibly_sensitive":false,"created_at":"2015-07-23T11:07:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Budget","id":"392741474"}],"annotations":{},"hashtags":[{"start":30,"end":39,"tag":"EUBudget"}],"urls":[{"start":98,"end":120,"url":"http://t.co/iV3MdGu1Gn","expanded_url":"http://europa.eu/!mm43xm","display_url":"europa.eu/!mm43xm"}]},"conversation_id":"624173766738857984","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624170985407778816"}],"lang":"en","text":"RT @EU_Budget: An overview of #EUBudget spending in 2014 - 142 bln € in commitments. Read more at http://t.co/iV3MdGu1Gn http://t.co/tRJdoJ…","id":"624173766738857984","possibly_sensitive":false,"created_at":"2015-07-23T11:06:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"}],"annotations":[{"start":40,"end":82,"probability":0.3603,"type":"Other","normalized_text":"Scientific Advice Regen Meds Seminar London"}],"hashtags":{},"urls":{}},"conversation_id":"624173675185577984","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624158678854332416"}],"lang":"en","text":"RT @NICESciAdvice: Pls come to our NICE Scientific Advice Regen Meds Seminar London 16 September 2015! Programme and registration: https://…","id":"624173675185577984","possibly_sensitive":false,"created_at":"2015-07-23T11:06:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":31,"end":41,"tag":"medicines"},{"start":46,"end":55,"tag":"children"},{"start":80,"end":91,"tag":"paediatric"}],"urls":[{"start":57,"end":79,"url":"http://t.co/yjVNSizDN7","expanded_url":"http://bit.ly/1CWw2Ug","display_url":"bit.ly/1CWw2Ug"}]},"conversation_id":"624158151273746432","source":"Bitly","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Stimulating the development of #medicines for #children: http://t.co/yjVNSizDN7 #paediatric","id":"624158151273746432","possibly_sensitive":false,"created_at":"2015-07-23T10:04:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":22,"end":30,"tag":"Hetlioz"},{"start":32,"end":44,"tag":"tasimelteon"},{"start":49,"end":58,"tag":"medicine"},{"start":75,"end":81,"tag":"sleep"},{"start":99,"end":105,"tag":"blind"}],"urls":[{"start":116,"end":138,"url":"http://t.co/uEU8nYhvJs","expanded_url":"http://bit.ly/1VuJ9lN","display_url":"bit.ly/1VuJ9lN"}]},"conversation_id":"624134478017990656","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Assessment report for #Hetlioz (#tasimelteon), a #medicine for non-24-hour #sleep-wake disorder in #blind patients: http://t.co/uEU8nYhvJs","id":"624134478017990656","possibly_sensitive":false,"created_at":"2015-07-23T08:30:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":61,"end":70,"tag":"guidance"},{"start":74,"end":84,"tag":"chemistry"}],"urls":[{"start":107,"end":129,"url":"http://t.co/U6kAbefrDI","expanded_url":"http://bit.ly/1DuLkuk","display_url":"bit.ly/1DuLkuk"}]},"conversation_id":"624134417120890880","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on concept paper on need for a single note for #guidance on #chemistry of active substances: http://t.co/U6kAbefrDI","id":"624134417120890880","possibly_sensitive":false,"created_at":"2015-07-23T08:30:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":51,"end":61,"tag":"biomarker"},{"start":96,"end":103,"tag":"kidney"},{"start":104,"end":112,"tag":"disease"}],"urls":[{"start":114,"end":136,"url":"http://t.co/h6YSX7wDkZ","expanded_url":"http://bit.ly/1Kknk4K","display_url":"bit.ly/1Kknk4K"}]},"conversation_id":"624134379384782848","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on total kidney volume as prognostic #biomarker for autosomal dominant polycystic #kidney #disease: http://t.co/h6YSX7wDkZ","id":"624134379384782848","possibly_sensitive":false,"created_at":"2015-07-23T08:30:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":44,"end":53,"tag":"Pistacia"},{"start":84,"end":91,"tag":"mastic"}],"urls":[{"start":105,"end":127,"url":"http://t.co/ZgYBHANtT0","expanded_url":"http://bit.ly/1IiObvT","display_url":"bit.ly/1IiObvT"}]},"conversation_id":"624134251684962304","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft #herbal monograph on #Pistacia lentiscus L., resin (mastix) (#mastic tree resin): http://t.co/ZgYBHANtT0","id":"624134251684962304","possibly_sensitive":false,"created_at":"2015-07-23T08:29:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":45,"end":53,"tag":"Ricinus"},{"start":74,"end":81,"tag":"castor"}],"urls":[{"start":88,"end":110,"url":"http://t.co/sgpwwoESOr","expanded_url":"http://bit.ly/1GCp6X7","display_url":"bit.ly/1GCp6X7"}]},"conversation_id":"624134214544400384","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft #herbal monograph for #Ricinus communis L., oleum (#castor oil): http://t.co/sgpwwoESOr","id":"624134214544400384","possibly_sensitive":false,"created_at":"2015-07-23T08:29:27.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":51,"end":82,"probability":0.5059,"type":"Organization","normalized_text":"Head of IT Operations Department"}],"hashtags":[{"start":108,"end":120,"tag":"recruitment"}],"urls":[{"start":85,"end":107,"url":"http://t.co/2HqaY0zRLh","expanded_url":"http://bit.ly/1R44uNO","display_url":"bit.ly/1R44uNO"}]},"conversation_id":"624133778794004480","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Deadline approaching to apply to our vacancy for a Head of IT Operations Department: http://t.co/2HqaY0zRLh #recruitment","id":"624133778794004480","possibly_sensitive":false,"created_at":"2015-07-23T08:27:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":12,"end":14,"probability":0.7074,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":{}},"conversation_id":"624133121244536832","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623919368200683520"}],"lang":"en","text":"RT @US_FDA: FDA Patient Network Newsletter covers topics such as product approvals, labeling changes, safety warnings and more. http://t.co…","id":"624133121244536832","possibly_sensitive":false,"created_at":"2015-07-23T08:25:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":[{"start":23,"end":39,"probability":0.5147,"type":"Other","normalized_text":"FDA Science Forum"}],"hashtags":[{"start":105,"end":114,"tag":"FDAvoice"}],"urls":[{"start":82,"end":104,"url":"http://t.co/VpBMFsS8Sf","expanded_url":"http://ht.ly/PXrj8","display_url":"ht.ly/PXrj8"}]},"conversation_id":"624133079469268993","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623936112562700289"}],"lang":"en","text":"RT @FDA_MCMi: Miss the FDA Science Forum? View highlights in this 5-minute video: http://t.co/VpBMFsS8Sf #FDAvoice","id":"624133079469268993","possibly_sensitive":false,"created_at":"2015-07-23T08:24:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"},{"start":113,"end":123,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":65,"end":70,"tag":"MERS"}],"urls":{}},"conversation_id":"624132976171950080","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624122472468754432"}],"lang":"en","text":"RT @ECDC_Outbreaks: Risk for travellers to countries affected by #MERS to acquire MERS-CoV infection is low. See @EU_Health advice http://t…","id":"624132976171950080","possibly_sensitive":false,"created_at":"2015-07-23T08:24:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"PGEU","id":"459292439"}],"annotations":{},"hashtags":[{"start":88,"end":101,"tag":"medsdisposal"}],"urls":[{"start":102,"end":124,"url":"http://t.co/krtWFqLixa","expanded_url":"http://ow.ly/OFzH2","display_url":"ow.ly/OFzH2"}]},"conversation_id":"624132861742989312","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624128095793082368"}],"lang":"en","text":"RT @PGEU: Be sure to dispose of your unused medicines safely. Learn how to do it today! #medsdisposal http://t.co/krtWFqLixa","id":"624132861742989312","possibly_sensitive":false,"created_at":"2015-07-23T08:24:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":43,"end":48,"tag":"EDQM"},{"start":87,"end":92,"tag":"CPhI"}],"urls":[{"start":118,"end":140,"url":"http://t.co/AkZaq7ldu8","expanded_url":"http://bit.ly/1LiAgXJ","display_url":"bit.ly/1LiAgXJ"}]},"conversation_id":"624132776070135808","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"624132643039395840"}],"lang":"en","text":"RT @edqm_news: Do you know that One-to-One #EDQM CEP Sessions will be available during #CPhI Worldwide? Sign up today http://t.co/AkZaq7ldu8","id":"624132776070135808","possibly_sensitive":false,"created_at":"2015-07-23T08:23:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":[{"start":38,"end":48,"tag":"Hepatitis"},{"start":109,"end":127,"tag":"WorldHepatitisDay"}],"urls":{}},"conversation_id":"623883227846045696","source":"TweetDeck","public_metrics":{"retweet_count":82,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623883206471847936"}],"lang":"en","text":"RT @WHO: Do you have any questions on #Hepatitis? Tweet them to us. \nWe'll tweet answers from our experts on #WorldHepatitisDay, 28 July","id":"623883227846045696","possibly_sensitive":false,"created_at":"2015-07-22T15:52:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":22,"end":30,"tag":"Hetlioz"},{"start":32,"end":44,"tag":"tasimelteon"},{"start":49,"end":58,"tag":"medicine"},{"start":75,"end":81,"tag":"sleep"},{"start":99,"end":105,"tag":"blind"}],"urls":[{"start":116,"end":138,"url":"http://t.co/uEU8nYhvJs","expanded_url":"http://bit.ly/1VuJ9lN","display_url":"bit.ly/1VuJ9lN"}]},"conversation_id":"623883052368982016","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Assessment report for #Hetlioz (#tasimelteon), a #medicine for non-24-hour #sleep-wake disorder in #blind patients: http://t.co/uEU8nYhvJs","id":"623883052368982016","possibly_sensitive":false,"created_at":"2015-07-22T15:51:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":29,"end":40,"tag":"Pregabalin"},{"start":56,"end":65,"tag":"medicine"},{"start":70,"end":79,"tag":"epilepsy"},{"start":84,"end":92,"tag":"anxiety"}],"urls":[{"start":103,"end":125,"url":"http://t.co/U5c6kY7Nvs","expanded_url":"http://bit.ly/1OlXZWi","display_url":"bit.ly/1OlXZWi"}]},"conversation_id":"623881293252702208","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the EPAR for #Pregabalin Sandoz GmbH, a #medicine for #epilepsy and #anxiety disorder: http://t.co/U5c6kY7Nvs","id":"623881293252702208","possibly_sensitive":false,"created_at":"2015-07-22T15:44:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":[{"start":25,"end":27,"probability":0.4159,"type":"Organization","normalized_text":"JRC"}],"hashtags":[{"start":37,"end":41,"tag":"ICT"},{"start":42,"end":53,"tag":"Innovation"},{"start":55,"end":60,"tag":"SMEs"},{"start":78,"end":81,"tag":"EU"}],"urls":[{"start":113,"end":135,"url":"http://t.co/Ps9FwHHI64","expanded_url":"http://dlvr.it/Bbxj8b","display_url":"dlvr.it/Bbxj8b"}]},"conversation_id":"623867845592616960","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623808723362803712"}],"lang":"en","text":"RT @innovationunion: The JRC writes: #ICT #Innovation: #SMEs make best use of #EU research funding - 22 Jul 2015 http://t.co/Ps9FwHHI64","id":"623867845592616960","possibly_sensitive":false,"created_at":"2015-07-22T14:50:59.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"annotations":{},"hashtags":[{"start":104,"end":108,"tag":"fda"},{"start":109,"end":123,"tag":"medicaldevice"}],"urls":[{"start":81,"end":103,"url":"http://t.co/32OI13q1C4","expanded_url":"http://1.usa.gov/1SBpg8m","display_url":"1.usa.gov/1SBpg8m"}]},"conversation_id":"623867732367405056","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623824819096809472"}],"lang":"en","text":"RT @FDADeviceInfo: Public Workshop - Medical Device Patient Labeling, 9/29-30/15 http://t.co/32OI13q1C4 #fda #medicaldevice","id":"623867732367405056","possibly_sensitive":false,"created_at":"2015-07-22T14:50:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":32,"end":40,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"623867696275394560","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623824883852660736"}],"lang":"en","text":"RT @EFSA_EU: health claims: new @EFSA_EU public consultation on the draft guidance document will be open until 11 Sept. More info: http://t…","id":"623867696275394560","possibly_sensitive":false,"created_at":"2015-07-22T14:50:24.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EUTenders","id":"294046348"},{"start":16,"end":30,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":[{"start":50,"end":57,"tag":"Tender"},{"start":125,"end":135,"tag":"EUtenders"}],"urls":[{"start":102,"end":124,"url":"http://t.co/FseUsKZjcD","expanded_url":"http://ow.ly/PVyk4","display_url":"ow.ly/PVyk4"}]},"conversation_id":"623867627505631232","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623828853157437440"}],"lang":"en","text":"RT @EUTenders: .@EU_Commission EU Chemical Agency #Tender Scientific services for ECHA – Exp. 15.9.15 http://t.co/FseUsKZjcD #EUtenders","id":"623867627505631232","possibly_sensitive":false,"created_at":"2015-07-22T14:50:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"annotations":{},"hashtags":{},"urls":[{"start":111,"end":134,"url":"https://t.co/0TJPpYw51X","expanded_url":"https://twitter.com/NACCHOalerts/status/623535566940962816","display_url":"twitter.com/NACCHOalerts/s…"}]},"conversation_id":"623867530818519040","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623835606444019713"}],"lang":"en","text":"RT @FDA_MCMi: Webinar July 23 - Radiological Legal Preparedness: Considerations, Research, and Lessons Learned https://t.co/0TJPpYw51X","id":"623867530818519040","possibly_sensitive":false,"created_at":"2015-07-22T14:49:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":38,"end":45,"probability":0.4289,"type":"Organization","normalized_text":"MERS-CoV"}],"hashtags":{},"urls":[{"start":105,"end":127,"url":"http://t.co/rsjE9JIUSt","expanded_url":"http://bit.ly/1GC6LcW","display_url":"bit.ly/1GC6LcW"}]},"conversation_id":"623867504318877696","source":"TweetDeck","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623836266124210176"}],"lang":"en","text":"RT @ECDC_EU: Since our last update on MERS-CoV, 13 new cases &amp; 7 deaths have been reported globally. http://t.co/rsjE9JIUSt http://t.co/qUc…","id":"623867504318877696","possibly_sensitive":false,"created_at":"2015-07-22T14:49:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":58,"end":78,"probability":0.3406,"type":"Other","normalized_text":"Synthetic Biology III"}],"hashtags":[{"start":15,"end":34,"tag":"PublicConsultation"},{"start":101,"end":108,"tag":"synbio"}],"urls":[{"start":109,"end":131,"url":"http://t.co/HJyXVv9BcS","expanded_url":"http://europa.eu/!pb47yR","display_url":"europa.eu/!pb47yR"}]},"conversation_id":"623867451793637376","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623842628816252928"}],"lang":"en","text":"RT @EU_Health: #PublicConsultation Preliminary opinion on Synthetic Biology III: Research priorities #synbio http://t.co/HJyXVv9BcS","id":"623867451793637376","possibly_sensitive":false,"created_at":"2015-07-22T14:49:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":38,"end":44,"tag":"PhEur"},{"start":114,"end":128,"tag":"animaltesting"}],"urls":{}},"conversation_id":"623867388107333632","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623848556642832386"}],"lang":"en","text":"RT @edqm_news: General Notices of the #PhEur have been updated with a view to reducing (and ultimately replacing) #animaltesting http://t.c…","id":"623867388107333632","possibly_sensitive":false,"created_at":"2015-07-22T14:49:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EUTenders","id":"294046348"},{"start":16,"end":24,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":25,"end":32,"tag":"Tender"},{"start":109,"end":119,"tag":"EUtenders"}],"urls":[{"start":86,"end":108,"url":"http://t.co/drD97zcrzA","expanded_url":"http://ow.ly/PVz7t","display_url":"ow.ly/PVz7t"}]},"conversation_id":"623867290711379968","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623852719825113088"}],"lang":"en","text":"RT @EUTenders: .@EFSA_EU #Tender Study and analysis on avian influenza – Exp. 26.8.15 http://t.co/drD97zcrzA #EUtenders","id":"623867290711379968","possibly_sensitive":false,"created_at":"2015-07-22T14:48:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":99,"end":113,"tag":"Pharmacopoeia"}],"urls":{}},"conversation_id":"623866464504815616","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623860975960244225"}],"lang":"en","text":"RT @edqm_news: New items were recently added to or deleted from the work programme of the European #Pharmacopoeia Commission http://t.co/U6…","id":"623866464504815616","possibly_sensitive":false,"created_at":"2015-07-22T14:45:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":61,"end":70,"tag":"guidance"},{"start":74,"end":84,"tag":"chemistry"}],"urls":[{"start":107,"end":129,"url":"http://t.co/U6kAbefrDI","expanded_url":"http://bit.ly/1DuLkuk","display_url":"bit.ly/1DuLkuk"}]},"conversation_id":"623855443291557892","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on concept paper on need for a single note for #guidance on #chemistry of active substances: http://t.co/U6kAbefrDI","id":"623855443291557892","possibly_sensitive":false,"created_at":"2015-07-22T14:01:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":51,"end":61,"tag":"biomarker"},{"start":96,"end":103,"tag":"kidney"},{"start":104,"end":112,"tag":"disease"}],"urls":[{"start":114,"end":136,"url":"http://t.co/h6YSX7wDkZ","expanded_url":"http://bit.ly/1Kknk4K","display_url":"bit.ly/1Kknk4K"}]},"conversation_id":"623854742301769729","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on total kidney volume as prognostic #biomarker for autosomal dominant polycystic #kidney #disease: http://t.co/h6YSX7wDkZ","id":"623854742301769729","possibly_sensitive":false,"created_at":"2015-07-22T13:58:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":44,"end":53,"tag":"Pistacia"},{"start":84,"end":91,"tag":"mastic"}],"urls":[{"start":105,"end":127,"url":"http://t.co/ZgYBHANtT0","expanded_url":"http://bit.ly/1IiObvT","display_url":"bit.ly/1IiObvT"}]},"conversation_id":"623850023906885635","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft #herbal monograph on #Pistacia lentiscus L., resin (mastix) (#mastic tree resin): http://t.co/ZgYBHANtT0","id":"623850023906885635","possibly_sensitive":false,"created_at":"2015-07-22T13:40:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":45,"end":53,"tag":"Ricinus"},{"start":74,"end":81,"tag":"castor"}],"urls":[{"start":88,"end":110,"url":"http://t.co/sgpwwoESOr","expanded_url":"http://bit.ly/1GCp6X7","display_url":"bit.ly/1GCp6X7"}]},"conversation_id":"623849555558318080","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on draft #herbal monograph for #Ricinus communis L., oleum (#castor oil): http://t.co/sgpwwoESOr","id":"623849555558318080","possibly_sensitive":false,"created_at":"2015-07-22T13:38:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":42,"end":53,"tag":"Pregabalin"},{"start":69,"end":78,"tag":"medicine"},{"start":83,"end":92,"tag":"epilepsy"},{"start":97,"end":105,"tag":"anxiety"}],"urls":[{"start":116,"end":138,"url":"http://t.co/U5c6kY7Nvs","expanded_url":"http://bit.ly/1OlXZWi","display_url":"bit.ly/1OlXZWi"}]},"conversation_id":"623787382370881536","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the assessment report for #Pregabalin Sandoz GmbH, a #medicine for #epilepsy and #anxiety disorder: http://t.co/U5c6kY7Nvs","id":"623787382370881536","possibly_sensitive":false,"created_at":"2015-07-22T09:31:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":54,"tag":"pharmacovigilance"}],"urls":[{"start":89,"end":111,"url":"http://t.co/sHNW1CFuH3","expanded_url":"http://bit.ly/1OtNfpm","display_url":"bit.ly/1OtNfpm"}]},"conversation_id":"623510685205549056","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the #minutes of our #pharmacovigilance committee (PRAC) meeting in June: http://t.co/sHNW1CFuH3","id":"623510685205549056","possibly_sensitive":false,"created_at":"2015-07-21T15:11:46.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":43,"end":83,"probability":0.3316,"type":"Organization","normalized_text":"Science and Innovation Support Department"}],"hashtags":[{"start":109,"end":121,"tag":"recruitment"}],"urls":[{"start":86,"end":108,"url":"http://t.co/2949i1v7Ri","expanded_url":"http://bit.ly/1IfXj4v","display_url":"bit.ly/1IfXj4v"}]},"conversation_id":"623510467936415744","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We're recruiting a Head of our Regulatory, Science and Innovation Support Department: http://t.co/2949i1v7Ri #recruitment","id":"623510467936415744","possibly_sensitive":false,"created_at":"2015-07-21T15:10:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{},"hashtags":{},"urls":[{"start":53,"end":75,"url":"http://t.co/Tliuten7Kd","expanded_url":"http://cordis.europa.eu/result/rcn/165919_en.html","display_url":"cordis.europa.eu/result/rcn/165…"},{"start":76,"end":98,"url":"http://t.co/hKZ4w5uo0z","expanded_url":"https://twitter.com/GCessak/status/623449409561456640/photo/1","display_url":"pic.twitter.com/hKZ4w5uo0z"}]},"conversation_id":"623460840256184320","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623449409561456640"}],"lang":"en","text":"RT @GCessak: Targeting cancer stem cells for therapy http://t.co/Tliuten7Kd http://t.co/hKZ4w5uo0z","id":"623460840256184320","possibly_sensitive":false,"created_at":"2015-07-21T11:53:42.000Z","author_id":"116716199","attachments":{"media_keys":["3_623449408441462785"]}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":31,"end":38,"tag":"plasma"},{"start":62,"end":69,"tag":"Europe"}],"urls":{}},"conversation_id":"623424438147633152","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623422542196441088"}],"lang":"en","text":"RT @edqm_news: Symposium: What #plasma components are used in #Europe? For what indications? What expectations do clinicians have? http://t…","id":"623424438147633152","possibly_sensitive":false,"created_at":"2015-07-21T09:29:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"},{"start":29,"end":42,"username":"HealthwatchE","id":"551004954"}],"annotations":{},"hashtags":[{"start":50,"end":61,"tag":"safelyhome"}],"urls":{}},"conversation_id":"623424398725394433","source":"TweetDeck","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623424342148386816"}],"lang":"en","text":"RT @NICEcomms: NICE welcomes @HealthwatchE report #safelyhome “An important report, patients need support after hospital discharge” https:/…","id":"623424398725394433","possibly_sensitive":false,"created_at":"2015-07-21T09:28:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":32,"end":45,"tag":"Aripiprazole"},{"start":60,"end":69,"tag":"medicine"},{"start":74,"end":88,"tag":"schizophrenia"},{"start":93,"end":101,"tag":"bipolar"}],"urls":[{"start":112,"end":134,"url":"http://t.co/xcWLA9KsgC","expanded_url":"http://bit.ly/1Jsy9fu","display_url":"bit.ly/1Jsy9fu"}]},"conversation_id":"623423340049530880","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Assessment report published for #Aripiprazole Pharmathen, a #medicine for #schizophrenia and #bipolar disorder: http://t.co/xcWLA9KsgC","id":"623423340049530880","possibly_sensitive":false,"created_at":"2015-07-21T09:24:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"}],"urls":[{"start":96,"end":118,"url":"http://t.co/yvYoSwpujO","expanded_url":"http://bit.ly/1LyfC5X","display_url":"bit.ly/1LyfC5X"}]},"conversation_id":"623423295690514432","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the #agenda of this week's meeting of our committee for human medicines (CHMP): http://t.co/yvYoSwpujO","id":"623423295690514432","possibly_sensitive":false,"created_at":"2015-07-21T09:24:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":47,"tag":"paediatric"}],"urls":[{"start":82,"end":104,"url":"http://t.co/CdsVyFdRa8","expanded_url":"http://bit.ly/1RJAxYX","display_url":"bit.ly/1RJAxYX"}]},"conversation_id":"623423205307453440","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the #minutes of our #paediatric committee (PDCO) meeting in June: http://t.co/CdsVyFdRa8","id":"623423205307453440","possibly_sensitive":false,"created_at":"2015-07-21T09:24:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":39,"end":79,"probability":0.3587,"type":"Organization","normalized_text":"Science and Innovation Support Department"}],"hashtags":[{"start":105,"end":117,"tag":"recruitment"}],"urls":[{"start":82,"end":104,"url":"http://t.co/2949i1v7Ri","expanded_url":"http://bit.ly/1IfXj4v","display_url":"bit.ly/1IfXj4v"}]},"conversation_id":"623418722179514368","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We're hiring a Head of our Regulatory, Science and Innovation Support Department: http://t.co/2949i1v7Ri #recruitment","id":"623418722179514368","possibly_sensitive":false,"created_at":"2015-07-21T09:06:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":28,"end":36,"tag":"minutes"},{"start":44,"end":62,"tag":"pharmacovigilance"}],"urls":[{"start":89,"end":111,"url":"http://t.co/sHNW1CFuH3","expanded_url":"http://bit.ly/1OtNfpm","display_url":"bit.ly/1OtNfpm"}]},"conversation_id":"623416120117215232","source":"Bitly","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the meeting #minutes of our #pharmacovigilance committee (PRAC) in June: http://t.co/sHNW1CFuH3","id":"623416120117215232","possibly_sensitive":false,"created_at":"2015-07-21T08:56:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":41,"end":50,"tag":"guidance"},{"start":54,"end":66,"tag":"manufacture"}],"urls":[{"start":92,"end":114,"url":"http://t.co/gBQ3esSykH","expanded_url":"http://bit.ly/1KfFhBv","display_url":"bit.ly/1KfFhBv"}]},"conversation_id":"623175268274991109","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on paper on need to revise #guidance on #manufacture of finished dosage form: http://t.co/gBQ3esSykH","id":"623175268274991109","possibly_sensitive":false,"created_at":"2015-07-20T16:58:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{},"hashtags":{},"urls":[{"start":70,"end":92,"url":"http://t.co/0F4C2Bn26b","expanded_url":"http://ow.ly/PQlVf","display_url":"ow.ly/PQlVf"}]},"conversation_id":"623162984299372544","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623147278258339840"}],"lang":"en","text":"RT @MHRAgovuk: Our annual report and accounts 2014 to 2015 is out now http://t.co/0F4C2Bn26b","id":"623162984299372544","possibly_sensitive":false,"created_at":"2015-07-20T16:10:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"},{"start":92,"end":107,"username":"EpilepsiaJourn","id":"2321292469"}],"annotations":{},"hashtags":[{"start":108,"end":117,"tag":"epilepsy"}],"urls":[{"start":118,"end":140,"url":"http://t.co/6KJtxMcpe9","expanded_url":"http://onlinelibrary.wiley.com/doi/10.1111/epi.13081/abstract","display_url":"onlinelibrary.wiley.com/doi/10.1111/ep…"}]},"conversation_id":"623162966570090497","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623147768073355264"}],"lang":"en","text":"RT @IlaeWeb: Rapid eye movement sleep reveals epileptogenic spikes for resective surgery... @EpilepsiaJourn #epilepsy http://t.co/6KJtxMcpe9","id":"623162966570090497","possibly_sensitive":false,"created_at":"2015-07-20T16:10:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"},{"start":69,"end":78,"username":"eurordis","id":"26993786"}],"annotations":{},"hashtags":[{"start":38,"end":53,"tag":"RareDiseaseDay"}],"urls":[{"start":113,"end":135,"url":"http://t.co/Ym36fQVqjj","expanded_url":"http://ow.ly/LQjuA","display_url":"ow.ly/LQjuA"}]},"conversation_id":"623162714442100736","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623161194304700416"}],"lang":"en","text":"RT @rarediseaseday: Did you know that #RareDiseaseDay was started by @EURORDIS? Find out more about what they do http://t.co/Ym36fQVqjj","id":"623162714442100736","possibly_sensitive":false,"created_at":"2015-07-20T16:09:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":32,"end":45,"tag":"Aripiprazole"},{"start":60,"end":69,"tag":"medicine"},{"start":74,"end":88,"tag":"schizophrenia"},{"start":93,"end":101,"tag":"bipolar"}],"urls":[{"start":112,"end":134,"url":"http://t.co/xcWLA9KsgC","expanded_url":"http://bit.ly/1Jsy9fu","display_url":"bit.ly/1Jsy9fu"}]},"conversation_id":"623156843523756032","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Assessment report published for #Aripiprazole Pharmathen, a #medicine for #schizophrenia and #bipolar disorder: http://t.co/xcWLA9KsgC","id":"623156843523756032","possibly_sensitive":false,"created_at":"2015-07-20T15:45:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"eular_org","id":"273422795"}],"annotations":{},"hashtags":[{"start":15,"end":21,"tag":"EULAR"},{"start":22,"end":27,"tag":"RODS"}],"urls":{}},"conversation_id":"623154359795339264","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623094512882216960"}],"lang":"en","text":"RT @eular_org: #EULAR #RODS meeting open for registration. Interest in registers &amp; longitudinal observational drug studies? More on http://…","id":"623154359795339264","possibly_sensitive":false,"created_at":"2015-07-20T15:35:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"}],"annotations":{},"hashtags":[{"start":23,"end":38,"tag":"CancerStrategy"}],"urls":[{"start":85,"end":107,"url":"http://t.co/R8FINhwAWz","expanded_url":"http://bit.ly/cancerstrategy2015","display_url":"bit.ly/cancerstrategy…"}]},"conversation_id":"623154284029415424","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623098405867401216"}],"lang":"en","text":"RT @NICESciAdvice: New #CancerStrategy calls for a radical approach to public health http://t.co/R8FINhwAWz","id":"623154284029415424","possibly_sensitive":false,"created_at":"2015-07-20T15:35:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"IAPOvoice","id":"180728609"},{"start":82,"end":91,"username":"eurordis","id":"26993786"}],"annotations":[{"start":50,"end":76,"probability":0.4835,"type":"Organization","normalized_text":"Rare Diseases International"}],"hashtags":[{"start":37,"end":45,"tag":"network"}],"urls":[{"start":93,"end":115,"url":"http://t.co/bC2CFJahud","expanded_url":"http://bit.ly/1fXPxSv","display_url":"bit.ly/1fXPxSv"},{"start":116,"end":138,"url":"http://t.co/svKKJkz1GV","expanded_url":"https://twitter.com/IAPOvoice/status/623099837647572992/photo/1","display_url":"pic.twitter.com/svKKJkz1GV"}]},"conversation_id":"623154254077919233","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623099837647572992"}],"lang":"en","text":"RT @IAPOvoice: How to build a global #network. By Rare Diseases International and @eurordis: http://t.co/bC2CFJahud http://t.co/svKKJkz1GV","id":"623154254077919233","possibly_sensitive":false,"created_at":"2015-07-20T15:35:26.000Z","author_id":"116716199","attachments":{"media_keys":["3_623099836632571904"]}},{"entities":{"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"}],"annotations":[{"start":44,"end":49,"probability":0.9903,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":35,"end":38,"tag":"MS"}],"urls":[{"start":106,"end":128,"url":"http://t.co/vIGq18NEDg","expanded_url":"http://bit.ly/1E8LoEt","display_url":"bit.ly/1E8LoEt"}]},"conversation_id":"623154195508686848","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623104658391855105"}],"lang":"en","text":"RT @eumsplatform: 1,200 + ppl with #MS from Europe have so far filled in our Pan European Patient survey: http://t.co/vIGq18NEDg Have you? …","id":"623154195508686848","possibly_sensitive":false,"created_at":"2015-07-20T15:35:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"},{"start":95,"end":108,"username":"atscommunity","id":"50076632"}],"annotations":{},"hashtags":[{"start":56,"end":60,"tag":"MDR"},{"start":61,"end":64,"tag":"TB"},{"start":83,"end":90,"tag":"TBChat"}],"urls":[{"start":109,"end":131,"url":"http://t.co/zBq133bJio","expanded_url":"http://www.atsjournals.org/doi/abs/10.1164/rccm.201505-0863ED?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed#.Va0CcPmqqkp","display_url":"atsjournals.org/doi/abs/10.116…"}]},"conversation_id":"623153938901172224","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623135177187950592"}],"lang":"en","text":"RT @WHO_Europe_TB: Preventive Therapy after Exposure to #MDR-#TB: Hopes and Fears: #TBChat via @atscommunity http://t.co/zBq133bJio","id":"623153938901172224","possibly_sensitive":false,"created_at":"2015-07-20T15:34:11.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":19,"end":27,"tag":"vacancy"}],"urls":{}},"conversation_id":"623153911709478912","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623135356238594049"}],"lang":"en","text":"RT @edqm_news: New #vacancy at the EDQM for a Principal Scientific Assistant to plan, implement and run selected laboratory studies http://…","id":"623153911709478912","possibly_sensitive":false,"created_at":"2015-07-20T15:34:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":80,"end":89,"probability":0.9525,"type":"Place","normalized_text":"Strasbourg"}],"hashtags":[{"start":28,"end":42,"tag":"Pharmacopoeia"}],"urls":{}},"conversation_id":"623153899126542336","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623135399301484544"}],"lang":"en","text":"RT @edqm_news: The European #Pharmacopoeia Commission held its 152nd session in Strasbourg on 16-17 June 2015. Read about it: http://t.co/o…","id":"623153899126542336","possibly_sensitive":false,"created_at":"2015-07-20T15:34:01.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"}],"urls":[{"start":96,"end":118,"url":"http://t.co/yvYoSwpujO","expanded_url":"http://bit.ly/1LyfC5X","display_url":"bit.ly/1LyfC5X"}]},"conversation_id":"623152993966362624","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the #agenda of this week's meeting of our committee for human medicines (CHMP): http://t.co/yvYoSwpujO","id":"623152993966362624","possibly_sensitive":false,"created_at":"2015-07-20T15:30:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":19,"end":50,"probability":0.4815,"type":"Organization","normalized_text":"British Pharmacopoeia Commission"}],"hashtags":{},"urls":{}},"conversation_id":"623144929942970368","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623141974120525824"}],"lang":"en","text":"RT @MHRAgovuk: The British Pharmacopoeia Commission has 8 new positions avail for 6 professional members and 2 lay members http://t.co/ucAE…","id":"623144929942970368","possibly_sensitive":false,"created_at":"2015-07-20T14:58:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ESCAIDE","id":"2974549409"}],"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"},{"start":60,"end":69,"tag":"Outbreak"}],"urls":{}},"conversation_id":"623143556329402368","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"623143143337271301"}],"lang":"en","text":"RT @ESCAIDE: #ESCAIDE symposium ‘Effective Communication in #Outbreak Management' w/ tools for health professionals: see agenda http://t.co…","id":"623143556329402368","possibly_sensitive":false,"created_at":"2015-07-20T14:52:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":47,"tag":"paediatric"}],"urls":[{"start":82,"end":104,"url":"http://t.co/CdsVyFdRa8","expanded_url":"http://bit.ly/1RJAxYX","display_url":"bit.ly/1RJAxYX"}]},"conversation_id":"623143466218987520","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the #minutes of our #paediatric committee (PDCO) meeting in June: http://t.co/CdsVyFdRa8","id":"623143466218987520","possibly_sensitive":false,"created_at":"2015-07-20T14:52:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":49,"end":58,"tag":"guidance"},{"start":62,"end":74,"tag":"manufacture"}],"urls":[{"start":100,"end":122,"url":"http://t.co/gBQ3esSykH","expanded_url":"http://bit.ly/1KfFhBv","display_url":"bit.ly/1KfFhBv"}]},"conversation_id":"623054269621661696","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation on concept paper on need to revise #guidance on #manufacture of finished dosage form: http://t.co/gBQ3esSykH","id":"623054269621661696","possibly_sensitive":false,"created_at":"2015-07-20T08:58:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Consulation"}],"urls":[{"start":111,"end":133,"url":"http://t.co/Tx6l2Y8nnm","expanded_url":"http://bit.ly/1HJwvZj","display_url":"bit.ly/1HJwvZj"}]},"conversation_id":"622074458799501312","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consulation ending on paper on criteria for evaluation of new active substance status of chemical substances: http://t.co/Tx6l2Y8nnm","id":"622074458799501312","possibly_sensitive":false,"created_at":"2015-07-17T16:04:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Consulation"},{"start":33,"end":47,"tag":"clinicaltrial"},{"start":48,"end":55,"tag":"safety"},{"start":64,"end":74,"tag":"guideline"},{"start":92,"end":103,"tag":"anticancer"},{"start":104,"end":114,"tag":"medicines"}],"urls":[{"start":116,"end":138,"url":"http://t.co/KqqTWP9Jqt","expanded_url":"http://bit.ly/1Jbrbgn","display_url":"bit.ly/1Jbrbgn"}]},"conversation_id":"622074406332932096","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consulation ending on reporting #clinicaltrial #safety data in #guideline on evaluation of #anticancer #medicines: http://t.co/KqqTWP9Jqt","id":"622074406332932096","possibly_sensitive":false,"created_at":"2015-07-17T16:04:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":24,"end":34,"tag":"medicines"}],"urls":[{"start":87,"end":109,"url":"http://t.co/MNA7vpQnyV","expanded_url":"http://bit.ly/1HyzXp2","display_url":"bit.ly/1HyzXp2"}]},"conversation_id":"622074321800966144","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Our committee for human #medicines (CHMP) meets next week. Highlights out next Friday: http://t.co/MNA7vpQnyV","id":"622074321800966144","possibly_sensitive":false,"created_at":"2015-07-17T16:04:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Consulation"},{"start":16,"end":26,"tag":"guideline"},{"start":58,"end":72,"tag":"immunological"},{"start":73,"end":84,"tag":"veterinary"},{"start":85,"end":95,"tag":"medicines"}],"urls":[{"start":104,"end":126,"url":"http://t.co/To0VDNORRv","expanded_url":"http://bit.ly/1RDgtr8","display_url":"bit.ly/1RDgtr8"}]},"conversation_id":"622074269913227264","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consulation on #guideline on production &amp; control of #immunological #veterinary #medicines, Rev.1: http://t.co/To0VDNORRv","id":"622074269913227264","possibly_sensitive":false,"created_at":"2015-07-17T16:03:58.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Consulation"},{"start":41,"end":53,"tag":"penicillins"}],"urls":[{"start":109,"end":131,"url":"http://t.co/RXhni08uA7","expanded_url":"http://bit.ly/1CKVwUx","display_url":"bit.ly/1CKVwUx"}]},"conversation_id":"622074230109261824","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consulation on use of extended-spectrum #penicillins in animals, development of resistance, health impacts: http://t.co/RXhni08uA7","id":"622074230109261824","possibly_sensitive":false,"created_at":"2015-07-17T16:03:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Consulation"},{"start":78,"end":92,"tag":"immunological"},{"start":93,"end":104,"tag":"veterinary"},{"start":105,"end":115,"tag":"medicines"}],"urls":[{"start":117,"end":139,"url":"http://t.co/GUgMmfjr2U","expanded_url":"http://bit.ly/1V9U4Bd","display_url":"bit.ly/1V9U4Bd"}]},"conversation_id":"622074189466464256","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consulation on demonstrating freedom from extraneous agents of seeds used in #immunological #veterinary #medicines: http://t.co/GUgMmfjr2U","id":"622074189466464256","possibly_sensitive":false,"created_at":"2015-07-17T16:03:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"622073886532890624","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"622028333811937280"}],"lang":"en","text":"RT @NICESciAdvice: Come to our NICE Scientific Advice Regen Meds Seminar London 16 September 2015. Programme and registration: https://t.co…","id":"622073886532890624","possibly_sensitive":false,"created_at":"2015-07-17T16:02:26.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{},"hashtags":[{"start":41,"end":44,"tag":"EU"},{"start":45,"end":52,"tag":"Pharma"},{"start":84,"end":95,"tag":"EUPharma50"}],"urls":[{"start":96,"end":118,"url":"http://t.co/5G836iSBre","expanded_url":"http://europa.eu/!nF67dj","display_url":"europa.eu/!nF67dj"}]},"conversation_id":"622073849807564800","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"622031968692211712"}],"lang":"en","text":"RT @EU_Health: Conference on 50 Years of #EU #Pharma legislation: register by 24.07 #EUPharma50 http://t.co/5G836iSBre http://t.co/OnAyjdeP…","id":"622073849807564800","possibly_sensitive":false,"created_at":"2015-07-17T16:02:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":66,"end":74,"tag":"Vacancy"},{"start":75,"end":78,"tag":"IT"},{"start":79,"end":102,"tag":"InfrastructureServices"}],"urls":[{"start":105,"end":127,"url":"http://t.co/A0kHnOyHR3","expanded_url":"http://bit.ly/1KcsdwO","display_url":"bit.ly/1KcsdwO"}]},"conversation_id":"622073709776474113","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"622043090338086912"}],"lang":"en","text":"RT @EFSA_EU: We are hiring a Service analyst. Apply by 30 August. #Vacancy #IT #InfrastructureServices   http://t.co/A0kHnOyHR3","id":"622073709776474113","possibly_sensitive":false,"created_at":"2015-07-17T16:01:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":60,"end":64,"probability":0.461,"type":"Other","normalized_text":"Ebola"},{"start":67,"end":74,"probability":0.2848,"type":"Place","normalized_text":"MERS-CoV"},{"start":80,"end":88,"probability":0.59,"type":"Place","normalized_text":"West Nile"}],"hashtags":{},"urls":[{"start":97,"end":119,"url":"http://t.co/RU9ToFNd4l","expanded_url":"http://bit.ly/1fQdD1e","display_url":"bit.ly/1fQdD1e"}]},"conversation_id":"622073563516940289","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"622062938082410496"}],"lang":"en","text":"RT @ECDC_EU: ECDC weekly threat report: includes updates on Ebola, MERS-CoV and West Nile fever. http://t.co/RU9ToFNd4l","id":"622073563516940289","possibly_sensitive":false,"created_at":"2015-07-17T16:01:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"622073455991762945","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"622068437993529344"}],"lang":"en","text":"RT @EU_ECHA: We welcome your input. Have a look at the ongoing consultations on harmonised classification and labelling http://t.co/OKHweoh…","id":"622073455991762945","possibly_sensitive":false,"created_at":"2015-07-17T16:00:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":[{"start":89,"end":94,"probability":0.3492,"type":"Organization","normalized_text":"Google"}],"hashtags":{},"urls":[{"start":63,"end":85,"url":"http://t.co/0kxO2Yv5kf","expanded_url":"http://ow.ly/PKzB7","display_url":"ow.ly/PKzB7"},{"start":101,"end":123,"url":"http://t.co/Uj9uvPVByT","expanded_url":"http://ow.ly/PKzB8","display_url":"ow.ly/PKzB8"}]},"conversation_id":"622073412568137728","source":"TweetDeck","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"622072321117941760"}],"lang":"en","text":"RT @MHRAgovuk: Download the Yellow Card app from the App Store http://t.co/0kxO2Yv5kf or Google Play http://t.co/Uj9uvPVByT to report probs…","id":"622073412568137728","possibly_sensitive":false,"created_at":"2015-07-17T16:00:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}],"urls":[{"start":109,"end":131,"url":"http://t.co/UwNalMNEY7","expanded_url":"http://bit.ly/1DkUIk4","display_url":"bit.ly/1DkUIk4"}]},"conversation_id":"622069430130974720","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Our #pharmacovigilance committee (PRAC) has confirmed its Chair and Vice-chair for a new three year mandate: http://t.co/UwNalMNEY7","id":"622069430130974720","possibly_sensitive":false,"created_at":"2015-07-17T15:44:44.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"nice_intl","id":"794424916133056512"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"622028260185100288","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621945045969670144"}],"lang":"en","text":"RT @nice_intl: We're hiring a co-ordinator! Get in touch if you are organised, able to prioritise, and thrive under pressure! http://t.co/d…","id":"622028260185100288","possibly_sensitive":false,"created_at":"2015-07-17T13:01:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"H2020SME","id":"874591855626858496"}],"annotations":{},"hashtags":[{"start":31,"end":37,"tag":"H2020"},{"start":38,"end":52,"tag":"SMEinstrument"}],"urls":{}},"conversation_id":"622028127007444993","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621957484383703040"}],"lang":"en","text":"RT @H2020SME: Applications for #H2020 #SMEinstrument Phase 1 or 2 can be submitted at any time during the year (4 cut-off dates) http://t.c…","id":"622028127007444993","possibly_sensitive":false,"created_at":"2015-07-17T13:00:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":57,"end":63,"tag":"PhEur"},{"start":112,"end":121,"tag":"european"},{"start":122,"end":136,"tag":"pharmacopoeia"}],"urls":[{"start":88,"end":110,"url":"http://t.co/CRekMrJMru","expanded_url":"http://bit.ly/1LtSeqD","display_url":"bit.ly/1LtSeqD"}]},"conversation_id":"622028096707891200","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621959011605323776"}],"lang":"en","text":"RT @edqm_news: Download the latest Work Programme of the #PhEur Commission (March 2015) http://t.co/CRekMrJMru  #european #pharmacopoeia","id":"622028096707891200","possibly_sensitive":false,"created_at":"2015-07-17T13:00:29.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":[{"start":46,"end":57,"probability":0.9373,"type":"Person","normalized_text":"David Haslam"}],"hashtags":{},"urls":[{"start":105,"end":127,"url":"http://t.co/IV1T7cIw0g","expanded_url":"http://www.nice.org.uk/news/blog/out-for-consultation","display_url":"nice.org.uk/news/blog/out-…"}]},"conversation_id":"622028071793750016","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621959918539698176"}],"lang":"en","text":"RT @NICEcomms: Read the latest blog post from David Haslam on the importance of our consultation process http://t.co/IV1T7cIw0g http://t.co…","id":"622028071793750016","possibly_sensitive":false,"created_at":"2015-07-17T13:00:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":{},"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/jv9mk2rJNS","expanded_url":"http://ow.ly/PGxnR","display_url":"ow.ly/PGxnR"}]},"conversation_id":"621995562573922304","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621968006927806464"}],"lang":"en","text":"RT @myESMO: Translating basic research to the patient’s bedside. Read the expert viewpoints and join the discussion! http://t.co/jv9mk2rJNS","id":"621995562573922304","possibly_sensitive":false,"created_at":"2015-07-17T10:51:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":7,"probability":0.348,"type":"Organization","normalized_text":"Infarmed"},{"start":27,"end":34,"probability":0.9906,"type":"Place","normalized_text":"Portugal"}],"hashtags":{},"urls":[{"start":77,"end":100,"url":"https://t.co/pjuXrkkUUM","expanded_url":"https://twitter.com/INFARMED_IP/status/621979811280474112","display_url":"twitter.com/INFARMED_IP/st…"}]},"conversation_id":"621995417379713024","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"621979811280474112"}],"lang":"en","text":"Infarmed's new campaign in Portugal on guaranteeing the quality of medicines https://t.co/pjuXrkkUUM","id":"621995417379713024","possibly_sensitive":false,"created_at":"2015-07-17T10:50:38.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"annotations":{},"hashtags":[{"start":12,"end":26,"tag":"eauguidelines"},{"start":27,"end":38,"tag":"paediatric"}],"urls":{}},"conversation_id":"621995083697651712","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621986459231260672"}],"lang":"en","text":"RT @Uroweb: #eauguidelines #paediatric early orchiopexy is important for fertility &amp; testis cancer prevention in adulthood http://t.co/KNq2…","id":"621995083697651712","possibly_sensitive":false,"created_at":"2015-07-17T10:49:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{},"hashtags":[{"start":73,"end":81,"tag":"Vacancy"},{"start":82,"end":85,"tag":"IT"},{"start":86,"end":94,"tag":"Sofware"},{"start":95,"end":108,"tag":"Architecture"},{"start":109,"end":115,"tag":"Cloud"}],"urls":[{"start":116,"end":138,"url":"http://t.co/qs8eA444ih","expanded_url":"http://bit.ly/1e4wqUS","display_url":"bit.ly/1e4wqUS"}]},"conversation_id":"621995056371736576","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621987498324062208"}],"lang":"en","text":"RT @EFSA_EU: We are hiring an Application architect. Apply by 30 August. #Vacancy #IT #Sofware #Architecture #Cloud http://t.co/qs8eA444ih","id":"621995056371736576","possibly_sensitive":false,"created_at":"2015-07-17T10:49:12.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":{},"urls":[{"start":110,"end":132,"url":"http://t.co/GNhItcjwgK","expanded_url":"http://bit.ly/1rsSElA","display_url":"bit.ly/1rsSElA"}]},"conversation_id":"621994978689032192","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621988896965062657"}],"lang":"en","text":"RT @edqm_news: Reference Standards Database: List of new reference standards &amp; new batches is available : http://t.co/GNhItcjwgK","id":"621994978689032192","possibly_sensitive":false,"created_at":"2015-07-17T10:48:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{},"hashtags":[{"start":17,"end":25,"tag":"mHealth"},{"start":59,"end":68,"tag":"patients"},{"start":72,"end":87,"tag":"ChronicDisease"}],"urls":[{"start":99,"end":121,"url":"http://t.co/8PExYOTkyB","expanded_url":"http://bit.ly/1eM0aGO","display_url":"bit.ly/1eM0aGO"}]},"conversation_id":"621994951757418496","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621990729447944192"}],"lang":"en","text":"RT @egagenerics: #mHealth technology promotes adherence of #patients to #ChronicDisease management http://t.co/8PExYOTkyB","id":"621994951757418496","possibly_sensitive":false,"created_at":"2015-07-17T10:48:47.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Consulation"},{"start":79,"end":93,"tag":"immunological"},{"start":94,"end":105,"tag":"veterinary"},{"start":106,"end":116,"tag":"medicines"}],"urls":[{"start":118,"end":140,"url":"http://t.co/GUgMmfjr2U","expanded_url":"http://bit.ly/1V9U4Bd","display_url":"bit.ly/1V9U4Bd"}]},"conversation_id":"621989794084704256","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consulation on demonstrating freedom from extraneous agents of seeds used for #immunological #veterinary #medicines: http://t.co/GUgMmfjr2U","id":"621989794084704256","possibly_sensitive":false,"created_at":"2015-07-17T10:28:17.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Consulation"},{"start":46,"end":58,"tag":"penicillins"}],"urls":[{"start":114,"end":136,"url":"http://t.co/RXhni08uA7","expanded_url":"http://bit.ly/1CKVwUx","display_url":"bit.ly/1CKVwUx"}]},"conversation_id":"621989168714018816","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consulation open on use of extended-spectrum #penicillins in animals, development of resistance, health impacts: http://t.co/RXhni08uA7","id":"621989168714018816","possibly_sensitive":false,"created_at":"2015-07-17T10:25:48.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Consulation"},{"start":21,"end":31,"tag":"guideline"},{"start":63,"end":77,"tag":"immunological"},{"start":78,"end":89,"tag":"veterinary"},{"start":90,"end":100,"tag":"medicines"}],"urls":[{"start":109,"end":131,"url":"http://t.co/To0VDNORRv","expanded_url":"http://bit.ly/1RDgtr8","display_url":"bit.ly/1RDgtr8"}]},"conversation_id":"621988115125792768","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consulation open on #guideline on production &amp; control of #immunological #veterinary #medicines, Rev.1: http://t.co/To0VDNORRv","id":"621988115125792768","possibly_sensitive":false,"created_at":"2015-07-17T10:21:37.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":24,"end":34,"tag":"medicines"}],"urls":[{"start":92,"end":114,"url":"http://t.co/MNA7vpQnyV","expanded_url":"http://bit.ly/1HyzXp2","display_url":"bit.ly/1HyzXp2"}]},"conversation_id":"621987082249052160","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Our committee for human #medicines (CHMP) is meeting next week. Highlights out next Friday: http://t.co/MNA7vpQnyV","id":"621987082249052160","possibly_sensitive":false,"created_at":"2015-07-17T10:17:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":14,"username":"PatientExpert","id":"1371958822676348932"}],"annotations":{},"hashtags":{},"urls":[{"start":119,"end":141,"url":"http://t.co/31p0OP2A8q","expanded_url":"http://bit.ly/1HCWe2V","display_url":"bit.ly/1HCWe2V"}]},"conversation_id":"621703473537642496","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"621751014492893184"}],"lang":"en","text":"@patientexpert It is only in Spanish but this infographic contains information on medicines packaging &amp; labelling: http://t.co/31p0OP2A8q","id":"621986196256915456","possibly_sensitive":false,"created_at":"2015-07-17T10:13:59.000Z","author_id":"116716199","in_reply_to_user_id":"2601284504","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Consulation"},{"start":34,"end":48,"tag":"clinicaltrial"},{"start":49,"end":56,"tag":"safety"},{"start":65,"end":75,"tag":"guideline"},{"start":93,"end":104,"tag":"anticancer"},{"start":105,"end":115,"tag":"medicines"}],"urls":[{"start":117,"end":139,"url":"http://t.co/KqqTWP9Jqt","expanded_url":"http://bit.ly/1Jbrbgn","display_url":"bit.ly/1Jbrbgn"}]},"conversation_id":"621982675969163264","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consulation closing on reporting #clinicaltrial #safety data in #guideline on evaluation of #anticancer #medicines: http://t.co/KqqTWP9Jqt","id":"621982675969163264","possibly_sensitive":false,"created_at":"2015-07-17T10:00:00.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":12,"tag":"Consulation"}],"urls":[{"start":112,"end":134,"url":"http://t.co/Tx6l2Y8nnm","expanded_url":"http://bit.ly/1HJwvZj","display_url":"bit.ly/1HJwvZj"}]},"conversation_id":"621981457720995840","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consulation closing on paper on criteria for evaluation of new active substance status of chemical substances: http://t.co/Tx6l2Y8nnm","id":"621981457720995840","possibly_sensitive":false,"created_at":"2015-07-17T09:55:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":38,"end":47,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":15,"end":17,"probability":0.896,"type":"Organization","normalized_text":"FDA"},{"start":20,"end":32,"probability":0.654,"type":"Organization","normalized_text":"EU Commission"}],"hashtags":[{"start":83,"end":92,"tag":"medicine"}],"urls":{}},"conversation_id":"621722144989429760","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621718934975344640"}],"lang":"en","text":"RT @EuropaBio: FDA, EU Commission and @EMA_News reinforce collaboration to advance #medicine development &amp; evaluation http://t.co/df1prarqL…","id":"621722144989429760","possibly_sensitive":false,"created_at":"2015-07-16T16:44:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":38,"end":47,"username":"EMA_News","id":"116716199"},{"start":52,"end":59,"username":"US_FDA","id":"208120290"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"621717947271282688","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621699996614795264"}],"lang":"en","text":"RT @EBGbiosimilars: Did you know that @EMA_News and @US_FDA increase efforts to avoid regulatory divergence that may delay patients’ access…","id":"621717947271282688","possibly_sensitive":false,"created_at":"2015-07-16T16:28:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":15,"end":21,"tag":"PhEur"},{"start":52,"end":62,"tag":"monograph"},{"start":90,"end":110,"tag":"radiopharmaceutical"}],"urls":{}},"conversation_id":"621717902698397696","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621699647875190785"}],"lang":"en","text":"RT @edqm_news: #PhEur Commission adopts new general #monograph on chemical precursors for #radiopharmaceutical preparations http://t.co/l2T…","id":"621717902698397696","possibly_sensitive":false,"created_at":"2015-07-16T16:27:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":96,"end":105,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":{},"urls":[{"start":69,"end":91,"url":"http://t.co/UTuIKuFD8e","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002367.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}]},"conversation_id":"621717851532079104","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621698957308207105"}],"lang":"fr","text":"RT @egagenerics: New EU/US cluster on patient engagement established http://t.co/UTuIKuFD8e via @EMA_News","id":"621717851532079104","possibly_sensitive":false,"created_at":"2015-07-16T16:27:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":56,"end":63,"username":"US_FDA","id":"208120290"},{"start":68,"end":77,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":20,"end":45,"probability":0.3494,"type":"Organization","normalized_text":"European Biosimilars Group"}],"hashtags":[{"start":121,"end":133,"tag":"biosimilars"}],"urls":{}},"conversation_id":"621717820276142080","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621698229583876097"}],"lang":"en","text":"RT @EBGbiosimilars: European Biosimilars Group welcomes @US_FDA and @EMA_News continued support to global development of #biosimilars http:…","id":"621717820276142080","possibly_sensitive":false,"created_at":"2015-07-16T16:27:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":29,"end":36,"username":"US_FDA","id":"208120290"},{"start":108,"end":117,"username":"EMA_News","id":"116716199"}],"annotations":{},"hashtags":[{"start":118,"end":125,"tag":"pharma"},{"start":126,"end":131,"tag":"news"}],"urls":[{"start":81,"end":103,"url":"http://t.co/UTuIKuFD8e","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002367.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}]},"conversation_id":"621717778173698048","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621697857712746496"}],"lang":"en","text":"RT @egagenerics: EC, EMA and @US_FDA strategic priorities for the next two years http://t.co/UTuIKuFD8e via @EMA_News #pharma #news","id":"621717778173698048","possibly_sensitive":false,"created_at":"2015-07-16T16:27:23.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":73,"end":96,"url":"https://t.co/dPPGUx1RbQ","expanded_url":"https://twitter.com/AEMPSGOB/status/621687938909384704","display_url":"twitter.com/AEMPSGOB/statu…"}]},"conversation_id":"621703473537642496","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"621687938909384704"}],"lang":"en","text":"Infographic on the information and symbols on the packaging of medicines https://t.co/dPPGUx1RbQ","id":"621703473537642496","possibly_sensitive":false,"created_at":"2015-07-16T15:30:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":15,"end":20,"tag":"EDQM"},{"start":34,"end":41,"tag":"Plasma"}],"urls":[{"start":112,"end":134,"url":"http://t.co/bfYYDFuzMu","expanded_url":"http://bit.ly/1KI2NT0","display_url":"bit.ly/1KI2NT0"}]},"conversation_id":"621703251927416832","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621687801629802496"}],"lang":"en","text":"RT @edqm_news: #EDQM Symposium on #Plasma for Direct Clinical Use will be held on 22-23 Sept. More information: http://t.co/bfYYDFuzMu","id":"621703251927416832","possibly_sensitive":false,"created_at":"2015-07-16T15:29:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{},"hashtags":{},"urls":[{"start":98,"end":120,"url":"http://t.co/4Bd9kew7UZ","expanded_url":"http://ow.ly/PHjOv","display_url":"ow.ly/PHjOv"}]},"conversation_id":"621703210827386881","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621687701838954496"}],"lang":"en","text":"RT @MHRAgovuk: Registrations for the good pharmacovigilance practice symposium (GPvP) is now open http://t.co/4Bd9kew7UZ Book now - spaces …","id":"621703210827386881","possibly_sensitive":false,"created_at":"2015-07-16T15:29:30.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"annotations":{},"hashtags":[{"start":17,"end":25,"tag":"Patient"},{"start":62,"end":70,"tag":"bigdata"}],"urls":[{"start":104,"end":126,"url":"http://t.co/o7gEHaDr5j","expanded_url":"http://bit.ly/1eLZIbk","display_url":"bit.ly/1eLZIbk"}]},"conversation_id":"621703052542779392","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621683711717740544"}],"lang":"en","text":"RT @egagenerics: #Patient information is growing up thanks to #bigdata... It's now entering adolescence http://t.co/o7gEHaDr5j http://t.co/…","id":"621703052542779392","possibly_sensitive":false,"created_at":"2015-07-16T15:28:53.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/JMSB49WYuF","expanded_url":"http://www.nice.org.uk/get-involved/join-a-committee/lay-member-heavy-menstrual-bleeding-gusc","display_url":"nice.org.uk/get-involved/j…"}]},"conversation_id":"621702965133504513","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621681555015135232"}],"lang":"en","text":"RT @NICEcomms: We're looking for expert lay members to help us update our guidance on heavy menstrual bleeding: http://t.co/JMSB49WYuF","id":"621702965133504513","possibly_sensitive":false,"created_at":"2015-07-16T15:28:32.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAcdrhIndustry","id":"66367559"}],"annotations":[{"start":25,"end":27,"probability":0.5161,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":94,"end":98,"tag":"fda"},{"start":99,"end":113,"tag":"medicaldevice"}],"urls":[{"start":71,"end":93,"url":"http://t.co/RvSgm7EcwP","expanded_url":"http://1.usa.gov/1K9b8B7","display_url":"1.usa.gov/1K9b8B7"}]},"conversation_id":"621702870182834176","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621679537814945793"}],"lang":"en","text":"RT @FDAcdrhIndustry: The FDA/CDC Antimicrobial Resistance Isolate Bank http://t.co/RvSgm7EcwP #fda #medicaldevice","id":"621702870182834176","possibly_sensitive":false,"created_at":"2015-07-16T15:28:09.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"annotations":[{"start":23,"end":25,"probability":0.5161,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":92,"end":96,"tag":"fda"},{"start":97,"end":111,"tag":"medicaldevice"}],"urls":[{"start":69,"end":91,"url":"http://t.co/mKU78fZ1DC","expanded_url":"http://1.usa.gov/1K9b8B7","display_url":"1.usa.gov/1K9b8B7"}]},"conversation_id":"621702820648091648","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621679537542307840"}],"lang":"en","text":"RT @FDADeviceInfo: The FDA/CDC Antimicrobial Resistance Isolate Bank http://t.co/mKU78fZ1DC #fda #medicaldevice","id":"621702820648091648","possibly_sensitive":false,"created_at":"2015-07-16T15:27:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{},"hashtags":[{"start":90,"end":108,"tag":"WorldHepatitisDay"}],"urls":{}},"conversation_id":"621702792332320769","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621679451110309888"}],"lang":"en","text":"RT @Hep_Alliance: How much do you know about hepatitis? Test your knowledge by taking our #WorldHepatitisDay prevention quiz! http://t.co/0…","id":"621702792332320769","possibly_sensitive":false,"created_at":"2015-07-16T15:27:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":15,"end":20,"tag":"EDQM"}],"urls":{}},"conversation_id":"621676055926042628","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621675212556341248"}],"lang":"en","text":"RT @edqm_news: #EDQM Upcoming Events in our Calendar - Take a look &amp; join us for our next training session or symposium! http://t.co/DsB8on…","id":"621676055926042628","possibly_sensitive":false,"created_at":"2015-07-16T13:41:36.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":42,"end":47,"tag":"EDQM"}],"urls":[{"start":101,"end":123,"url":"http://t.co/J5AzSbqi0S","expanded_url":"http://bit.ly/1J0a1oC","display_url":"bit.ly/1J0a1oC"}]},"conversation_id":"621675934802944000","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621674974328279044"}],"lang":"en","text":"RT @edqm_news: Employment opportunities - #EDQM  has two vacancies which might be of interest to you http://t.co/J5AzSbqi0S","id":"621675934802944000","possibly_sensitive":false,"created_at":"2015-07-16T13:41:07.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{},"hashtags":{},"urls":[{"start":69,"end":91,"url":"http://t.co/lheNycx5Cr","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002370.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}]},"conversation_id":"621675615759020032","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621666299530354688"}],"lang":"en","text":"RT @GCessak: Public register of parallel distribution now available: http://t.co/lheNycx5Cr","id":"621675615759020032","possibly_sensitive":false,"created_at":"2015-07-16T13:39:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"annotations":[{"start":59,"end":61,"probability":0.7837,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":{}},"conversation_id":"621665573227859968","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621663767953342464"}],"lang":"en","text":"RT @US_FDA: Are you a Health Professional? Read the latest FDA Updates for Health Professionals newsletter and sign up http://t.co/xztiUUxl…","id":"621665573227859968","possibly_sensitive":false,"created_at":"2015-07-16T12:59:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"},{"start":20,"end":27,"username":"BIA_UK","id":"26476395"},{"start":34,"end":44,"username":"MHRApress","id":"330990243"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"621658547487670272","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621658517271916545"}],"lang":"en","text":"RT @euparkinsons: * @BIA_UK &amp; @MHRApress publish report following joint conference Pathway of Innovation from Research 2 Patients http://t.…","id":"621658547487670272","possibly_sensitive":false,"created_at":"2015-07-16T12:32:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":[{"start":117,"end":127,"probability":0.8976,"type":"Place","normalized_text":"Netherlands"}],"hashtags":[{"start":32,"end":48,"tag":"VonHippelLindau"}],"urls":{}},"conversation_id":"621658503988543488","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621658425416622080"}],"lang":"en","text":"RT @eurordis: The International #VonHippelLindau Symposium for Young Adults 2015 will take place 31 July – 3 August, Netherlands http://t.c…","id":"621658503988543488","possibly_sensitive":false,"created_at":"2015-07-16T12:31:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":38,"tag":"paediatric"}],"urls":[{"start":93,"end":115,"url":"http://t.co/zVLAhQZgS3","expanded_url":"http://bit.ly/1SmKFC4","display_url":"bit.ly/1SmKFC4"}]},"conversation_id":"621658464272674816","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"The #agenda of this week's #paediatric committee (PDCO) meeting is available on our website: http://t.co/zVLAhQZgS3","id":"621658464272674816","possibly_sensitive":false,"created_at":"2015-07-16T12:31:42.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":87,"end":109,"url":"http://t.co/EBD0m9zeb4","expanded_url":"http://bit.ly/1Dh6xYp","display_url":"bit.ly/1Dh6xYp"}]},"conversation_id":"621657677928755200","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've made our register of parallel distribution of medicines available to the public: http://t.co/EBD0m9zeb4","id":"621657677928755200","possibly_sensitive":false,"created_at":"2015-07-16T12:28:34.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":56,"end":79,"probability":0.5219,"type":"Organization","normalized_text":"IT Operations Department"}],"hashtags":[{"start":106,"end":118,"tag":"recruitment"}],"urls":[{"start":82,"end":104,"url":"http://t.co/2HqaY0zRLh","expanded_url":"http://bit.ly/1R44uNO","display_url":"bit.ly/1R44uNO"}]},"conversation_id":"621657470197497856","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two more weeks to apply for the vacancy for Head of our IT Operations Department: http://t.co/2HqaY0zRLh  #recruitment","id":"621657470197497856","possibly_sensitive":false,"created_at":"2015-07-16T12:27:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{},"hashtags":[{"start":32,"end":50,"tag":"WorldHepatitisDay"}],"urls":[{"start":104,"end":127,"url":"https://t.co/W1zFPXaSOx","expanded_url":"https://goo.gl/VQSrMM","display_url":"goo.gl/VQSrMM"}]},"conversation_id":"621657160821415936","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621651763318276096"}],"lang":"en","text":"RT @Hep_Alliance: 12 days until #WorldHepatitisDay! Download our toolkits in seven different languages: https://t.co/W1zFPXaSOx http://t.co…","id":"621657160821415936","possibly_sensitive":false,"created_at":"2015-07-16T12:26:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":73,"end":96,"url":"https://t.co/VVENzY1Hdw","expanded_url":"https://twitter.com/AEMPSGOB/status/621648720375992321","display_url":"twitter.com/AEMPSGOB/statu…"}]},"conversation_id":"621657015287443457","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Infographic on the information and symbols on the packaging of medicines https://t.co/VVENzY1Hdw","id":"621657015287443457","possibly_sensitive":false,"created_at":"2015-07-16T12:25:56.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":{},"hashtags":[{"start":12,"end":15,"tag":"EU"},{"start":20,"end":28,"tag":"Armenia"}],"urls":[{"start":103,"end":125,"url":"http://t.co/ImYoNiJrw9","expanded_url":"http://www.emcdda.europa.eu/news/2015/fs6/armenia-mou","display_url":"emcdda.europa.eu/news/2015/fs6/…"}]},"conversation_id":"621656789013168128","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621641320734552065"}],"lang":"en","text":"RT @EMCDDA: #EU and #Armenia will cooperate more actively on monitoring the drug phenomenon in future: http://t.co/ImYoNiJrw9","id":"621656789013168128","possibly_sensitive":false,"created_at":"2015-07-16T12:25:02.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{},"hashtags":{},"urls":[{"start":90,"end":112,"url":"http://t.co/yc7DWjsoOt","expanded_url":"http://ow.ly/PGmO3","display_url":"ow.ly/PGmO3"}]},"conversation_id":"621656492438069248","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621631431626915840"}],"lang":"en","text":"RT @MHRAgovuk: Dec/ Jan dates set for good manufacturing distribution practice symposiums http://t.co/yc7DWjsoOt Register to be notified ab…","id":"621656492438069248","possibly_sensitive":false,"created_at":"2015-07-16T12:23:52.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":91,"end":103,"username":"pharmaguapa","id":"106681538"}],"annotations":{},"hashtags":[{"start":50,"end":58,"tag":"patient"},{"start":104,"end":112,"tag":"mHealth"},{"start":113,"end":123,"tag":"ePatients"}],"urls":[{"start":64,"end":86,"url":"http://t.co/JsCEHj73Yz","expanded_url":"http://bit.ly/1IOhw1T","display_url":"bit.ly/1IOhw1T"}]},"conversation_id":"621656290281005056","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621623058554425345"}],"lang":"en","text":"RT @egagenerics: We are now at “the dawn of a new #patient era” http://t.co/JsCEHj73Yz via @pharmaguapa #mHealth #ePatients","id":"621656290281005056","possibly_sensitive":false,"created_at":"2015-07-16T12:23:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"621656103823233024","source":"TweetDeck","public_metrics":{"retweet_count":52,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621620769106337792"}],"lang":"en","text":"RT @WHO: In 2012, all 194 WHO Member States endorsed the Global Vaccine Action Plan &amp; committed to 90% DTP3 vax coverage in all countries b…","id":"621656103823233024","possibly_sensitive":false,"created_at":"2015-07-16T12:22:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":73,"end":88,"username":"V_Andriukaitis","id":"575269517"},{"start":96,"end":103,"username":"epc_eu","id":"1192644307"}],"annotations":{},"hashtags":{},"urls":{}},"conversation_id":"621656064480690176","source":"TweetDeck","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621620282856488960"}],"lang":"en","text":"RT @EU_Health: 'Strong focus on disease prevention and health promotion' @V_Andriukaitis speech @epc_eu CHES annual lecture http://t.co/Hl0…","id":"621656064480690176","possibly_sensitive":false,"created_at":"2015-07-16T12:22:10.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"ERC_Research","id":"467551928"},{"start":25,"end":41,"username":"bbcworldservice","id":"786764"},{"start":74,"end":81,"username":"Moedas","id":"20058825"}],"annotations":[{"start":88,"end":103,"probability":0.5037,"type":"Person","normalized_text":"Pres Bourguignon"}],"hashtags":[{"start":83,"end":87,"tag":"ERC"},{"start":106,"end":114,"tag":"ERC5000"}],"urls":{}},"conversation_id":"621655903436173312","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621612410303041536"}],"lang":"en","text":"RT @ERC_Research: Missed @bbcworldservice debate on European science with @Moedas, #ERC Pres Bourguignon, #ERC5000 grantee? Listen here htt…","id":"621655903436173312","possibly_sensitive":false,"created_at":"2015-07-16T12:21:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"},{"start":45,"end":52,"username":"BIA_UK","id":"26476395"}],"annotations":{},"hashtags":{},"urls":[{"start":80,"end":102,"url":"http://t.co/jHXkWO1kSI","expanded_url":"http://ow.ly/PGblF","display_url":"ow.ly/PGblF"}]},"conversation_id":"621655596576677888","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621606802107535360"}],"lang":"en","text":"RT @MHRApress: We've published a report with @BIA_UK following joint conference http://t.co/jHXkWO1kSI Pathway of Innovation from Research …","id":"621655596576677888","possibly_sensitive":false,"created_at":"2015-07-16T12:20:18.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{},"hashtags":[{"start":47,"end":60,"tag":"HorizonPrize"}],"urls":[{"start":94,"end":116,"url":"http://t.co/XVjbZAA6m1","expanded_url":"http://ec.europa.eu/research/horizonprize/index.cfm?prize=better-use-antibiotics","display_url":"ec.europa.eu/research/horiz…"},{"start":117,"end":140,"url":"https://t.co/mUHuh9m8ib","expanded_url":"https://twitter.com/JPIonAMR/status/620963993029582849","display_url":"twitter.com/JPIonAMR/statu…"}]},"conversation_id":"621655449105006592","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621606352536907777"}],"lang":"en","text":"RT @EU_H2020: Don't forget the EU's €1 million #HorizonPrize  for 'Better use of antibiotics' http://t.co/XVjbZAA6m1 https://t.co/mUHuh9m8ib","id":"621655449105006592","possibly_sensitive":false,"created_at":"2015-07-16T12:19:43.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":43,"end":48,"tag":"EDQM"},{"start":87,"end":92,"tag":"CPhI"}],"urls":[{"start":118,"end":140,"url":"http://t.co/AkZaq7ldu8","expanded_url":"http://bit.ly/1LiAgXJ","display_url":"bit.ly/1LiAgXJ"}]},"conversation_id":"621654932471549953","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621594170721980416"}],"lang":"en","text":"RT @edqm_news: Do you know that One-to-One #EDQM CEP Sessions will be available during #CPhI Worldwide? Sign up today http://t.co/AkZaq7ldu8","id":"621654932471549953","possibly_sensitive":false,"created_at":"2015-07-16T12:17:40.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.8647,"type":"Organization","normalized_text":"FDA"}],"hashtags":{},"urls":[{"start":108,"end":131,"url":"https://t.co/PgqVsuLq7D","expanded_url":"https://twitter.com/Aifa_ufficiale/status/621585306538655744","display_url":"twitter.com/Aifa_ufficiale…"}]},"conversation_id":"621588465478684672","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"621585306538655744"}],"lang":"en","text":"FDA issues guideline for companies on shape, dimensions and size of equivalents for patients with dysphagia https://t.co/PgqVsuLq7D","id":"621588465478684672","possibly_sensitive":false,"created_at":"2015-07-16T07:53:33.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":[{"start":56,"end":79,"probability":0.5325,"type":"Organization","normalized_text":"IT Operations Department"}],"hashtags":[{"start":105,"end":117,"tag":"recruitment"}],"urls":[{"start":82,"end":104,"url":"http://t.co/2HqaY0zRLh","expanded_url":"http://bit.ly/1R44uNO","display_url":"bit.ly/1R44uNO"}]},"conversation_id":"621585010328498176","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Two weeks left to apply for the vacancy for Head of our IT Operations Department: http://t.co/2HqaY0zRLh #recruitment","id":"621585010328498176","possibly_sensitive":false,"created_at":"2015-07-16T07:39:49.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{},"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"},{"start":77,"end":84,"tag":"Cancer"}],"urls":[{"start":95,"end":117,"url":"http://t.co/JyLfV8gVyD","expanded_url":"http://dlvr.it/BXgVbz","display_url":"dlvr.it/BXgVbz"}]},"conversation_id":"621583534692671488","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621583056298618882"}],"lang":"en","text":"RT @innovationunion: #ResearchHeadlines - Biomarkers for personalised breast #Cancer treatment http://t.co/JyLfV8gVyD","id":"621583534692671488","possibly_sensitive":false,"created_at":"2015-07-16T07:33:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{},"hashtags":[{"start":21,"end":32,"tag":"orphandrug"}],"urls":[{"start":47,"end":69,"url":"http://t.co/6SGAic3i9w","expanded_url":"http://ow.ly/PdNaJ","display_url":"ow.ly/PdNaJ"}]},"conversation_id":"621369250486337536","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621295955367870464"}],"lang":"en","text":"RT @eurordis: 11 new #orphandrug designations! http://t.co/6SGAic3i9w","id":"621369250486337536","possibly_sensitive":false,"created_at":"2015-07-15T17:22:28.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAcdrhIndustry","id":"66367559"}],"annotations":{},"hashtags":[{"start":135,"end":139,"tag":"fda"}],"urls":[{"start":112,"end":134,"url":"http://t.co/jp6Xh3lnnQ","expanded_url":"http://1.usa.gov/1GlHaF4","display_url":"1.usa.gov/1GlHaF4"}]},"conversation_id":"621369214499205120","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621299995594113024"}],"lang":"en","text":"RT @FDAcdrhIndustry: Labelers of intraocular lenses may resume submission of identifier records to UDI Database http://t.co/jp6Xh3lnnQ #fda…","id":"621369214499205120","possibly_sensitive":false,"created_at":"2015-07-15T17:22:19.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAcdrhIndustry","id":"66367559"}],"annotations":{},"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/HHFBYGOJ6X","expanded_url":"http://1.usa.gov/1I2X1xK","display_url":"1.usa.gov/1I2X1xK"}]},"conversation_id":"621369157704122368","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621303502585901056"}],"lang":"en","text":"RT @FDAcdrhIndustry: Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devs - Draft Guidance http://t.co/HHFBYGOJ6X #…","id":"621369157704122368","possibly_sensitive":false,"created_at":"2015-07-15T17:22:06.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{},"hashtags":[{"start":55,"end":61,"tag":"PhEur"},{"start":94,"end":114,"tag":"radiopharmaceutical"}],"urls":{}},"conversation_id":"621369113076740096","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621305347270123521"}],"lang":"en","text":"RT @edqm_news: A gap in quality is now filled with new #PhEur text on chemical precursors for #radiopharmaceutical preparations http://t.co…","id":"621369113076740096","possibly_sensitive":false,"created_at":"2015-07-15T17:21:55.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"EFCNIwecare","id":"878785026"}],"annotations":{},"hashtags":{},"urls":[{"start":85,"end":107,"url":"http://t.co/8ZkykNMJy3","expanded_url":"http://ic2030.org/","display_url":"ic2030.org"}]},"conversation_id":"621368940908933123","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621328800287211520"}],"lang":"en","text":"RT @EFCNIwecare: Reimagining Global Health: 30 high-impact innovations to save lives http://t.co/8ZkykNMJy3","id":"621368940908933123","possibly_sensitive":false,"created_at":"2015-07-15T17:21:14.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"annotations":{},"hashtags":[{"start":34,"end":44,"tag":"pregnancy"}],"urls":[{"start":114,"end":136,"url":"http://t.co/XngiCnkqNC","expanded_url":"http://ow.ly/G0y8w","display_url":"ow.ly/G0y8w"}]},"conversation_id":"621368894268305408","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621332234432303104"}],"lang":"en","text":"RT @FDAWomen: Medicine use during #pregnancy has doubled in last 30 yrs. Learn about registries for your patients http://t.co/XngiCnkqNC","id":"621368894268305408","possibly_sensitive":false,"created_at":"2015-07-15T17:21:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{},"hashtags":[{"start":27,"end":36,"tag":"Epilepsy"}],"urls":[{"start":109,"end":131,"url":"http://t.co/Zz6zcTjFrN","expanded_url":"http://www.ilae.org/Visitors/Publications/ED-EditorsChoice.cfm","display_url":"ilae.org/Visitors/Publi…"}]},"conversation_id":"621368868922105856","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621335511676882945"}],"lang":"en","text":"RT @IlaeWeb: Management of #Epilepsy in resource-limited settings - Editor's Choice from Epileptic Disorders http://t.co/Zz6zcTjFrN","id":"621368868922105856","possibly_sensitive":false,"created_at":"2015-07-15T17:20:57.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":58,"end":78,"probability":0.3406,"type":"Other","normalized_text":"Synthetic Biology III"}],"hashtags":[{"start":15,"end":34,"tag":"PublicConsultation"},{"start":101,"end":108,"tag":"synbio"}],"urls":[{"start":109,"end":131,"url":"http://t.co/HJyXVv9BcS","expanded_url":"http://europa.eu/!pb47yR","display_url":"europa.eu/!pb47yR"}]},"conversation_id":"621368854476910592","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621335710071717888"}],"lang":"en","text":"RT @EU_Health: #PublicConsultation Preliminary opinion on Synthetic Biology III: Research priorities #synbio http://t.co/HJyXVv9BcS","id":"621368854476910592","possibly_sensitive":false,"created_at":"2015-07-15T17:20:54.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"annotations":[{"start":28,"end":40,"probability":0.8624,"type":"Place","normalized_text":"Latin America"},{"start":100,"end":103,"probability":0.979,"type":"Place","normalized_text":"Peru"}],"hashtags":[{"start":73,"end":87,"tag":"ClincalTrials"}],"urls":[{"start":105,"end":127,"url":"http://t.co/9C15AXPGRe","expanded_url":"http://ow.ly/PD3vi","display_url":"ow.ly/PD3vi"}]},"conversation_id":"621368817063698434","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621339772313837568"}],"lang":"en","text":"RT @myESMO: ESMO members in Latin America: apply to join the SLACOM-ESMO #ClincalTrials workshop in Peru http://t.co/9C15AXPGRe http://t.co…","id":"621368817063698434","possibly_sensitive":false,"created_at":"2015-07-15T17:20:45.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":101,"end":110,"username":"IMI_EPAD","id":"2979700941"}],"annotations":[{"start":122,"end":134,"probability":0.9943,"type":"Person","normalized_text":"Craig Ritchie"}],"hashtags":[{"start":39,"end":50,"tag":"prevention"},{"start":54,"end":63,"tag":"dementia"}],"urls":{}},"conversation_id":"621368757949173760","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621344467950391296"}],"lang":"en","text":"RT @JeanGeorgesAE: Got questions about #prevention of #dementia? Check out this great interview with @IMI_EPAD researcher Craig Ritchie htt…","id":"621368757949173760","possibly_sensitive":false,"created_at":"2015-07-15T17:20:31.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":[{"start":21,"end":22,"probability":0.5747,"type":"Organization","normalized_text":"EU"}],"hashtags":[{"start":95,"end":99,"tag":"SAM"}],"urls":[{"start":117,"end":139,"url":"http://t.co/89nBWDROin","expanded_url":"http://ec.europa.eu/research/sam/index.cfm?pg=home","display_url":"ec.europa.eu/research/sam/i…"}]},"conversation_id":"621368719894315008","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621346493882994689"}],"lang":"en","text":"RT @innovationunion: EU research and scientific policy organisations to propose candidates for #SAM High-Level Group http://t.co/89nBWDROin…","id":"621368719894315008","possibly_sensitive":false,"created_at":"2015-07-15T17:20:21.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{},"hashtags":{},"urls":[{"start":107,"end":130,"url":"https://t.co/JqkWVfc4hx","expanded_url":"https://www.niceconference.org.uk/payment/select-your-ticket","display_url":"niceconference.org.uk/payment/select…"}]},"conversation_id":"621368643880910849","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621347345091923968"}],"lang":"en","text":"RT @NICEcomms: Early bird booking for the NICE Annual Conference closes this Friday, get your tickets here https://t.co/JqkWVfc4hx","id":"621368643880910849","possibly_sensitive":false,"created_at":"2015-07-15T17:20:03.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"annotations":{},"hashtags":[{"start":12,"end":18,"tag":"NMIBC"},{"start":85,"end":99,"tag":"eauguidelines"}],"urls":[{"start":100,"end":122,"url":"http://t.co/7C64lKKosh","expanded_url":"http://bit.ly/1JRel8l","display_url":"bit.ly/1JRel8l"}]},"conversation_id":"621368551253876737","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"621367384411017217"}],"lang":"en","text":"RT @Uroweb: #NMIBC a second-look TURBT is advocated in every T1G3/high grade disease #eauguidelines http://t.co/7C64lKKosh","id":"621368551253876737","possibly_sensitive":false,"created_at":"2015-07-15T17:19:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":35,"end":48,"tag":"consultation"},{"start":70,"end":79,"tag":"guidance"}],"urls":[{"start":108,"end":130,"url":"http://t.co/85msQ4AxCx","expanded_url":"http://bit.ly/1DgtlYg","display_url":"bit.ly/1DgtlYg"}]},"conversation_id":"621368481217409024","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Improving bioequivalence studies - #consultation on batch of specific #guidance for four active substances: http://t.co/85msQ4AxCx","id":"621368481217409024","possibly_sensitive":false,"created_at":"2015-07-15T17:19:25.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":50,"end":60,"tag":"guideline"},{"start":64,"end":72,"tag":"quality"}],"urls":[{"start":110,"end":132,"url":"http://t.co/0znzATYPWt","expanded_url":"http://bit.ly/1HrH84z","display_url":"bit.ly/1HrH84z"}]},"conversation_id":"621368411378085888","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation ending on paper on development of a #guideline on #quality and equivalence of topical products: http://t.co/0znzATYPWt","id":"621368411378085888","possibly_sensitive":false,"created_at":"2015-07-15T17:19:08.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":{},"urls":[{"start":56,"end":78,"url":"http://t.co/EBD0m9zeb4","expanded_url":"http://bit.ly/1Dh6xYp","display_url":"bit.ly/1Dh6xYp"}]},"conversation_id":"621351329336832001","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Public register of parallel distribution now available: http://t.co/EBD0m9zeb4","id":"621351329336832001","possibly_sensitive":false,"created_at":"2015-07-15T16:11:15.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":54,"tag":"paediatric"}],"urls":[{"start":81,"end":103,"url":"http://t.co/zVLAhQZgS3","expanded_url":"http://bit.ly/1SmKFC4","display_url":"bit.ly/1SmKFC4"}]},"conversation_id":"621280262148726784","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the #agenda of this week's #paediatric committee (PDCO) meeting: http://t.co/zVLAhQZgS3","id":"621280262148726784","possibly_sensitive":false,"created_at":"2015-07-15T11:28:51.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":35,"end":48,"tag":"consultation"},{"start":74,"end":83,"tag":"guidance"}],"urls":[{"start":112,"end":134,"url":"http://t.co/85msQ4AxCx","expanded_url":"http://bit.ly/1DgtlYg","display_url":"bit.ly/1DgtlYg"}]},"conversation_id":"621274682105417728","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"Improving bioequivalence studies - #consultation on new batch of specific #guidance for four active substances: http://t.co/85msQ4AxCx","id":"621274682105417728","possibly_sensitive":false,"created_at":"2015-07-15T11:06:41.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":51,"end":61,"tag":"guideline"},{"start":65,"end":73,"tag":"quality"}],"urls":[{"start":111,"end":133,"url":"http://t.co/0znzATYPWt","expanded_url":"http://bit.ly/1HrH84z","display_url":"bit.ly/1HrH84z"}]},"conversation_id":"621239864122560512","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"#Consultation closing on paper on development of a #guideline on #quality and equivalence of topical products: http://t.co/0znzATYPWt","id":"621239864122560512","possibly_sensitive":false,"created_at":"2015-07-15T08:48:20.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":58,"end":69,"tag":"veterinary"}],"urls":[{"start":88,"end":110,"url":"http://t.co/J9ohyAEUw2","expanded_url":"http://bit.ly/1gzfpUB","display_url":"bit.ly/1gzfpUB"}]},"conversation_id":"621238086782058496","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've published the #minutes from the June meeting of our #veterinary committee (CVMP): http://t.co/J9ohyAEUw2","id":"621238086782058496","possibly_sensitive":false,"created_at":"2015-07-15T08:41:16.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":40,"end":47,"username":"US_FDA","id":"208120290"},{"start":52,"end":66,"username":"EU_Commission","id":"157981564"}],"annotations":{},"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/vVj1FaTozl","expanded_url":"http://bit.ly/1M8cqiP","display_url":"bit.ly/1M8cqiP"}]},"conversation_id":"621238037322854400","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":4,"quote_count":0},"referenced_tweets":{},"lang":"en","text":"We've reinforced our collaboration with @US_FDA and @EU_Commission to advance medicine development and evaluation: http://t.co/vVj1FaTozl","id":"621238037322854400","possibly_sensitive":false,"created_at":"2015-07-15T08:41:04.000Z","author_id":"116716199","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{},"hashtags":[{"start":32,"end":50,"tag":"WorldHepatitisDay"}],"urls":[{"start":86,"end":108,"url":"http://t.co/I0DoY39rCz","expanded_url":"http://goo.gl/51zrks","display_url":"goo.gl/51zrks"}]},"conversation_id":"620981994986582016","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"620981275969630208"}],"lang":"en","text":"RT @Hep_Alliance: 2 weeks until #WorldHepatitisDay! Find out how you can get involved http://t.co/I0DoY39rCz","id":"620981994986582016","possibly_sensitive":false,"created_at":"2015-07-14T15:43:39.000Z","author_id":"116716199","attachments":{"media_keys":{}}}]
